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1.1 Flavin and its biologically Active Derivatives 
Enzymes are versatile biocatalysts present in every organism in all domains of life. Understanding 
their mode of actions at an atomic level is of primary interest since enzymes are both potential drug 
targets for the pharmaceutical industry and potential catalysts under physiological conditions for the 
chemical industry. A subclass are flavoenzymes, enzymes that bind derivatives of riboflavin (vitamin 
B2), and of which a plethora has already been identified and characterized (Palfey and Fagan 2010). 
Flavoenzymes also harbor the aforementioned versatility with respect to the ability of catalyzing 
chemical reactions. Hence, they are involved in a multitude of biological processes including energy 
production, light-induced signal transduction and DNA repair to name only a few (Conrad, Manahan, 
and Crane 2014; Palfey and Fagan 2010). The probably most fascinating feature of flavoenzymes is 
their aptitude to act as carriers for reducing equivalents thereby transferring electrons from a donor 
reactant to an acceptor reactant. Thus, flavoenzymes play a pivotal role in metabolism acting as key 
players in the respiratory chain. 
Flavins consist of a tricyclic isoalloxazine moiety attached to a ribityl chain at the N10 atom (Figure 
1.1). The most prominent enzyme bound flavin derivatives are flavin mononucleotide (FMN) and 
flavin adenine dinucleotide (FAD). FMN results from phosphorylation at the 5’-OH atom of the ribityl 
chain and FAD is the product from an esterification of AMP and FMN. Generally, flavins and 
enzymes form noncovalent complexes characterized by small binding constants making a covalent 
attachment of the cofactor to the enzyme almost unnecessary. The tight binding is achieved by 
interactions of the protein with the ribityl chain and the 5’-phosphate group, and, in case of FAD, by 
interactions of a secondary structure element (Rossmann fold) with its ADP portion (Hanukoglu 
2015). However, covalent attachment occasionally occurs to form the holoprotein via the 8-ɑ (methyl) 
or the C6 atom of the dimethylbenzene moiety (Palfey and Fagan 2010) or at both sides at once 
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1.2 Reactivity of Flavins 
The reactive part of flavins is the heterocyclic isoalloxazine ring system and three stable oxidation 
states can be assigned to the cofactor: fully oxidized, semiquinone (1-electron reduced), and 
hydroquinone (2-electron reduced) (Figure 1.2). The ring system is planar in solution and also in most 
protein structures, but it was also demonstrated that the flavin redox potential can be tuned by 
conformational effects leading to deviations from this planarity. Especially bending of the ring system 
along the N5-N10 axis was demonstrated to influence the ability to accept one or two electrons 
(Hasford, Kemnitzer, and Rizzo 1997; Lyubimov et al. 2007; Walsh and Miller 2003) making the 
electron-deficient isoalloxazine a target for nucleophilic attack at N5, C4a, and C6 (Palfey and Fagan 
2010). Oxidized flavins harbor a shiny yellow color and are highly polarizable whereas the resulting 
reactivity is mainly influenced by interactions with the respective enzyme. 
The single-electron reduced state is called semiquinone which is thermodynamically unstable in 
aqueous solutions (Gibson, Massey, and Atherton 1962). However, some proteins provide 
surroundings drastically increasing the lifetime of the semiquinone whereas others completely prevent 
its formation (Beel et al. 2012; Massey and Palmer 1966). Flavin semiquinones either exist as neutral 
(blue) radicals or as anionic (red) radicals in which the free electron is delocalized over the 
isoalloxazine (Ehrenberg, Müller, and Hemmerich 1967; Müller et al. 1970). EPR spectroscopy 
demonstrated that the highest spin density can be found at C4a for the neutral radical and at N5 for the 
anionic radical. During redox reactions they can act as single-electron donors/acceptors or also form 
radical pairs (Palfey and Fagan 2010). 
The flavin hydroquinone is pale yellow. It is the two-electron reduced state which is mostly planar and 
















Flavin adenine dinucleotide (FAD)




small-molecule structures and some protein structures, but to a much more pronounced extent (>30 °) 
(Palfey and Fagan 2010). Bending is most likely determined by protonation of N1 since the protonated 
hydroquinone was shown to adopt a butterfly conformation whereas the anionic hydroquinone is 
planar (Rizzo 2001; Rodríguez-Otero et al. 2002; Zheng and Ornstein 1996). In contrast to 
semiquinones, hydroquinones can react as single-electron donors, as hydride donors, or as 





1.3 Biological Functions of Lipoamide Dehydrogenases 
Lipoamide dehydrogenases (EC 1.8.1.4) belong to the flavoenzymes family of pyridine nucleotide-
disulfide oxidoreductases which share several structural and mechanistic properties (Palfey and Fagan 
2010). This family further includes: glutathione reductase (EC 1.6.4.2), mycothione reductase (EC 
1.8.1.15), trypanothione reductase (EC 1.8.1.12), and mercuric reductase (EC 1.16.1.1), all pivotal for 
maintaining metabolic and cellular functions. Lipoamide dehydrogenases are part of ketoacid 
dehydrogenase multienzyme complexes and the glycine cleavage system and catalyze the reoxidation 
of lipoamide cofactors with concomitant transfer of reducing equivalents to NAD
+
 thereby generating 
NADH (Figure 1.3) (Perham 2000; Reed 1974, 2001). 
  
Figure 1.2 Chemical states of flavin. 
The absorption maxima are approximate values and may slightly differ due to the 
respective enzyme surrounding. Wavelengths below 300 nm were not taken into 
account. 
1
(Ghisla et al. 1974) 
2
(Hitomi et al. 1997; Massey and Palmer 1966) 
3
(Choong and Massey 1980; Talfournier et al. 2001b). 
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As part of the pyruvate dehydrogenase multienzyme complex (PDHc) lipoamide dehydrogenases are 
directly involved in energy metabolism by linking glycolysis and citric acid cycle. PDHc is present in 
a multitude of organisms, namely in respiratory eubacteria and the mitochondria of eukaryotes (Bates 
et al. 1977; Patel and Roche 1990; Perham 2000). It catalyzes the irreversible conversion of pyruvate, 
co-enzyme A and NAD
+
 into CO2, acetyl-CoA and NADH. Acetyl-CoA then serves as a precursor for 
the citric acid cycle and the biosynthesis of fatty acids and steroids, while NADH eventually feeds 
reducing equivalents into the respiratory chain for oxidative phosphorylation (ATP synthesis) (Patel 
and Roche 1990). PDHc consists of multiple copies of three major enzyme components: a thiamine 
diphosphate-dependent pyruvate dehydrogenase (E1 (EC 1.2.4.1)), a dihydrolipoamide transacetylase 
(E2 (EC 2.3.1.12)), which carries lipoyl groups covalently linked to the ε-amino group of lysine 
residues (N6-(lipoyl)-lysine, lipoamide cofactor), and the aforementioned lipoamide dehydrogenase 
(E3) (Korotchkina and Patel 2001; Patel and Korotchkina 2001). An important and outstanding ability 
of PDHc is the mechanism of covalent substrate channeling between the different components. The 
N6-(lipoyl)-lysine conjugate is structurally highly flexible. A 14 Å “swinging arm” permits active site 
coupling between the E1, E2 and E3 components by movement of the lipoyl moiety itself and by 
additional movement of the whole protein domain. This domain (Lip-domain) carries the lipoamide 
cofactor thus providing an appendage that is capable to bridge the physical gaps between the active 
centers on the different components (Perham and Reche 1998; Perham 2000). 
In all PDHc, the reaction cycle is catalyzed by those enzymes and can be subdivided into several steps. 
Initially, E1 binds pyruvate and catalyzes its irreversible decarboxylation yielding 2-hydroxyethyl- 
thiamine diphosphate. Afterwards, E1 transfers the C2-fragment to the oxidized dithiolane ring of the 
lipoamide cofactor of E2. This reductive acetylation results in the formation of a high-energy thioester 
linkage between a sulfur atom of the reduced lipoamide dithiolane moiety and the acetyl fragment 
derived from pyruvate (Patel and Roche 1990). In the following, E2 itself catalyzes the acyl group 
transfer from reduced S-acetyldihydrolipoamide to Coenzyme A leading to the formation of acetyl-
CoA (Akiyama and Hammes 1981). The reduced lipoamide cofactor must be oxidized in order to 
permit subsequent cycles of catalysis. This reaction step is catalyzed by lipoamide dehydrogenases 
under transient reduction of an intrinsic disulfide bond and further transfer of reducing equivalents to 
Figure 1.3 Regeneration of lipoamide cofactors. 
Lipoamide dehydrogenases catalyze the NAD
+
-dependent oxidation of the dihydrolipoyl cofactors that 
are covalently linked to the acyltransferase components of multienzyme complexes. 
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the enzyme-bound flavin (Argyrou, Blanchard, and Palfey 2002). Generation of NADH by E3 finally 
completes the reaction cycle. 
1.4 Three Dimensional Structure of E. coli Lipoamide Dehydrogenase 
Several crystal structures of lipoamide dehydrogenases from various species have been solved over the 
years (Brautigam et al. 2005; Mattevi et al. 1993; Mattevi, Schierbeek, and Hol 1991); that of the 
E. coli enzyme recently (Chandrasekhar et al. 2013). The tertiary structures reflect very high similarity 
and only minor structural differences can be observed in surface exposed loop regions (Chandrasekhar 
et al. 2013). In addition, lipoamide dehydrogenase is structurally homologous to glutathione reductase, 
a further member of the flavoenzyme disulfide reductases. All described lipoamide dehydrogenases 
are homo-dimeric enzymes with two active sites formed at the dimer interface (Figure 1.4A). Each 
monomer thereby consists of four domains. A large N-terminal FAD-binding domain (residues 1–149; 
referring to E. coli numbering) which contacts the three remaining domains: the NAD-binding domain 
(150–282), the central domain (283–350), and the interface domain (351–474) (Figure 1.4B). The 
dimeric form of E. coli lipoamide dehydrogenase is based on its active site architectures involving 
residues of both monomers, respectively. The redox active disulfide bridge Cys45 to Cys50 which 
directly interacts with lipoamide cofactors is located at the dimer interface on the si face of the tightly 
but non-covalently bound flavin (Figure 1.4C). Above this electron transfer site, at the re face of the 
flavin, the NAD
+
/NADH binding site is housed. The highly conserved catalytic diad (His445 and 
Glu450) from the adjacent monomer involved in acid/base chemistry completes the active site (Benen, 
Van Berkel, Dieteren, et al. 1992; Kim and Patel 1992b). 
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Figure 1.4 Crystal structure of EcE3. 
(A) Structure of the biologically functional dimer of EcE3 (Chandrasekhar et al. 2013) in cartoon 
representation with the bound flavin cofactor (ball representation). Individual monomers are shown in 
blue and red. (B) Domain structure of EcE3 in cartoon representation: N-terminal FAD-binding (red), 
NAD-binding domain (green), central domain (blue) and C-terminal interface domain (purple). (C) 
Interactions of the FAD molecule with E3. The enzymatic disulfide (ball representation) is located on 
the si face of the flavin. The nearby histidine is involved in acid/base chemistry. Interactions are 
























1.5 Catalytic Mechanism of E. coli Lipoamide Dehydrogenase 
Generally, the catalytic cycles of flavoenzymes can be divided into reductive and oxidative half-
reactions (Figure 1.5). In the reductive half-reaction, the oxidized flavoenzyme is reduced by the first 
substrate, yielding in a reduced flavoenzyme. In the oxidative half-reaction, a second substrate 
oxidizes the reduced enzyme (Palfey and Fagan 2010). This usually results in ping-pong kinetic 
mechanisms since often the product of the reductive half-reaction dissociates prior to the beginning of 





The ping-pong kinetic mechanism of EcE3 involves two half-reactions, each completely reversible 
and has been studied in detail (Argyrou et al. 2003, 2002; Sahlman and Williams 1989; Wilkinson and 
Williams 1979, 1981). In the reductive half-reaction, the substrate dihydrolipoamide binds to the 
oxidized state of EcE3 (Eox), and Cys45 forms a mixed disulfide with the substrate. Transfer of 
electrons yield to thiolate formation of Cys50 and thus the two-electron reduced state (EH2). This 
reaction is general-acid-base catalyzed by an essential and conserved catalytic diad located at the C-
terminus of the adjacent monomer of the homo-dimeric enzyme (Benen, Van Berkel, Dieteren, et al. 
1992; Kim and Patel 1992b). Release of lipoamide completes the reductive half-reaction (Figure 1.6). 
In the oxidative half-reaction, NAD
+
 binds to the two-electron reduced state of the enzyme (EH2). This 
induces an internal electron transfer from the redox active disulfide towards the flavin cofactor 
yielding in a transiently formed [NAD
+
-FADH2] intermediate. The internal electron transfer is thought 





Figure 1.5 Typical catalytic cycle of flavoenzymes. 
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“FAD-C4a-cysteinyl adduct” (Miller et al. 1990; Thorpe and Williams 1976a, 1976b). The flavin is 
immediately reoxidized by NAD
+
 generating NADH and the oxidized form of the enzyme (Eox). 





During catalysis, the enzyme cycles between the oxidized and two-electron reduced states. However, 
the E. coli enzyme is easily overreduced by a small molar excess of NADH to the four-electron 
reduced state (EH4) (Williams 1965). In this catalytically inactive dead-end complex, the redox-active 
disulfide and the flavin are reduced (Figure 1.6). NAD
+
 has an activating effect because the pyridine 
nucleotide can oxidize the dead-end complex, increasing the amount of catalytic active EH2 
(Matthews, Ballou, and Williams 1979). The severe susceptibility to overreduction by NADH, and 
thus NADH inhibition, is based on the redox potentials of the EH2 and EH4 states. At first, comparison 
of the reduction potentials for the two redox couples of lipoamide dehydrogenases from E. coli (-
264 and -317 mV, respectively) (Wilkinson and Williams 1979), pig heart (-280 and -346 mV) 
(Matthews and Williams 1976), and M. tuberculosis (-309 and -382 mV) (Argyrou et al. 2002) 
Figure 1.6 Simplified, general reaction scheme of lipoamide dehydrogenases. 
E3-catalyzed oxidation of reduced lipoamide cofactors and subsequent generation of NADH: R = 
ribityl-ADP, Eox oxidized, EH2 = two-electron reduced and EH4 = four-electron reduced state of the 
enzyme. Reaction intermediates are indicated. For explanation see text. 
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demonstrate that the E. coli enzyme has the most positive Eox/EH2 and EH2/ EH4 redox couples. 
Secondly, the redox potentials of the EH2 and EH4 pairs are closer than in the enzymes from the 
aforementioned organisms. Consequently, due to the closer potentials, the EH2 state of the E. coli 
enzyme exists as a fast equilibrating mixture of three species: the oxidized flavin–dithiol species 
(Figure 1.7I), the oxidized flavin–thiolate charge transfer (II), and the reduced flavin-disulfide (III), all 
harboring different spectroscopic properties (Wilkinson and Williams 1979). The physiological 




1.6 The Physiological Importance of E. coli Lipoamide Dehydrogenase 
As a facultative heterotroph Escherichia coli is able to grow under aerobic and anaerobic conditions. 
While growing aerobically glucose is metabolized using glycolysis, PDH complex and citric acid 
cycle. The NADH generated during these reactions is oxidized by the final electron acceptor oxygen. 
In contrast, under anaerobic growth glycolytic intermediates serve as electron acceptors to maintain 
the redox balance. However, this leads to an increased NADH/NAD
+
 ratio compared to aerobic 
growth (Graef et al. 1999; Snoep et al. 1993). In both growth modes, pyruvate is the key intermediate 
in the catabolism in E. coli. Its subsequent conversion by either pyruvate formate lyase (PFL) or the 
PDH complex can be claimed as the major switch between mixed acid fermentation and the citric acid 
cycle and subsequent respiration. Though PDH activity is obligate for aerobic growth of the 
bacterium, its activity was also detected in cell extracts grown under anaerobic conditions albeit at a 
very low or nearly undetectable amount (Graef et al. 1999; Smith and Neidhardt 1983; Snoep et al. 
1993). 
The regulation of E. coli PDH activity is rather complex, but the E1 and the E3 components have been 
identified as main targets for regulation several decades ago (Hansen and Henning 1966). Whereas the 
mammalian E1 is regulated by phosphorylation (Cooper, Randle, and Denton 1974; Hucho et al. 1972; 
Figure 1.7 Distribution of 
species at the EH2 level in EcE3. 
Species II has a characteristic 
red color derived from the 
charge transfer interaction 
between Cys50-thiolate and 
FAD - adapted from (Wilkinson 
and Williams 1979). 
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Seifert et al. 2007), the availability of metabolic intermediates regulate the E. coli E1 activity. On the 
one hand acetyl-CoA inhibits E1 (Hansen and Henning 1966) on the other hand glycolytic 
intermediates enhance the PDH activity presumably by accelerating the carbon flow towards the citric 
acid cycle (Shen et al. 1968). As the most efficient activator fructose-1,6-bisphosphate was identified, 
however PDH activity is also enhanced by fructose-6-P, glycerolaldehyde-3-P, phosphoenolpyruvate, 
dihydroxyacetone-P and glucose-6-P. 
EcE3 is regulated by the ratio of reduction equivalents rather than by glycolytic intermediates. As 
described by WILKINSON & WILLIAMS EcE3 suffers from severe product inhibition by NADH due to 
reduction of the catalytically active two-electron reduced enzyme intermediate (EH2) to the inactive 
four-electron reduced form (EH4) while NAD
+
 is able to oxidize this dead-end complex, increasing the 
amount of EH2 (Wilkinson and Williams 1981). This inhibitory effect of NADH not only holds true 
for the isolated EcE3 but also for the entire E. coli PDH (Bisswanger 1981; Hansen and Henning 
1966; Wilkinson and Williams 1981). Thus, PDH activity is also modulated by the NAD
+
/NADH pool 
affecting the redox state of EcE3. 
As aforementioned, anaerobically growing E. coli metabolizes pyruvate with the help of the pyruvate-
formate lyase complex (FHL) to acetyl-CoA whereas the reducing equivalents are temporary stored as 
formate (Clark 1989). Succinate is only a minor fermentation product (Fraenkel 1996) and lactate is 
mainly formed under strong acidic growth conditions (Clark 1989). Formate is finally removed by 
disproportionation to H2 and CO2 without influencing the NADH/NAD
+
 ratio (Rosentel et al. 1995). 
The remaining NADH derived from preceding glycolytic steps is then oxidized using acetyl-CoA as 
electron acceptor with the penultimate production of ethanol by aldehyde-alcohol dehydrogenase 
(Clark 1989). However, the reduction of acetyl-CoA to ethanol requires two equivalents of NADH and 
therefore the degradation of the remaining acetyl-CoA molecule to acetate via acetyl phosphate by 
phosphotransacetylase and acetate kinase is mandatory. Hence, the fermentation profile of E. coli 
harbors equimolar amounts of ethanol and acetate (Figure 1.8A). 
E. coli strain AH242 lacks pyruvate-formate lyase (pflB) and fermentative lactate dehydrogenase 
(ldhA) and is therefore defective for anaerobic growth (Clark 1989; Kim, Ingram, and Shanmugam 
2007). Kim et al. isolated and described an E. coli mutant (SE2378) derived of strain AH242 that 
produced ethanol as the main fermentation product (Kim et al. 2007). The mutation was identified as a 
single change in the EcE3 amino acid sequence (Glu354Lys354). This mutation led to a reduced 
sensitivity of EcE3 - and thus the PDH complex - towards NADH inhibition leading to PDH activity 
under anaerobic growth conditions which concomitantly changed the fermentation profile of mutant 
SE2378 (Figure 1.8B) (Kim, Ingram, and Shanmugam 2008). With the PDH being active under 
anaerobic conditions mutant SE2378 produces four NADH molecules during the degradation of one 
molecule glucose to two acetyl-CoA molecules. In order to maintain the redox balance these four 
NADH molecules are then reoxidized by reduction of the two acetyl-CoA molecules to two ethanol 
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molecules by the alcohol/acetaldehyde dehydrogenase (adhE). This study further underpinned the 
physiological importance of EcE3 and showed that even a single amino acid mutation has the potential 
to change a bacterium’s growth behavior. 
 
 
Figure 1.8 Comparison of mixed acid pathway for glucose fermentation. 
(A) pathway in native E. coli and (B) in the ldhA and pflB deficient E. coli strain SE2378. 
G6P, glucose 6-phosphate; PEP, phosphoenolpyruvate; ldhA, lactate dehydrogenase; pflB, pyruvate 
formate lyase; FHL, formate hydrogenlyase complex; pta, phosphotransacetylase; adhE, aldehyde-
alcohol dehydrogenase; ackA, acetate kinase; PDH, pyruvate dehydrogenase complex. 
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1.7 The Relevance of Covalent Flavin-C4a-cysteinyl Adducts 
As described in the previous chapter (1.5) the FAD-C4a-cysteinyl adduct is a central intermediate 
during catalysis of E. coli lipoamide dehydrogenase. It is also found in other flavoenzymes belonging 
to the family of pyridine nucleotide-disulfide oxidoreductases, like glutathione reductase and mercuric 
reductase (Miller et al. 1990; Thorpe and Williams 1981). In these metabolic enzymes, the adduct 
ensures internal electron transfer from redox active disulfides to the flavin cofactor and vice versa. 
However, the function of FAD-C4a-cysteinyl adducts is not limited to electron transfer reactions, 
which involves thiol/disulfide chemistry. The FAD-C4a-cysteinyl adduct is also a central reaction 
intermediate in a class of flavoprotein light sensors: the light-oxygen-voltage (LOV) domains. These 
photosensor proteins can be found in plants, fungi, archaea and bacteria and are a subset of the PER-
ARNT-SIM domain superfamily containing a noncovalently bound flavin cofactor (FMN or FAD) 
(Conrad et al. 2014). Using diverse output and effector domains, the photochemistry of LOV domains 
acts as signal transducer helping to mediate a variety of physiological functions like phototropism, 
chloroplast and leaf movements, and stomatal opening (Möglich et al. 2010). Blue light exposure 
induces the formation of a covalent FAD-C4a-cysteinyl adduct between the flavin and a conserved 
cysteine residue located at the active site (Figure 1.9). However, the structural rearrangements are not 
limited to the adduct site. Adduct formation requires the flavin N5 becoming protonated which causes 
a flipping of a conserved glutamine residue interacting with N5 (Figure 1.9B). This flipping was 
identified as a major event during signal transmission from the LOV domain to the output and effector 
domains (Raffelberg et al. 2011).  
The LOV domain photocycle has been investigated thoroughly, but several key details are 
controversially discussed (Kennis and Groot 2007; Losi and Gärtner 2011; Zoltowski and Gardner 
2011). In the dark state, the flavin is oxidized harboring an absorption maximum at ~447 nm and is not 
attached to the protein backbone. The blue light induced covalent bond formation between flavin and 
the conserved cysteine leads to a hypsochromic shift resulting in a new absorption maximum at ~390 
nm (Figure 1.9). The intermediate states prior to adduct formation are fast and comprise formation of 
an excited singlet state (S1) followed by an intersystem crossing yielding an excited triplet state 
(Alexandre et al. 2009; Pfeifer et al. 2009). The mechanism of the following adduct formation is a 
matter in controversy. On the one hand, the reaction is thought to proceed via an ionic intermediate, 
where a proton is transferred to flavin N5 before bond formation (Kennis and Groot 2007; Losi and 
Gärtner 2011, 2012; Zoltowski and Gardner 2011), on the other hand, further data suggest that the 
flavin cofactor is unprotonated in the excited triplet state immediately before reacting with the cysteine 
(Alexandre et al. 2009; Pfeifer et al. 2009). There is also some evidence for a neutral semiquinone 
intermediate between the triplet and the adduct state (Bauer et al. 2011) so that the identities of the 
intermediates prior to adduct formation are not quite clear. In addition, the proton source for N5 
protonation has not been ultimately identified (Conrad et al. 2014). 
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The major difference between FAD-C4a-cysteinyl adducts in LOV domain photoreceptor proteins and 
pyridine nucleotide-disulfide oxidoreductases is the lifetime of the adduct. In the oxidoreductases the 
intermediate is only transiently formed making a direct observation tedious work (Miller et al. 1990; 
Thorpe and Williams 1976b). On the contrary, LOV domains provide a surrounding which keeps the 
covalent adduct stable for at least 500 ms, but the lifetime can even be expanded to hours (Conrad et 
al. 2014). The thermally driven recovery back to the dark state requires flavin N5 deprotonation, 
covalent bond breakage and protonation of the cysteine sulfur atom (Losi and Gärtner 2012). 
Generally, the rates of adduct decay depend on solvent access to the active site, the hydrogen bonding 
network around the flavin and its electronic environment (Conrad et al. 2014). However, it is 
suggested that the (de)protonation of N5 is the rate limiting step in the LOV photocycle (Kottke et al. 
















Figure 1.9 LOV domain photocycle and light-driven structural rearrangement. 
(A) Light excites the dark-state FMN to a singlet state (S1) followed by an intersystem crossing 
(ISC) to an excited triplet state (T*). T* stimulates reaction of the C4a position (red) with an 
active site Cys residue to form a covalent adduct. Protonation of N5 (blue) during adduct 
formation leads to reorientation of a conserved glutamine residue (adapted from (Conrad et al. 
2014). (B) Crystal structure of Adiantum LOV2 in dark (PDB: 1G28) and in lit state (PDB: 
1JNU). Light induces covalent bond formation between Cys966 and C4a and the concomitant 
switch of Gln1029 from a H-bond donor in dark state to an H-bond acceptor towards N5 in lit 
state. 
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1.8 Motivation 
Lipoamide dehydrogenases have been extensively studied over the last decades and thus a detailed 
kinetic and structural knowledge about the mode of action of these enzymes could be gained. 
However, central reactions steps still lack both spectroscopic and structural information. The goal of 
this project is therefore to provide these information using the enzyme of E. coli (EcE3). Major 
emphasis will thereby be devoted to the spectroscopic and structural detection of the covalent FAD-
C4a-cysteinyl adduct. The existence of this central intermediate has been predicted, but a direct 
evidence, especially in wild type enzymes, has not yet been given. Moreover, the reasons for its 
supposed transience are not fully understood (Argyrou et al. 2002). Structural data might help to 
explain the basis for the short-lived nature of the intermediate. 
Spectroscopic analysis of the wild type enzyme and active-site mutants with conventional and 
stopped-flow UV-Vis spectroscopy shall be used to detect the FAD-C4a-cysteinyl adduct. Both single 
wavelength or photodiode array setups may help to identify active site residues which are crucial for 
adduct formation and/or the reported transience of the intermediate. The Investigations will be carried 
out from the forward and the reverse direction of the reaction cycle. NADH is a commonly used 
substrate which allows the investigation of different enzyme species harboring distinct spectroscopic 
signatures (Argyrou et al. 2002; Matthews and Williams 1976). However, the usage of NADH only 
allows the tracking of the oxidative half-reaction. Therefore, it is aimed to isolate an entire lipoyl 
domain from the E2 component of EcPDHc which may serve as an in vivo substrate for EcE3 after 
reduction of its lipoamide cofactor. This would allow the tracking of the reductive half-reaction with 
the aforementioned methods and further allow investigations in the field of protein-protein 
interactions. 
Besides the characterization of the FAD-C4a-cysteinyl adduct a further intermediate state of the 
enzyme is of primary interest. The two-electron reduced state (EH2) of EcE3 is the catalytically active 
species prior to generation of NADH. Detailed spectroscopic studies on this species have been carried 
out, but the ultimate factors stabilizing the anionic form of the cysteine facing the flavin cofactor 
remain unclear (Hopkins and Williams 1995a; Wilkinson and Williams 1979). An illumination of the 
thiolate stabilization by means of structural information is therefore obligate to further expand the 
knowledge about the EH2 state. 
The three-dimensional structure of the lipoamide dehydrogenases enzyme revealed a striking 
similarity to the active site of LOV (light-oxygen-voltage) blue-light receptors (Chandrasekhar et al. 
2013; Conrad et al. 2014; Mattevi et al. 1991). A common feature of the oxidoreductases and the light-
sensing proteins is the formation of a covalent FAD-C4a-cysteinyl adduct during the respective 
reaction cycle (1.7). This study attempts the conversion of the metabolic EcE3 into a pseudo-LOV 
blue-light-sensing protein via structure-guided protein engineering which is capable of a light-driven 
MATERIAL AND METHODS 
31 
C4a-cysteinyl adduct formation. If successful, a novel system for the light-driven generation of 
reducing equivalents could be obtained. An investigation of the photochemical response of re-
engineered EcE3 variants using steady-state and time-resolved absorption spectroscopy. 
Further attention will be dedicated to the dimer interface of EcE3. It was demonstrated that the dimer 
interaction modulates the redox properties of the active site flavin cofactor in the A. vinelandii enzyme 
(Benen, Van Berkel, Veeger, et al. 1992). In addition, mutations in the same region reduced the 
sensitivity towards NADH inhibition of EcE3 and concomitantly affected the entire fermentation 
profile of E. coli (Kim et al. 2008). Hence, the role of the interface is also of interest and will be 
investigated with respect to its ability to act as determinate for the flavin redox potential. 
2 Material and Methods 
2.1 Material 
2.1.1 Fine chemicals 
Compound      Supplier 
Acetic acid      Carl Roth GmbH & Co KG, Karlsruhe 
Acrylamide      Carl Roth GmbH & Co KG, Karlsruhe 
Agar       AppliChem GmbH, Darmstadt 
Agarose      AppliChem GmbH, Darmstadt 
Aldrithiol (4,4’-dithiopyridine)    Sigma-Aldrich GmbH, Deisenhofen 
Ammonium sulfate     AppliChem GmbH, Darmstadt 
Ammonium peroxodisulfate     Carl Roth, Karlsruhe 
Calcium chloride     Carl Roth GmbH & Co KG, Karlsruhe 
Carbenicillin disodium salt    AppliChem, Darmstadt 
Coomassie Brillant blue G-250    AppliChem GmbH, Darmstadt 
Dithiothreitol (DTT)     AppliChem GmbH, Darmstadt 
Ethylenediaminotetraacetic acid (EDTA)  AppliChem GmbH, Darmstadt 
Ethanol       Carl Roth GmbH & Co KG, Karlsruhe 
FAD       AppliChem GmbH, Darmstadt 
FMN       AppliChem GmbH, Darmstadt 
D-Glucose      AppliChem GmbH, Darmstadt 
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Glycerol (99 %)     AppliChem GmbH, Darmstadt 
Glycine      Carl Roth GmbH & Co KG, Karlsruhe 
Hydrochloric acid (37%)    Carl Roth GmbH & Co KG, Karlsruhe 
Imidazole      AppliChem GmbH, Darmstadt 
Kanamycin sulfate     Carl Roth GmbH & Co KG, Karlsruhe 
Lipoamide Sigma-Aldrich GmbH, Deisenhofen 
Lipoic acid      Sigma-Aldrich GmbH, Deisenhofen 
Lumichrom      Sigma-Aldrich GmbH, Deisenhofen 
Magnesium chloride, hexahydrate   Carl Roth GmbH & Co KG, Karlsruhe 
Magnesium sulfate     Carl Roth GmbH & Co KG, Karlsruhe 
β-Mercaptoethanol     Carl Roth GmbH & Co KG, Karlsruhe 
NAD
+
 / NADH      AppliChem GmbH, Darmstadt 
Phenylmethylsulfonyl fluoride    AppliChem GmbH, Darmstadt 
Phosphoric acid (85 %)     Carl Roth GmbH & Co KG, Karlsruhe 
Potassium chloride     Carl Roth GmbH & Co KG, Karlsruhe 
Potassium dihydrogen phosphate   Carl Roth GmbH & Co KG, Karlsruhe 
Potassium hydroxide     AppliChem GmbH, Darmstadt 
Polyethylene glycol (PEG) 400    Fluka Chemie AG, Buchs, Switzerland 
Polyethylene glycol (PEG) 4000   Carl Roth GmbH & Co KG, Karlsruhe 
Riboflavin      Sigma-Aldrich GmbH, Deisenhofen 
Sodium chloride     AppliChem GmbH, Darmstadt 
N,N,N´,N´-Tetramethylethylendiamin    Carl Roth GmbH & Co KG, Karlsruhe 
Thiamine hydrochloride    AppliChem GmbH, Darmstadt 
Tris(2-carboxyethyl)phosphine hydrochloride   Sigma-Aldrich Chemie, Deisenhofen 
Tryptone      AppliChem GmbH, Darmstadt 




 System    Waters Corporation, Milford, USA 
Äkta Prime Plus     GE Healthcare, Munich 
Äkta Purifier      GE Healthcare, Munich 
Agilent 6540 UH Accurate-Mass-Q-TOF MS   Agilent Technologies, Böblingen 
Agilent 8453 UV-visible spectrophotometer  Agilent Technologies, Santa Clara, USA 
Autoclave      Zirbus, Bad Grund  
Balance Kern EW     Kern, Balingen-Frommern 
Balance Kern ABJ     Kern, Balingen-Frommern 
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Centrifuge Avanti J-20 XPIJA-20   Beckmann Coulter, Krefeld 
Centrifuge Avanti J-30 I    Beckmann Coulter, Krefeld 
Centrifuge Hettich Universal 320 R   Hettich, Tuttlingen 
Conducting meter FiveEasy    Mettler-Toledo, Giessen 
EPR 
Spectrometer: Lab-built X-Band spectrometer with: 
Microwave bridge ER 041 MR    Bruker, Rheinstetten 
Microwave controller ER 048 R   Bruker, Rheinstetten 
Magnet power supply ER 081 S    Bruker, Rheinstetten 
Field controller BH 15     Bruker, Rheinstetten 
Cavity resonator ER 4122 SHQ E   Bruker, Rheinstetten 
SR 810 lock-In detector     Stanford Research Systems, Sunnyvale, USA 
53181A frequency counter     Agilent Technologies, Santa Clara, USA 
ESR 910 cryostat     Oxford Instruments, East Grinstead, UK 
ITC503 temperature controller    Oxford Instruments, East Grinstead, UK 
Sample tubes: 3.0 mm/3.9 mm diameter quartz   Qsil, Ilmenau 
Frac-920 Fraction Collector    GE Healthcare, Munich 
Incubator Unitron     HT Infors, Bottmingen 
Incubator CrystalMotion    Rigaku, Kent, England  
iTC200 MicroCalorimeter    Microcal, Northampton, USA 
LCT Premier
TM
 ESI-TOF-MS    Waters Corporation, Milford, USA 
MALDI-TOF Reflex III    Bruker Daltonics, Bremen 
Carrier MTP 384 polished steel    Bruker Daltonics, Bremen 
Microfluidizer 110 S     Microfluidics, Newton, USA 
pH meter FiveEasy     Mettler-Toledo, Giessen 
Pipette robot Phoenix RE    Art Robbins Instruments, USA 
Rotor  JA-30.50 Ti     Beckmann Coulter, Krefeld 
Rotor JLA 8.1000     Beckmann Coulter, Krefeld 
SDS gel electrophoresis SE250    Hoefer, Holliston, USA 
UPLC eLambda 800 nm    Waters Corporation, Milford, USA 
X-ray detector mar345     Marresearch, Norderstedt 
X-ray diffractometer RU-H3R    Rigaku/MSC, Japan 
Spectrometers 
 Chirascan (CD)     Applied Photophysics, GB 
 Stopped-flow system SX.20 MV   Applied Photophysics Ltd., UK 
NanoDrop2000     Thermo Scientific, Schwerte 
 V-650 (UV/Vis)    JASCO, Gross-Umstadt 
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Stereomicroscope SZ 60    Olympus, Japan 
Thermocycler TProfessional    Biometra, Göttingen 
Vortex-Genie 2      Scientific Industries, New York, USA 
Water bath Isotemp 202    Fisher Scientific, Schwerte 
Commodities 
0.2 and 0.45 µm Filter      Sartorius AG, Göttingen 
Circular cover slides, 18 mm    Jena Bioscience, Jena 
Crystallization plates (24 well)    Costar Corning, Inc., USA 
UV- and CD-cuvettes     Hellma, Müllheim 
Spin-X
®
 UF concentrator     Corning, Corning, USA 
ZipTipC18 Pipette Tips     Millipore, Billerica, USA 
2.1.3 Chromatography Columns 
HiPrep™ 26/10 Desalting    GE Healthcare, Munich 
HisTrap™ Ni-NTA-Sepharose (25 ml)    GE Healthcare, Munich 
Superdex™ 200 XK 16/600     GE Healthcare, Munich 
2.1.4 Molecular Weight Marker 
Unstained Protein Molecular Weight Marker  Thermo Scientific, Schwerte 




 Extract II     Macherey-Nagel, Düren 
NucleoSpin
®
 Plasmid      Macherey-Nagel, Düren 
QuikChange site directed mutagenesis kit  Stratagene, USA 
2.1.6 Materials for Molecular Biology 
6X DNA Loading Dye     Thermo Scientific, Schwerte 
dNTPs (Mix 10 mM)      Thermo Scientific, Schwerte 
FastAP™ Thermosensitive Alkaline Phosphatase Thermo Scientific, Schwerte 
GeneRuler™ 1 kb DNA Ladder    Thermo Scientific, Schwerte 
HF-buffer      Thermo Scientific, Schwerte  
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Magnesium chloride (25 mM)    Thermo Scientific, Schwerte 
Phusion Polymerase      Thermo Scientific, Schwerte 
T4 DNA Ligase     Thermo Scientific, Schwerte 
T4 DNA Ligase Buffer      Thermo Scientific, Schwerte 
Taq Buffer (10-fold)     Thermo Scientific, Schwerte 
Taq Polymerase      Thermo Scientific, Schwerte 
2.1.7 Restriction Endonucleases 
NdeI       Thermo Scientific, Schwerte 
XhoI       Thermo Scientific, Schwerte 
DpnI       Thermo Scientific, Schwerte 
2.1.8 Bacterial Strains 
Strain    Genotype       Reference 
E. coli BL21 (DE3)  F
-




) gal dcm (DE3)   Invitrogen 
E. coli BL21 Star™ (DE3) F
-




) gal dcm rne131 (DE3)  Invitrogen 
E. coli DH5α™   F
-
 Φ80lacZΔM15 Δ(lacZYA-argF) U169  Invitrogen 









1 gyr96 relA1 
2.1.9 Vectors 
pET15b-EcE2      GENEART, Regensburg 
pET28a      Merck KGaA, Darmstadt  
pGS523      John R. Guest, University of Sheffield 
pET-SUMO      Invitrogen, Darmstadt 
2.1.10 Enzymes 
DNase I       AppliChem, Darmstadt 
Lysozyme       AppliChem, Darmstadt 
SUMO-Protease     provided by Dr. Stefan Lüdtke 
Thrombin      Sigma-Aldrich GmbH, Deisenhofen 
Trypsin       Promega, Mannheim 
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2.1.11 Crystallization Screens 
Ammonium sulfate     Qiagen, Hilden 
JCSG       Molecular Dimensions, Suffolk, UK 
JBScreen Nuc-Pro HTS     Jena Bioscience, Jena 
Morpheus screen     Fabrice Gorrec, Cambridge, UK 
Natrix HT      Hampton Research, Aliso Viejo, USA 
PGA-LM HT-96     Molecular Dimensions, Suffolk, UK 
ProPlex      Molecular Dimensions, Suffolk, UK 
2.1.12 Software 
CCP4 suite       Winn et al., 2011 
Chromas 1.45 McCarthy, C., Griffith University, 
Australia 
Crystallography & NMR System (CNS)  (Brunger 2007) 
ESPript 3.0       http://espript.ibcp.fr/ESPript/ESPript 
/index.php 
ExPasy, ProtParam      http://web.expasy.org/protparam/ 
FlexAnalysis      Bruker Daltonics, Bremen 
Gene runner V.3.05      Hastings Software, Inc. 
Origin-7       OriginLab Corporation, USA 
PeptideCutter      http://web.expasy.org/peptide_cutter/ 
Phenix suite       Adams et al., 2010 
PYMOL       Schrödinger, LLC 
Mass Hunter Qualitative Analysis software (B.06.00) Agilent Technologies, Böblingen, Germany 
MassLynx V4.1 SCN779    Waters Corporation, Milford, USA 
METLIN      https://metlin.scripps.edu/index.php 
MicroCal ITC-ORIGIN Analysis Software  Microcal, Northampton, USA  
MOLPROBITY      http://molprobity.biochem.duke.edu/ 
Multalin      Corpet 2010 
SigmaPlot Version 11.0     Systat Software, Inc. 
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2.2 Methods 
2.2.1 Molecular Biology 
The gene of EcE3 was amplified from pGS523 (Machado, Clark, and Guest 1992), kindly provided 
from Prof. John Guest (University of Sheffield), and cloned into the pET28a expression vector using 
the XhoI and NdeI restriction sites. This expression construct encodes for EcE3 with an N-terminal 
hexa-histidine tag followed by a thrombin cleavage site. The N-terminal tag extends EcE3 by 20 
amino acids, of which three will remain after thrombin cleavage. The amino acid sequences of all 
purified proteins are shown in the appendix (5.1). 
The EcLip3 gene encodes for amino acids 201 – 286 of the E. coli E2 component and thus represents 
the isolated innermost lipoyl domain. The EcLip3 gene was amplified from pET15b-EcE2 and cloned 
into the target vector pET-SUMO using the TA cloning
®
 strategy according to the Champion™ pET 
SUMO Protein Expression System manual. 
To introduce specific amino acid exchanges within the sequence of EcE3 site-directed mutagenesis 
was used. Variants were generated according to the QuikChange-Kit (Stratagene, USA) with 
oligonucleotides containing the mutated codons. Double variants were generated starting with a single 
mutated plasmid as template. All used template amplification and mutagenesis primer pairs are listed 
in Table 2.1. 
Table 2.1 List of used primer pairs (Synthesized by Sigma-Aldrich, Taufkirchen). 
Restriction sites are underlined, unspecific overhangs are uncapitalized, mutations sites are shown in 
bold face type. 
 
Template amplification primer pairs 






Mutagenesis primer pairs 
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2.2.1.1 Concentration Determination of DNA 
DNA concentrations were determined spectroscopically using a NanoDrop2000 by measuring the 
absorption at 260 nm. The following correlation was used to determine the concentrations: 1 A260 = 
50 μg/ml doubled stranded DNA. 
2.2.1.2 Agarose Gelelectrophoresis 
Agarose gelelectrophoresis was used for analysis of DNA fragments after PCR reactions. Samples 
were supplemented with DNA loading dye (6 x DNA loading dye: 30 % (v/v) glycerol, 0.25 % (w/v) 
bromophenol blue) and were separated using a horizontal electrophoresis. Gels typically contained 
1 % agarose and 1 x TAE buffer (40 mM Tris, 1 mM EDTA, 20 mM acetate, pH 8.5). For 
visualization the gel was transferred into a solution containing 2 μg/ml ethidium bromide and 
incubated for 5-10 min prior to detection under UV light in a gel documentation system. 
2.2.1.3 Polymerase Chain Reaction (PCR) 
PCR was used for both amplification of gene fragments and for site directed mutagenesis. A standard 
reaction of a total volume of 50 μl contained 10 μl 5x HF buffer, 1 μl dNTP mix (10 mM), 5-50 ng 
template DNA, 25 pmol sense and antisense primer, and 0.5 μl Phusion DNA Polymerase (2 U/μl). 
The PCR protocol included an initial denaturation step (step 1; 95 °C, 1 min), another denaturation 
step (step 2; 95°C, 30 s), a primer annealing step (step 3; 50-60 °C, 30 s), an elongation step (step 4; 
72 °C, 20 s per kb product), and an end elongation (step 5; 72 °C, 7 min). Steps 2-4 were repeated 25 
times. If site-directed mutagenesis PCR was carried out the mixture was supplemented with DpnI after 
the PCR to digest template DNA (see QuikChange site-directed mutagenesis kit). 
2.2.1.4 DNA Sequencing 
Correctness of was confirmed using two commercially available sequencing services from Seqlab-
Microsynth GmbH, Göttingen and GATC Biotech AG, Cologne. 
2.2.1.5 Plasmid Transformation 
Transfer of plasmid DNA into different E. coli strains was performed using the following standard 
protocols chemical-competent cells were prepared according to Inoue et al. (Inoue, Nojima, and 
Okayama 1990). Competent cells were stored at -80 °C. In a standard transformation, 1 μl of plasmid 
DNA was mixed with 50 μl of chemo-competent E. coli cells followed by an incubation step for 
20 min on ice. For DNA transformation the cells were heat-shocked for 45 s at 42 °C and subsequently 
cooled on ice for 2 min. Afterwards, 500 μl of SOC medium (2 % (w/v) tryptone, 0.5 % (w/v) yeast 
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extract, 0.05 % (w/v) NaCl, 2.5 mM KCl, 10 mM MgCl2, 2 % (w/v) glucose) was added and the cells 
were incubated for 45 min at 37 °C under shaking. Transformed cells were selected on LB-agar plates 
supplemented with the appropriate antibiotic. Final antibiotic concentrations in media were 50 μg/ml 
kanamycin, or 50 μg/ml carbenicillin. 
2.2.2 Protein Chemistry 
2.2.2.1 Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
All proteins were analyzed by SDS-PAGE based on a protocol of Laemmli and Weber (Laemmli 
1970). The stacking gel consisted of 5 % acrylamide, 125 mM Tris (pH 6.8) polymerized with 0.3 % 
w/v APS and 0.03 % TEMED, whereas the separating gel contained 12-15 % acrylamide, 375 mM 
Tris (pH 8.8) polymerized with 0.3 % APS and 0.3 % TEMED. Prior to loading protein samples were 
mixed with SDS loading buffer (4 % (w/v) glycerol, 80 mM SDS, 150 mM Tris, pH 6.8) and heated to 
95 °C for 5 min. Gels were usually run at 1 mA/cm
2
 in SDS running buffer (25 mM Tris, 200 mM 
glycine und 3.5 mM SDS). After protein separation was completed the gels were stained with 0.25 % 
(w/v) Coomassie Brilliant Blue in 30 % ethanol and 6 % acetic acid for 30 min and destained in 30 % 
ethanol and 10 % acetic acid. For short-term storage gels were covered with ddH2O and kept at room 
temperature. 
2.2.2.2 Protein Expression and Purification of EcE3 and multiple Variants from pGS523 
Expression and purification of EcE3 was basically described by LINDSEY (Lindsay et al. 2000). The 
expression plasmid pGS523 (encoding the entire EcPDHc) was transformed into chemical competent 
E. coli BL21™ cells. An overnight preculture grown at 37 °C in Luria-Bertani medium containing 
50 μg/mL carbenicillin was used to inoculate a main culture of the same medium to an OD600 of 0.1. 
Cells were grown at 37 °C to an OD600 of 0.8 and expression was started by addition of 50 µM IPTG 
and 100 µM FMN. After four hours of expression the cells were harvested by centrifugation at 
5000 x g, resuspended in lysis buffer supplemented with lysozyme (tip of a spatula) and DNase I (tip 
of a spatula). Cell disruption was performed using a Microfluidizer 110 S followed by removal of the 
cell debris by centrifugation (74,000 x g for 30 min at 4 °C). The supernatant was subjected to a heat 
precipitation at 65 °C for 10 minutes using a water bath. Precipitated proteins were removed by 
centrifugation (74,000 x g for 30 min at 4 °C). Subsequently the clarified supernatant was loaded onto 
a HiLoad™ 26/10 Q Sepharose™ HP anion exchange column equilibrated in buffer A. EcE3 was 
eluted using a linear gradient of high salt buffer (buffer B) over two CV. Fractions containing EcE3 
were combined and desalted using a HiPrep™ 26/10 Desalting column equilibrated in buffer C. 
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Table 2.2 Overview of buffers used for purification of EcE3 from pGS523 
Lysis buffer Buffer A Buffer B Buffer C 
Imidazole 20 mM 
MgCl2 1 mM 
PSMSF 1 mM 
pH 6.5 
Imidazole 20 mM 
pH 6.5 
 
Imidazole 20 mM 




KH2PO4 20 mM 




2.2.2.3 Protein Expression and Purification of EcE3 and multiple Variants from pET28a 
For expression, pET28aEcE3 was transformed into chemical competent E.coli BL21 Star
TM
 cells. An 
overnight preculture grown at 37 °C in Luria-Bertani medium containing 50 μg/mL kanamycin was 
used to inoculate a main culture of the same medium to an OD600 of 0.1. Cells were grown at 37 °C to 
an OD600 of 0.8 and expression was started by addition of 500 µM IPTG. After four hours of 
expression the cells were harvested by centrifugation at 5000 x g, resuspended in lysis buffer 
supplemented with lysozyme (tip of a spatula), DNase I (tip of a spatula). Cell disruption was 
performed using a Microfluidizer 110 S followed by removal of the cell debris by centrifugation 
(74,000 x g for 30 min at 4 °C). The supernatant was loaded onto a Ni-NTA FF Sepharose FF 
equilibrated in buffer A and N-terminal His6tagged-EcE3 was eluted using high imidazole buffer B in 
a single step. Appropriate fractions were pooled, desalted with low imidazole buffer and the His-tag 
was removed by thrombin cleavage in the presence of 5 mM CaCl2 in the cold room for 12 hours. 
Cleaved His-tags were trapped by a second cycle of IMAC. Subsequently, the flow through was 
concentrated and loaded onto a HiLoad 16/600 S200 gel filtration column equilibrated in buffer C. If 
the His6-tag remained on EcE3 the protein was directly desalted against buffer C after the Ni-NTA 
column. All pET28aEcE3 variants were expressed and purified to homogeneity according to the 
method for the wild type. 
 
Table 2.3 Overview of buffers used for purification of EcE3 from pET28a 
Lysis buffer Buffer A Buffer B Buffer C 
Hepes 50 mM 
NaCl 300 mM 
Imidazole 20 mM 
MgCl2 2 mM 
PSMSF 1 mM 
FAD 100 µM 
pH 7.6 
Hepes 50 mM 
NaCl  300 mM 
Imidazole 20 mM 
pH 7.6 
 
Hepes 50 mM 
NaCl 300 mM 




KH2PO4 50 mM 
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2.2.2.4 Expression and Purification of EcLip3 
For expression pET-SUMO-EcLip3 was transformed into chemical competent E.coli BL21 Star
TM
 
cells. An overnight preculture grown at 37 °C in Luria-Bertani medium containing 50 μg/mL 
kanamycin was used to inoculate a main culture of the same medium to an OD600 of 0.1. In addition, 
the main culture contained 1 % (w/v) glucose to prevent basal expression. Cells were grown at 37 °C 
to an OD600 of 0.8 and expression was started by addition of 500 µM IPTG. To ensure a sufficient 
degree of lipoylation expression was carried out in chicane flasks and in the presence of 0.2 mM lipoic 
acid. After four hours of expression the cells were harvested by centrifugation at 5000 x g, 
resuspended in lysis buffer supplemented with lysozyme (tip of a spatula), DNase I (tip of a spatula). 
Cell disruption was performed using a Microfluidizer 110 S followed by removal of the cell debris by 
centrifugation (74,000 x g for 30 min at 4 °C). The supernatant was loaded onto a Ni-NTA FF 
Sepharose FF equilibrated in buffer A and N-terminal His6tagged-SUMO-EcLip3 was eluted using 
high imidazole buffer B in a single step. Appropriate fractions were pooled, desalted with low 
imidazole buffer and the SUMO part was removed by cleavage with SUMO protease (16.1 μM in 
50 % (v/v) glycerol, 25 mM Tris-HCl pH 8.0, 250 mM NaCl, 0.5 mM dithiothreitol, 0.1 % (v/v) 
IGEPAL) in a 1:2000 molar ratio at 4 °C for 12 hours. Cleaved SUMO protein, protease and residual 
uncleaved fusion protein were trapped by a second cycle of IMAC. Subsequently, the flow through 
was desalted using a HiPrep™ 26/10 Desalting column equilibrated in buffer C.  
Table 2.4 Overview of buffers used for purification of EcLip3 
Lysis buffer Buffer A Buffer B Buffer C 
KH2PO4 50 mM 
Imidazole 20 mM 
NaCl      300 mM 
MgCl2 1 mM 
PSMSF 1 mM 
pH 7.6 
KH2PO4 50 mM 
Imidazole 20 mM 
NaCl 300 mM 
pH 7.6 
 
KH2PO4 50 mM 
Imidazole 250 mM 




KH2PO4 50 mM 
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2.2.2.5 Generation of dihydro-EcLip3 (EcLip3H2) 
Purified EcLip3 was transferred in its dihydro form by reduction of the lipoamide cofactor with a 5-
fold molar excess of TCEP for 5 minutes at room temperature. The reducing agent was removed from 
the protein by applying the reaction mixture to a HiPrep™ 26/10 Desalting column equilibrated in 
buffer C. 
 
Figure 2.1 Simplified reaction scheme of the EcLip3 reduction by TCEP. 
Reduction of the dithiolane moiety by TCEP leads to a ring opening and a concomitant loss of the 
chromophoric nature of the cystine at 333 nm (Levitch 1958; Seifert 2010). 
 
2.2.2.6 Concentration Determination of Proteins 
The concentration of proteins harboring a chromophoric cofactor was determined spectroscopically at 
the appropriate wavelength. EcE3 enzyme bound FAD was determined at 455 nm with an 




 (Wilkinson and Williams 1981). The concentration of EcLip3 was determined at 




 due to the absorption of the dithiolane moiety of the lipoamide 
cofactor (Levitch 1958). 
2.2.2.7 Concentration Determination of dihydro-EcLip3 
The concentration of EcLip3H2 was determined from the reduction of excess 4,4’-dithiopyridine to 




) (Argyrou et al. 2003). Note that one molecule 
EcLip3 harbors two thiol groups. 
 
Figure 2.2 Reaction scheme of the concentration determination of free thiol groups. 
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2.2.2.8 Determination of Extinction Coefficients of Multiple Variants 
The extinction coefficient of protein-bound FAD was determined by releasing the FAD from the 
protein followed by quantitating the free FAD (Hopkins and Williams 1995b). The absorbance at the 
flavin peak was measured at concentrations between 8-180 µM in 50 mM KPP, pH 7.6 and 100 mM 
NaCl. Guanidinium chloride (8 M, in 10 mM KPP pH 7.6) was added to a final concentration of 4.5 M 
at room temperature. Samples supplemented with guanidinium chloride were centrifuged for 30 min at 
21000 x g. The extinction coefficient of free FAD is enhanced in the presence of 4.5 M guanidinium 




 and thus was used in the calculations to determine the extinction 
coefficients of enzyme-bound FAD. 
Table 2.5 Molar extinction coefficients of EcE3 and respective variants. 
Enzyme variant Spectroscopic characteristic Reference 




 Wilkinson & Williams 1981 




 This work 




 This work 




 This work 




 Hopkins & Williams 1995 




 Hopkins & Williams 1995 




 Hopkins & Williams 1995 




 Hopkins & Williams 1995 




 This work 




 This work 




 Maeda-Yorita et al. 1991 




 This work 




 This work 




 This work 




 This work 




 This work 
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2.2.2.9 Determination of Redox Potentials of selected EcE3 Variants 
Measurements were performed by Lena-Sophie Dreher in the laboratory of Prof. Bruce Palfey at the 
University of Michigan, Ann Arbor, USA. The redox potential of FAD bound to EcE3 variants was 
determined by reductive titration of ~20 µM enzyme under anaerobic conditions in presence or 
absence of ~20 µM dye (Table 2.6) (McDonald, Liu, and Palfey 2013). All solutions were made 
anaerobic by multiple rounds of vacuum and oxygen-free argon flushing. 3 mM sodium dithionite was 
used to titrate the enzyme, the enzyme-dye mixture and the dye to complete reduction. The titration of 
the dye in absence of the enzyme served as control. All measurements were carried out at 25 °C in a 
1 mL reaction volume monitored by a UV-2550 spectrophotometer (Shimadzu Corp.) recording 
spectra from 300-700 nm. Data were fitted by Nernst analysis of the absorbance changes of enzyme 













]Dye  eq. 2.1 
Where n is the number of electrons in the reduction; F = Faraday’s constant; R = gas constant; T = 
absolute temperature; Em;dye and Em,Enz are the midpoint potentials of the dye and enzyme, respectively; 
Ai is an absorbance during the experiment; Aox is the absorbance at the start of the experiment when 
enzyme and dye are oxidized and Ared is the absorbance at the end of the experiment when enzyme and 
dye are reduced. Enz and Dye refer to absorbance values sensitive to these components. 
Corresponding wavelengths of the used enzyme/dye-pairs are listed in Table 2.6. Redox potentials 
were taken from BIRD and MANSFIELD (Bird and Kuhn 1981; Mansfield 1960). The recorded UV-Vis 
spectra are listed in the appendix (5.10). 
Table 2.6 Redox pairs for the redox potential titrations. 
Enzyme-dye pair wavelengths 
Redox potential (Dye) 
Em7.6 
EcE3C45A/K54Q / phenosafranin 
EcE3C45S/C50S / methylviologen 
EcE3C50A / neutral red 
403 nm / 530 nm 
450 nm / 600 nm 





2.2.2.10 Photobleaching of EcE3 and Variants thereof 
EcE3 and variants thereof (in 50 mM KPP pH 7.6, 100 mM NaCl) were exposed to 455 nm light 
(50 mW/cm
-2
) at room temperature and concomitant spectral read-out on a photo diode array attached 
to an Agilent 8453 UV-visible spectrophotometer. Solution recovery experiments were measured with 
  MATERIAL AND METHODS 
46 
the same experimental setup. EPR samples (2.2.5.4) were taken at time points indicated in the results 
part and subsequently frozen in liquid nitrogen. Photobleached cofactors were released from the 
enzyme and analyzed by ESI-TOF-MS (2.2.6.5). 
2.2.3 Substrates and Substrate Analogs 
Substrates used for functional assays and for crystallization were purchased from Sigma-Aldrich or 
AppliChem.  
2.2.3.1 Concentration Determination of Substrates and Cofactors 
The concentration of substrates and the cofactor analogues was determined spectroscopically using 
molecular absorbance coefficients listed in Table 2.7. 
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Lipoamide 
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2.2.4 Kinetic Methods 
2.2.4.1 Steady-State Activity Assay 
The activity of EcE3 and all variants was determined under pseudo steady state conditions in the 
presence of 100 µM NADH, 500 µM NAD
+
, 0.125 – 3 mM lipoamide and 5.25 % ethanol in 50 mM 
KPP pH 7.6 and 100 mM NaCl. Measurements were carried out at 20 °C and the reaction was started 
by addition of the enzyme while the consumption of NADH was tracked at 340 nm. If applicable, the 
dependency of the initial rates on the substrate concentration was analyzed according to                                       
eq. 2.2. It should be noted that the solubility of lipoamide is limited at 3 mM in the used buffer 
condition resulting in an underdetermined . Therefore, the determined specific activities represent the 
maximum substrate turnover in the presence of 3 mM lipoamide and 500 µM NAD
+
 at pH 7.6. 
              v = 
Vmax∙[S]
KM+[S]
                                      eq. 2.2 
2.2.4.2 NAD+ activation Experiments 
NAD
+
 activation experiments were carried out under the same conditions as described for the steady-
state activity assay. The lipoamide was kept constant at a concentration of 3 mM while the NAD
+
 
concentration was varied between 0 and 3 mM. The dependency of the initial rates on the NAD
+
 
concentration was used to determine the specific activity. 
2.2.4.3 pH Dependency Experiments under a constant ionic Strength 
The pH dependency of the EcE3 activity was determined under steady state conditions (2.2.4.1) in the 
presence of 100 µM NADH, 0 - 500 µM NAD
+
, 3 mM lipoamide and 5.25 % ethanol. A mixture 
comprised of 50 mM Acetic Acid, 50 mM MES and 100 mM Tris served as buffer system ensuring a 
constant ionic strength in a pH range from 4.5 to 9.5 (Ellis and Morrison 1982). Measurements were 
carried out at 20 °C and the reaction was started by addition of the enzyme while the consumption of 
NADH was tracked at 340 nm. The dependency of the initial rates on the pH was used to determine 
the pH optimum. 
2.2.4.4 Fast Kinetics-Stopped Flow Absorbance Spectroscopy 
Rapid reaction measurements experiments were carried out on an Applied Photophysics SX20 MV 
stopped-flow spectrophotometer at 4 °C. Spectra were recorded in equidistant time intervals on a 
photo diode array detector whereas single wavelength measurements were recorded with a logarithmic 
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time scale. Final concentrations of enzymes, cofactors and substrates after mixing are shown 
individually in the results part. 
Single mixing experiments 
Single wavelength measurements were performed at wavelengths of 380, 487, 523 and 650 nm. 
Enzyme and substrates were mixed in all cases in a 1 to 1 volume ratio. The final concentrations of 
enzymes, cofactors and substrates after mixing are shown in the figures in the results part. 
Sequential mixing experiments 
Sequential mixing experiments were used to study the reoxidation of the two-electron reduced state 
(EH2) of EcE3 by NAD
+
. First, EcE3-EH2 was formed by pre-mixing EcE3 and EcLip3H2 (both at the 
same concentrations) followed by mixing with the final electron acceptor NAD
+
. The optimal time 
point for the second mixing step was obtained from the single mixing experiments. The final 
concentrations of enzymes, cofactors and substrates after the second mixing step are shown in the 
figures in the results part. 
2.2.5 Biophysical Methods 
2.2.5.1 UV-Vis Spectroscopy 
UV-Vis spectra were collected between 300 – 700 nm in a Jasco V-650 spectrophotometer using 
Quartz cuvettes with a path length of 1 cm and a band width of 1 nm. The acquisition speed was 
100 nm/min with a data pitch of 1 nm. As buffer system for all UV-Vis experiments served 50 mM 
potassium phosphate pH 7.6 and 100 mM NaCl. 
2.2.5.2 CD spectroscopy 
Circular dichroism spectra were recorded for EcE3 and EcLip3 including active site variants with a 
Chirascan CD-spectropolarimeter. Secondary structure elements were detected by collection of far UV 
spectra between 180 – 260 nm with a path length of 1 mm at in 50 mM potassium phosphate buffer 
pH 7.6. Near UV/Vis spectra were collected between 300 – 500 nm with a path length of 1 cm. Used 
buffers and added substrates are indicated in the figure legend. 
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Table 2.8 Acquisition parameters for CD spectroscopy experiments 
 Far UV spectra Near UV spectra 
enzyme concentration 0.1 – 0.2 mg/mL 2.5 mg/mL 
data interval 1 nm 1 nm 
band width 1 nm 1 nm 
response 2 s 3 s 
path length 1 mm 1 cm 
wavelength 180 – 260 nm 300 – 500 nm 
 
2.2.5.3 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) allows the direct and quantitative determination of the binding 
thermodynamics of a biological process. Under optimal conditions the association constant, the 
binding enthalpy, the binding entropy and the stoichiometry of a binding event can be calculated from 
a single ITC experiment. An ITC200 MicroCalorimeter system was used to investigate both the 
interaction between EcE3 and EcLip3 and the cofactor binding of NAD
+
 to EcE3 and variants thereof. 
The enzymes were buffer exchanged into the same buffer (50 mM KPP pH 7.6, 100 mM NaCl). The 
ITC cell was filled with 100 µM (active sites) EcE3. The injection syringe was filled with 1 mM of 
EcLip3. Measurements were performed at 20 °C with a stirring speed of 500 min
-1
. A titration of 
1 mM EcLip3 into buffer served as control to check for heat effects due to dilution. The interaction of 
NAD
+
 with the enzymes was assayed under the same conditions while dissolving NAD
+
 directly in the 
buffer system. 
2.2.5.4 EPR 
Measurements on EcE3C45A/K54Q (pseudoLOV) were performed by Christopher Engelhard in the 
laboratory of Prof. Robert Bittl at the Freie Universität Berlin. Acquisition parameters were as follows: 
 -Modulation amplitude: 3G 
- Time constant: 30ms 
- Lock-in frequency 100 kHz 
- Sensitivity: 1 mV 
- Microwave frequency: ~9.38 GHz, all spectra frequency-corrected to 9.60 GHz 
- Microwave power: 63.2 nW (-35 dB on a standard 200 mW microwave source) 
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2.2.6 Mass Spectrometry 
2.2.6.1 MALDI-TOF Mass Spectrometry 
It could be shown that MALDI-TOF Mass Spectrometry is suitable method to detect the state of a 
lipoylation of an isolated hybrid lipoyl domain of E. coli PDHc (Wei et al. 2003). This method was 
also applied to the lipoyl domain II of the human PDHc by members of this group (Güttler 2008; 
Seifert 2010). In both cases, the entire domain was subjected to MALDI-TOF MS. In this work a 
MALDI-TOF mass spectrometric approach of an isolated lipoyl domain of the E. coli PDH after 
tryptic digestion of the latter will be presented. 
2.2.6.2 Determination of the Lipoylation State of EcLip3 
Digestion of a protein with trypsin leads to fragments showing specific cleavages after arginine or 
lysine residues, respectively. These tryptic peptides are then used for exact mass determination, also 
allowing the detection of putative post-translational modifications of amino acid side chains. On the 
one hand, the lipoamide cofactor bound to EcLip3 directly leads to an increase in mass of the distinct 
peptide on the other hand it also leads to an altered digestion pattern since the covalent bond between 
lipoic acid and the ε-amino group of lysine45 prevents a tryptic digestion at this site. Tryptic peptides 
of EcLip3 including their corresponding masses were predicted with the PeptideCutter interface (Table 
5.1). The peptides required for analysis of the lipoylation state of EcLip3 are listed in Table 2.9. 















In the case of fully lipoylated EcLip3, the peptides unlipoylated I and II are not expected occur since 
trypsin will not cleave due to the covalent attachment of lipoic acid to lysine45 (highlighted in 
yellow). In contrast, only one bigger fragment should appear after tryptic digestion (lipoylated). This 
fragment has a total mass of 3032.5 Da comprising the masses of the two individual fragments 
(unlipoylated I and II) including the bound lipoamide cofactor. 
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2.2.6.3 MALDI-TOF Sample Preparation 
Samples of EcLip3 for tryptic digestion were taken after purification. 15 µL sample were added to 
25 µL 25 mM ammonium hydrogen carbonate and 10 µL trypsin (100 µg/mL). After an overnight 
digestion at 37 °C the reaction was stopped by the addition of 85 % FA in a 1:1 volume ratio. MALDI-
TOF samples were desalted using ZipTips pipette tips containing C18-silica beads with a binding 
capacity of 5 µg protein. ZipTips were washed three times with a solution made of 10 µL 70 % ACN / 
0.3 % FA followed by an equilibration with 10 µL 1 % FA. After the loading of the sample the 
column was washed again with 10 µL 1 % FA as described above. Tryptic peptides were eluted with 
10 µL of 70 % ACN / 0.3 % FA Table 2.10. 
Table 2.10 ZipTip preparation for MALDI-TOF samples 















70 % ACN / 0.3 % FA 
 
2.2.6.4 MALDI-TOF Measurement and Data Evaluation 
The MALDI-TOF device was calibrated using the Peptide Calibration Standard (Table 2.11 and 
Figure 2.3). 2 µL of desalted sample were mixed with 2 µL of saturated DHB matrix solution. 2 µL 
thereof were then pipetted on a MTP 384 polished steel sample carrier. The mixture was dried on air. 
Data were acquired in a mass range from m/z 650 to 3500 using an acceleration voltage of 20 kV. 40 
shots were collected with a laser intensity of 40 % per measurement. In total, ten measurements were 
carried out resulting in the accumulation of 400 shots. Data acquisition and analysis were done using 
the Flex analysis software package and corresponding graphs were compiled with SigmaPlot. 
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Figure 2.3 MALDI-TOF mass spectrum of the Peptide Calibration Standard 
 
2.2.6.5 UPLC-ESI-TOF Sample Preparation 
The enzyme-bound flavin cofactor was released before and after photoexcitation (2.2.2.10), 
respectively, by different protein precipitation methods. First, EcE3 and variants thereof were heated 
to 95 °C for ten minutes with occasional vortexing. Secondly, EcE3 was precipitated by addition of ice 
cold 50 % (w/v) TCA to a final concentration of 5 % (w/v) followed by an incubation on ice for ten 
minutes. Thirdly, one volume of protein solution was mixed with four volumes of ice cold acetone 
followed by an incubation step at -70 °C for ten minutes. In all cases precipitated protein was removed 
by three rounds of centrifugation at 21,000 x g for 30 minutes at 4 °C. Prior to MS and MS/MS 
analyses, the resulting supernatant containing the released cofactor was diluted with ddH2O as 
indicated in the results part. 
m/z
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2.2.6.6 UPLC-ESI-TOF-MS 
Analysis of the released EcE3 cofactor was performed on an ultra-performance liquid chromatography 
(UPLC) ACQUITY system coupled to an UPLC eLambda 800 nm photo diode array detector (Waters 
Corporation, Milford, USA), followed by an LCT Premier orthogonal electrospray ionization time-of-
flight mass spectrometer (ESI-TOF-MS, Waters Corporation, Milford, USA). For analysis, the UPLC 
was equipped with an ACQUITY UPLC HSS T3 column (1.0 x 100 mm, 1.8 µm particle size, Waters 
Corporation, Milford, USA) held at 40 °C and a flow rate of 0.2 mL/min. The following gradient 
program was run: 0 – 0.5 min 1 % B, 0.5 – 3 min 1 % B to 20 % B, 3 – 8 min 20 % B to 100 % B, 8 – 
10 min 100 % B, 10 – 10.1 min 100 % B to 1 % B, 10.1 – 14 min 1 % B (solvent system A: 
water:formic acid (100:0.1, v/v); B: acetonitrile:formic acid (100:0.1, v/v)). UV-VIS data were 
collected between 190 – 800 nm in 1.2 nm steps. 
The ESI-TOF-MS was run at negative ionization mode for all samples. Data were collected over a 
mass range from m/z 50.00 – 1200.00 and a runtime from 0 - 13 min using a capillary voltage of 
2500 V. The cone voltage was maintained at 30 V, the desolvation temperature at 350 °C and the 
source temperature at 80 °C. Data acquisition was carried out by using the MassLynx software in 
centroid data format. Nitrogen was used as cone and desolvation gas at a flow of 30 and 800 l/h, 
respectively. The dynamic range enhancement mode was used for data recording. All analyses were 
calibrated by applying the lock spray reference compound leucine-enkephaline ([M-H]
-
 554.262 as 
well as its 13C isotopologue ([M-H]
-
 555.2653; Sigma-Aldrich, Deisenheim, Germany) at a 
concentration of 0.5 µg/mL in acetonitrile:water (50:50, v/v) and a flow rate of 20 µL/min. The 
measurements for the lumichrom reference were run at positive ionization mode using the same 
parameters except a capillary voltage of 2700 V and a calibration by applying the aforementioned lock 
spray reference ([M+H]
+
 556.2766 as well as its 2x13C isotopologue [M+H]
+
 558.2833). UPLC-ESI-
TOF-MS measurements and subsequent data analysis were carried out by Dr. Kirstin Feussner. 
2.2.6.7 UHPLC-ESI-QTOF-MS 
MS/MS fragmentation experiments were performed via UHPLC-ESI-QTOF-MS. For UHPLC, an 
Agilent 1290 Infinity series UHPLC system (Agilent Technologies, Böblingen, Germany) with an 
ACQUITY UPLC BEH C18 column (2.1 x 100 mm, 1.7 µm particle size, Waters Corporation, 
Milford, USA) kept at 40 °C was used with a flow rate of 0.5 mL/min. The solvent system and the 
applied gradient were comparable to that of method 2.2.6.6. Mass detection was performed with an 
Agilent 6540 UH Accurate-Mass-Q-TOF MS (Agilent Technologies, Böblingen, Germany). The MS 
was operated using an ESI source with Agilent Dual jet Stream Technology (Agilent Technologies, 
Böblingen, Germany) in negative and positive ionization mode. Ionization parameters were as follows: 
gas temperature 300 °C, gas flow 8 L/min, nebulizer pressure 35 psi, sheath gas temperature 350 °C, 
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sheath gas flow 11 L/min, VCap 3 kV, nozzle voltage 100 V. As a collision cell, a linear hexapole 
collision cell with nitrogen as collision gas was used with collision energies of 40 eV – 45 eV. For 
data acquisition, the Mass Hunter Workstation Acquisition Software was used (B.05.01.), with Mass 
Hunter Qualitative Analysis software (B.06.00) as analysis tool. For structure elucidation the MS/MS 
spectra of FAD derivatives were interpreted in comparison to FAD spectra (METLIN ID2302) 
deposited in the METLIN database. UHPLC-ESI-QTOF-MS measurements and subsequent data 
analysis were carried out by Dr. Kirstin Feussner 
2.2.7 X-ray Crystallography 
X-ray diffraction datasets, collected in-house or at different synchrotron radiation facilities (BESSYII, 
Berlin; DESY, Hamburg), were processed with XDS (Kabsch 2010). Protein models were iteratively 
refined and improved with PHENIX (Adams et al. 2010) and validated with MOLPROBITY (Davis et 
al. 2007).  
2.2.7.1 Crystallization 
Crystallization of EcE3 
Crystals were obtained using the hanging drop vapor-diffusion method. EcE3 (derived from pGS523) 
was concentrated to 14-16 mg/mL in 50 mM imidazole pH 6.5, 150 mM NaCl. All further steps were 
performed at 6-8 °C. EcE3 was mixed with equal amounts of reservoir solution, comprising 1.8 – 
2.4 M ammonium sulfate and 0.1 M potassium phosphate buffer pH 7.0. Drop size was 4 µL. Crystals 
were cryoprotected using reservoir solution supplemented with 25 % glycerol (v/v) before flash 
freezing and storage in liquid nitrogen. For substrate soaking experiments the cryo solution was 




Crystallization of EcE3C45S 
EcE3C45S was desalted against 50 mM imidazole pH 6.5, 150 mM NaCl and concentrated to 
13.5 mg/mL. The protein solution was mixed with equal amounts of reservoir solution, comprising 
2.4 M ammonium sulfate and 0.1 M MES buffer pH 6.5. Directly after preparation drops were 
microseeded with wild type crystals pre-grown in 8 – 13 % (w/v) PEG 4000, 200 mM NaCl, 1-4 % 
(v/v) PEG400 and 0.1 M MES pH 6.5. Crystals were cryoprotected the same way as the crystals of the 
wild type enzyme. 
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2.2.7.2 Data Processing and Molecular Replacement 
Datasets were processed and scaled with XDS (Kabsch 2010). Data processing was mainly done by 
Dr. Piotr Neumann (Department for Molecular Structural Biology, University of Göttingen). Data 
collection- and structure refinement statistics can be found in the appendix (Table 5.3). The structure 
of EcE3 was determined by molecular replacement using dihydrolipoamide dehydrogenase of 
Neisseria meningitidis (PDB: 1OJT) as initial search model with PHASER (McCoy 2006). 
2.2.7.3 Model Building, Refinement and Validation 
Structure refinement was carried out using PHENIX (Adams et al. 2010) employing the maximum 
likelihood method, with 1.5 to 5% of randomly chosen data for validation by the Rfree factor (Brünger 
1992). After a rigid body refinement models were inspected manually with COOT (Emsley et al. 
2010) checking the conformation of side chains and the position of water molecules or other ligands. 
Validation of the refined models was carried out using COOT and MOLPROBITY. Sigma A-weighted 
electron density maps (2mFo-DFc, mFo-DFc) were generated with PHENIX. Simulated-annealing 
(SA) omits maps were calculated as implemented in CNS (Brunger 2007) by Dr. Piotr Neumann 
(Department for Molecular Structural Biology, University of Göttingen). Figures were compiled with 
PYMOL (DeLano 2003). 
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3 Results and Discussion 
3.1 Spectroscopic and Crystallographic Characterization of EcE3 
Major emphasis was devoted to the spectroscopic and crystallographic detection of reaction 
intermediates of the EcE3 reaction cycle. Therefore a convenient and robust expression system has 
been established which allowed the subsequent study of the wild type enzyme and selected active site 
variants thereof. These enzymes were first characterized by conventional UV-Vis spectroscopy and 
steady-state kinetics and then further investigated by stopped-flow absorbance spectroscopy and 
transient kinetic analyses. Based on these results crystallization trials with active site mutants capable 
of stabilizing a distinct reaction step were conducted to expand the gained spectroscopic knowledge by 
crystallographic data. 
3.1.1 Kinetic Characterization of EcE3 in dependence of Lipoamide, NAD+ and pH 
Steady-state parameters of lipoamide dehydrogenase from Escherichia coli have been investigated in 
detail over the last decades (Wilkinson and Williams 1981; Williams 1965; Williams et al. 1967). In 
addition, the mechanism of the severe product inhibition by NADH could be determined in significant 
detail (Wilkinson and Williams 1981). The following results briefly summarize the effects of 
lipoamide, NAD
+
 and pH on the steady-state catalysis of EcE3 purified from modern expression 
systems and demonstrate the consistency with already published data (Figure 3.1). In the absence of 
NAD
+
 the initial velocity of EcE3 is very low when tracking the reverse reaction with NADH as 
reductant and lipoamide as electron acceptor. With increasing NAD
+
 concentrations the inhibitory 
effect of NADH is overcome leading to enhanced initial rates (Figure 3.1A). The activation by NAD
+
 
is complete at about 2.0 mM added NAD
+
 under the conditions tested (Figure 3.1B). The apparent 
binding constant was determined to be 400 µM (Wilkinson and Williams 1981). Although the 
activating effect of NAD
+
 is unquestionable the absolute influence of the pyridine nucleotide is also 
pH dependent (Figure 3.1C) (Reed, Koike, and Shah 1960; Wilkinson and Williams 1981). At all 
tested pH values the reverse reaction is very slow without externally added NAD
+
. In the presence of 
50 µM NAD
+
 the enzyme shows a clear catalytic optimum at pH 8.5 harboring a ~5-fold increased 
reaction rate compared to the reactions lacking externally added NAD
+
. When adding 500 µM NAD
+
 
the pH profile is bell shaped peaking at pH 8.0. It is obvious that the chosen pH acts as a determinate 
whether NAD
+
 functions only as an activator or, at higher concentrations, both at activator and an 
inhibitor. This phenomenon has already been discussed elsewhere (Wilkinson and Williams 1981). 
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A standard steady-state assay was therefore used to compare the relative activities of active site 
mutants during the course of the study. This assay comprised 500 µM NAD
+
, 3 mM lipoamide and 
100 µM NADH at pH 7.6. The chosen pH was a consequence of high catalytic activity with respect to 
EcE3 but was further determined by the usage of an isolated lipoyl domain of the EcE2 component 
(EcLip3) as reductant to track the reductive half-reaction (3.2). This isolated domain showed to be 
most stable at pH 7.6 and thus a pH below 8.0 was obligate for further investigations. Hence, the used 
standard steady-state assay reflected a compromise with respect to activity of EcE3 and stability of 
EcLip3 at pH 7.6. The resulting steady-state kinetic under the assay conditions chosen for EcE3 is 
shown in Figure 3.1D. Due to the limited solubility of lipoamide in aqueous solutions (Argyrou and 
Blanchard 2001) the resulting plot lacks a hyperbolic shape. Catalytic activities will therefore be 
referred to units/mg. Catalytic activities for all investigated (double) variants of EcE3 under the 
conditions described can be found in the appendix (5.4). 
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Figure 3.1 Steady-state characterization of EcE3. 
(A) Time course of the NADH-lipoamide reaction, effect of added NAD
+
. The assay comprised 
100 µM NADH and 3 mM lipoamide. (B) Effect of NAD
+
 on the observed initial rates in the 
NADH-lipoamide reaction. Conditions of the assay are as in A, except that NAD
+
 was added at the 
indicated concentrations before the addition of enzyme. (C) pH activity profile for the NADH-
lipoamide reaction, effect of added NAD. (D) Lipoamide dependence standard assay of EcE3 
comprising 500 µM NAD
+
 3 mM lipoamide and 100 µM NADH. The reaction was started by 
addition of the enzyme. All experiments were carried out at pH 7.6. 
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3.1.2 Detection of Reaction Intermediates using Stopped-flow Absorbance 
Spectroscopy 
Besides the establishment of a standard steady-state assay also transient kinetic analyses should be 
performed at appropriate conditions using stopped-flow absorbance spectroscopy. It was demonstrated 
that this technique is suitable to study both the spectroscopic and kinetic properties of lipoamide 
dehydrogenase from Mycobacterium tuberculosis (Argyrou et al. 2002). Hence, the kinetic rate 
constants for single reaction steps could be determined in significant detail. It was therefore the aim to 
transfer the method established by ARGYROU and co-workers to the E. coli system which consequently 
allowed the spectroscopic characterization of the EcE3wt and active site mutants. Major emphasis was 
thereby devoted to the detection of the covalent FAD-C4a-cysteinyl adduct. 
As described for all lipoamide dehydrogenases the reaction cycle consist of multiple reaction steps, 
which are completely reversible (Massey, Gibson, and Veeger 1960). This allows to follow the 
reaction cycle from both half-reactions, from the reductive half-reaction (dihydrolipoamide as 
reductant; forward direction) or from the oxidative half-reaction (NADH as reductant; reverse 
direction). Due to the absence of commercially available dihydrolipoamide the reduced pyridine 
nucleotide was chosen as reductant, which harbors further advantages compared to dihydrolipoamide 
besides its unlimited availability. In contrast to lipoamide, NADH does not show limited solubility in 
aqueous solution as (dihydro)lipoamide does (Argyrou and Blanchard 2001) and secondly, it was 
demonstrated that NADH has the ability to overreduce lipoamide dehydrogenases to the EH4 state, 
which allows the observation of further reaction intermediates (Argyrou et al. 2003, 2002). In addition, 
it was evident that stopped-flow experiments had to be conducted at low temperature (4 °C) due to the 
high turnover rates of the enzyme (Wilkinson and Williams 1981). 
Oxidized EcE3 (Eox) has absorbance maxima at 369 and 455 nm, a shoulder at 482 nm, and minima at 
312 and 395 nm (Figure 3.2A). Upon reduction with an equimolar amount of NADH the enzyme is 
transformed into its two-electron reduced form (EH2) by intramolecular transfer of electrons from the 
reduced flavin to the disulfide. At the EH2 state the flavin remains oxidized while the redox active 
cystine is reduced. The flavin absorbance is attenuated and the entire spectrum is blue-shifted relative 
to the spectrum of Eox. In addition, the absorbance rises in the longer wavelengths region yielding in a 
shoulder at 523 nm which was attributed to the Cys50-thiolate FAD charge transfer complex (Thorpe 
and Williams 1976a, 1976b, 1981). This specific absorption change is based on an electron donor-
acceptor relation rather than on formation of a flavin radical species as demonstrated by independent 
experiments: At first, the complex shows clear pH-dependent absorption changes yielding in a loss of 
the charge transfer signal at lower pH values which is indicative for protonation of the anionic electron 
donor (Matthews and Williams 1976). Secondly, the EH2 state was shown to be devoid of any 
detectable EPR signal (Massey and Gibson 1964; Searls, Peters, and Sanadi 1969) further 
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underpinning the presence of a thiolate rather than a flavin radical giving rise to the absorption in the 
523 nm region. 
Flavin reduction and thiolate formation occur at the same apparent rate constant with ~55 s
-1
 (Figure 
3.2C and Figure 5.1). Though the flavin peak resides in its blue-shifted form during the recorded time 
the thiolate starts to decay. This is most likely due to the property of the EH2 state of the E. coli 
enzyme which is indeed a mixture of different spectrally distinct species (Wilkinson and Williams 
1979). At the pH used for the experiments (pH 7.6) it is possible that Cys50 becomes protonated and 
concomitantly the interchange thiol (Cys45) becomes deprotonated leading to a prototropic tautomer 
which explains the loss in absorbance at 523 nm. Further reduction to the four-electron reduced state 
(EH4) requires the flavin also being reduced. This is accompanied by reduction with a 5-fold molar 
excess of NADH (Figure 3.2B). In the EH4 state the absorbance maxima are further reduced and the 
523 nm charge transfer decayed entirely. Moreover, the excess of NADH enables the detection of the 
FADH2-NAD
+
 intermediate giving rise in absorption between 600 and 700 nm (Argyrou et al. 2002). 
The latter complex can only be observed to minute amounts under equimolar conditions (Figure 3.2A). 
However, its formation is completed within the dead-time of mixing at both used substrate 
concentrations indicating the transience of the complex. The transience can be related to the redox 
potential of the flavin cofactor which is significantly more positive compared to the ones of pig heart 
and Mycobacterium tuberculosis lipoamide dehydrogenase, respectively (Argyrou et al. 2002; 
Matthews and Williams 1976; Wilkinson and Williams 1979). Noteworthy, no significant increase in 
absorbance at 380 nm was observed in the reaction of Eox with NADH under single turnover 
conditions (Figure 3.2D). The absence of an increase in absorbance at this wavelengths, that is typical 
for flavin-C4a adducts, suggests that the C4a-cysteinyl adducts does not accumulate to detectable 
amounts in the forward direction in EcE3 using NADH as reductant. The finding of this high 
instability of the intermediate is consistent with previously reported observations (Argyrou et al. 
2002). It was suggested that this instability could arise if formation of the covalent adduct in both 
directions is considerably slower than its decay in both directions (Argyrou et al. 2002). Apparently, 
this also holds true for this central intermediate in EcE3. 
In summary, the spectral properties of the three enzyme species detected are very similar to the spectra 
of the corresponding species of the pig heart and the aforementioned Mycobacterium tuberculosis 
lipoamide dehydrogenase (Argyrou et al. 2002; Matthews and Williams 1976). A transfer to the E. coli 
system was therefore successful and was thus used to study active site mutants to further investigate 
the reaction mechanism of EcE3 (3.3). A trustworthy approach to track the reductive half-reaction of 
EcE3, and thus the ability to test for the accumulation of the covalent C4a-flavin adduct in the forward 
direction, is presented in 3.2. 
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Figure 3.2 Stopped-flow absorbance traces of EcE3 during reduction with NADH. 
20 µM EcE3 were mixed with 20 µM (A) or with 100 µM NADH (B) at 4 °C and pH 7.6. The 
dashed line represents the oxidized form of EcE3 (Eox) derived from a single mixing event with 
buffer. The solid spectra were recorded using a diode-array detector after mixing with NADH at the 
concentrations indicated. Panel C indicates selected absorbance traces for the reduction under 
equimolar conditions. D Absorbance trace at 380 nm under single turnover conditions. No increase 
in absorbance can be detected indicating that the covalent C4a-cysteinyl adduct does not accumulate 
during the reduction process. Note the logarithmic time-scales.  
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3.1.3 Structure of EcE3 – Active Site Dynamics underlie Catalysis 
The crystal structure of EcE3 was recently solved at medium resolution (2.5 Å, PDB: 4JDR) 
(Chandrasekhar et al. 2013) and thus expanded the plethora of already determined structures of 
lipoamide dehydrogenases. The crystals belonged to space group I422 with two monomers assembled 
as functional dimer occupying the asymmetric unit. However, it was the aim this study to improve the 
existing structural data by means of resolution and model quality. An improved structural knowledge 
may help to gather insights in the transient nature of the enzyme’s reaction cycle (3.1.2). Thus, a 
correlation of the structural findings with spectroscopic results in solution was applied whenever 
possible.  
EcE3wt could be crystallized in a new polymorphic form and the crystal structure was determined 
successfully with improved resolution and atomic model reliability as judged by refinement statistics 
(5.12). As described previously ammonium sulfate was used as precipitant but the crystallization 
condition harbored an increased pH (7.0). Crystals exhibited a shiny yellow color clearly indicating 
the presence of the flavin cofactor (Figure 3.4) and belonged to space group P212121. Six monomers 
were present in the asymmetric unit corresponding to a solvent content of 59.99 %, labeled A – F, 
assembled into three functional dimers. The altered space group and the increased number of 
monomers occupying the asymmetric unit is likely due to the increased pH in the crystallization buffer 
which most likely influenced crystal packing. The structure of EcE3 was solved by molecular 
replacement with PHASER (McCoy et al. 2007) using a monomer of lipoamide dehydrogenase from 
Neisseria meningitidis as search model (PDB: 1OJT) and could be refined at 2.1 Å resolution to 
Rwork/Rfree of 17.7 /20.8 % (Table 5.3). After model completion and refinement, several difference map 
peaks (mFo-DFc at 3 sigma level) could be observed. Owing to the presence of sulfate in the 
crystallization condition and glycerol served as cryoprotectant, these peaks were modelled as sulfates 
and glycerols taking into account the character of interactions with surrounding residues. Interestingly, 
a sulfate acts as a placeholder molecule residing very close to the binding site for the diphosphate 
anchor of NAD
+
 (Figure 5.22). At least 469 out of the 474 residues were visible in each of the six 
molecules occupying the asymmetric unit whereas the missing residues are housed in the C-terminal 
part are most likely disordered. The structure EcE3 is similar to the already published one, for 
instance, dimerAB can be superimposed with an r.m.s.d. of 0.49 Å calculated on Cɑ positions, 
indicates the high similarity.  
Despite the high similarity with respect to the overall fold essential differences around the active site, 
particularly at the redox active cystine, could be observed. It was stated that the geometry of the redox 
active disulfide bridge in the E. coli enzyme deviates from the geometry observed in other organisms 
(Chandrasekhar et al. 2013). The dihedral angles (Cβ-Sγ-Sγ-Cβ) were reported to be 29 and 46 ° in 
one functional dimer. However, based on improved structural data presented here these results seem to 
be questionable. The dihedral angle in chain A was -131 ° and is thus consistent with earlier published 
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geometries (Brautigam et al. 2005; Mande et al. 1996; Mattevi et al. 1991). Moreover, it was possible 
to model both an open and a closed conformation for the disulfide bridge contributing to the redox 
center (Figure 3.3A). Multiple refinements with different occupancies as starting point all converged 
into a defined model with a distribution of 50 % open and 50 % closed conformation for the cystine. 
Partial opening of the disulfide bridge is induced by the synchrotron radiation and leads to formation 
of two different redox states of EcE3 simultaneously. The closed conformation of the cystine 
resembles the oxidized state (Eox) and the open conformation resembles the two-electron reduced form 
(EH2) of the enzyme. This radiation-induced reduction enabled the observation of structural 
rearrangements required for catalysis and gave first insights into the local plasticity of the active site. 
Further structural changes which are pivotal to stabilize the two-electron state of EcE3 and the 




The flexibility of the active site is not restricted to the redox active cystine. The aromatic isoalloxazine 
moiety of the flavin cofactor also deviates from planarity. The pteridine part is bent ~2.7 °, the 
dimethylbenzene part ~2.5 ° with respect to the N5-N10 axis of the cofactor (Figure 3.3B). It was 
demonstrated that the flavin redox potential can be tuned by conformational effects, especially by 

















Figure 3.3 Local flexibility of the active site. 
(A) The redox active disulfide bridge of EcE3 is 
formed between Cys45 and Cys50. Its open and 
closed conformation could be refined with 50 % 
occupancy, respectively. The 2mFo-DFc electron 
density map is countered at 2 σ. The closed 
conformation reflects the oxidized, the open 







(B) Deviation from planarity of the flavin 
cofactor. Superposition of the flavin cofactor 
from PDB: 4JDR (light grey) and EcE3 at 2.1 Å 
(yellow). The pteridine part deviates ~2.7, the 
dimethylbenzene part ~2.5 ° from planarity 
(2mFo-DFc map countered at 2 σ).  
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uses this tool maintaining the optimal redox potential. However, deviation from planarity is not as 
pronounced as observed in other studied flavoenzymes (Müller et al. 1994; Neumann et al. 2008). 
3.1.4 Spectroscopic and Crystallographic Investigation of the two-electron reduced 
State – EH2 
The two-electron reduced state (EH2) of EcE3 is the catalytically active species that is formed prior to 
generation of NADH (3.1.2). During studies on the redox active disulfide it could be demonstrated that 
replacement of Cys45 to a serine residue (EcE3C45S) leads to a stable formation of an artificial EH2 
state in which the remaining cysteine (Cys50) is present to ~95 % in its anionic form (Hopkins and 
Williams 1995a, 1995b). The residual ~5 % were estimated to be a fluorescent species in which Cys50 
resides in its thiol form. EcE3C45S harbored an orange-red color and its UV-Vis spectrum resembled 
that of the two-electron reduced wild type enzyme. It is characterized by an ~10 nm blue shifted flavin 
peak and the presence of an broad thiolate-FAD charge transfer absorbance between 500 to 600 nm 
(Figure 3.4A). The absence of an absorbance in the 380 nm range excluded the accumulation of a 
cysteinyl-C4a adduct in the resting state (Figure 3.4A, inset). It has been suggested that binding of 
oxidized pyridine nucleotides may facilitate flavin-disulfide interaction (Matthews et al. 1979). 
Therefore, EcE3C45S was subjected to NAD
+
-titrations, which were carried out at 10 °C in order to 
slow down a putative FAD-C4a-cysteinyl adduct formation. However, even in the presence of the 
pyridine nucleotide a significant absorption increase in the characteristic wavelength region at 380 nm 
was not detectable (Figure 3.4B) and hence an NAD
+
-induced collapse between Cys50 and FAD-C4a 
is unlikely. The mechanism of cysteinyl-C4a adduct formation will be discussed below in detail (3.1.5 
and 3.1.6). 
To extend the understanding of how the two-electron reduced state of the E. coli lipoamide 
dehydrogenase is stabilized, EcE3C45S was crystallized and the crystal structure was determined 
successfully. As for the wild type, the presence of ammonium sulfate as precipitant EcE3C45S was 
necessary. However, a lower pH value was required (pH 6.5 compared to pH 7.0). The obtained 
crystals also showed a pale orange-red color indicating that the charge transfer interaction is still 
active in crystallo (Figure 3.4C). EcE3C45S crystals belonged to space group I422 and contained two 
monomers per asymmetric unit assembled into a functional homodimer. The structure was solved by 
molecular replacement using the ground state EcE3 structure as search model (3.1.3) was refined to 
Rwork/Rfree of 23.3 %/27.4 % against data to 2.50 Å resolution (Table 5.3). Difference map peaks (mFo-
DFc at 3 sigma level) of tetrahedral shape were modeled as sulfate ions as described for the ground 
state structure. 472 out of the 477 residues were traceable in both molecules whereas the residues 
resulting from cloning artefacts and the last C-terminal residues could not be traced and are most 
likely disordered. The overall fold of EcE3C45S is similar to the ground state structure. Two catalytic 
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functional dimers can be superimposed with an r.m.s.d. of 0.67 Å calculated on Cɑ positions 
indicating the high similarity. However, slight differences can be observed which, are mainly located 
in the surface exposed regions of the NAD
+
- and FAD-binding domain whereas the enzyme’s core 
regions are almost identical. Since the structural data of EcE3C45S was of reasonable quality the 
resulting model resembles a snapshot of the two-electron reduced state of the enzyme and thus 
provides structural information about a central intermediate during catalysis. In this intermediate step 
the disulfide bridge is entirely broken and the cysteine residue facing the flavin cofactor is present as a 
thiolate (3.1.2). Major emphasis was therefore devoted to the hydrogen bond network at the active site 
which stabilizes the anionic form of Cys50. 
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Figure 3.4 General characterization of EcE3-EH2. 
(A) Resting state absorbance spectra of EcE3wt and C45S. The broad absorbance band between 500 
and 600 nm indicates the charge transfer complex between the anionic Cys50 and FAD. (B) NAD
+
-
titration of EcE3C45S at pH 7.6. Addition of NAD
+
 does not lead to increase in absorbance at 
380 nm.  An accumulation of the cysteinyl-C4a adduct is therefore unlikely. (C) Schematic of the 
active sites in EcE3wt and C45S (top) and corresponding protein crystals. EcE3C45S retained its 
orange-red color in crystallo indicating that the charge transfer complex between Cys50 and FAD is 
still active. (D) Hydrogen bond network in EcE3-EH2. The thiolate of Cys50 is stabilized by a 
hydrogen bond to the OH-group of Ser45 and the 2’-hydroxyl group of the ribityl chain (distances in 
Å). 
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A direct interaction of the Cys50-thiolate between the hydroxyl group of Ser45 and the 2‘-hydroxyl of 
the ribityl side chain could be observed (Figure 3.4D). In addition, Ser45 might be stabilized by a 
polar interaction with His445. However, the mentioned polar interactions span distances in the range 
of >3 Å and are thus of a weak nature. Therefore, it is likely that additional elements contribute to 
thiolate stabilization (see discussion below). The ε-amino group of Lys54 is coordinated by the flavin 
cofactor as well as by Glu189. The N5 and O=4 atom of the isoalloxazine form polar interactions to 
Lys54 as well as to the carboxylic function of the adjacent residue. Arg386, an active site nearby 
residue, is not involved in the hydrogen bond network. The role of the catalytic diad (His445 and 
Glu450) and of Lys54 and Arg386 during catalysis will be discussed later (3.3.1 and 3.3.2). 
The stabilization of the thiolate in lipoamide dehydrogenases has been discussed controversially over 
the last decades. It was assumed that the imidazole of the conserved histidine directly functions as 
stabilizer of the thiolate (Kim and Patel 1992b; Matthews et al. 1979). The structural investigation of 
the ground state structure and of EcE3C45S revealed that the N3 atom of His445 cannot donate a 
hydrogen bond to Cys50 (3.3.1.1). However, weak interaction is observed to Ser45 the major 
hydrogen bond donor to the thiolate attributing a more indirect role for His445 during thiolate 
stabilization. The pKa for Cys50 was determined to be 2.7 and is thus relatively low compared to other 
cystine containing oxidoreductases (Hopkins and Williams 1995a). This denotes that the particular 
milieu of the redox active cystine is pivotal for the acidity of the respective thiol. Besides the hydrogen 
bond network described above further factors may contribute to thiolate stabilization and the lowering 
of the pKa value. At first, the redox active cystine is part of a long alpha helix belonging to the FAD-
binding domain located in the core of the catalytic unit (3.1.3). It was suggested that the positive end 
originating from such helix dipole might contribute to stabilization of the thiolate (Benen et al. 1991). 
Secondly, π-stacking interactions between the electron-rich sulfur and the electron-deficient FAD 
cofactor also may contribute to stabilization implying that cofactor and cysteine residue truly act as an 
electron-donor-acceptor complex. The concomitant alteration in the electronic property of the FAD is 
underpinned by a further bending of the cofactor compared to the ground state structure (Figure 5.23). 
In summary, the crystal structure analysis of the two-electron reduced state of EcE3 revealed that the 
catalytic role of the interchange thiol (Cys45) has to be expanded. So far, this residue was stated to be 
solely important with regard to bond formation with the substrate dihydrolipoamide forming a mixed 
disulfide and the subsequent electron transfer to Cys50 yielding the charge transfer complex. 
However, Cys45 also stabilizes the latter complex by a hydrogen bond contributing directly to a 
further central catalytic state. Moreover, the results obtained allow the prediction that Cys45 is 
protonated during this state of catalysis in the wild type enzyme.  
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3.1.5 Spectral Evidence for the Cysteinyl-C4a Adduct in a monothiol Variant of EcE3 
Rapid reaction experiments showed that the covalent C4a-flavin adduct is highly instable leading to a 
limited accumulation which make this central intermediate undetectable during the transfer of 
electrons from the reduced flavin to the redox active  cystine (3.1.2). These results are consistent with 
previously published data for the lipoamide dehydrogenase from Mycobacterium tuberculosis 
(Argyrou et al. 2002). Further, a direct kinetic observation of the intermediate during catalysis has 
never been possible. The putative accumulation from the opposite direction, transfer from the reduced 
disulfide to the oxidized flavin is discussed in 3.2.3. Thus far, the C4a-cysteinyl adduct has only been 
observed under non-physiological conditions using several enzymes belonging to the class of flavin-
dependent oxidoreductases. At first, in monoalkylated pig heart lipoamide dehydrogenase upon 
addition of NAD
+
 (Thorpe and Williams 1976b, 1981), secondly, in the two electron reduced 
thioredoxin reductase substituted with 1-deaza-FAD at low pH (O’Donnell and Williams 1984), and 
thirdly, also at low pH in mercuric reductase upon rapid mixing with NADPH (Sahlman, Lambeir, and 
Lindskog 1986). In the latter three cases, the spectrum of the adduct was estimated by extrapolation. 
However, there was also direct spectral evidence for the C4a adduct, when an oxidized active site 
triple variant (three out of the four catalytic cysteines were replaced by an alanine, ACAA mutant) of 
mercuric ion reductase was titrated with NADP
+
 also at low pH (Miller et al. 1990). 
Therefore, a monothiol variant (EcE3C45A) was generated in which the interchange thiol forming the 
mixed disulfide during catalysis was replaced by an alanine. This catalytically almost inactive variant 
(5.4) was then subjected to NAD
+
 titrations at lower pH values since it is apparent that both lower pH 
values and the presence of the pyridine nucleotide facilitate adduct formation. The UV-Vis ground 
state spectrum of EcE3C45A is clearly different from that of the wild type enzyme (5.2B). The 
spectrum shows a hypsochromic shift yielding in a λmax = 448 nm, a way less pronounced shoulder in 
the 470 nm region and a very small absorbance between 500 and 700 nm. Interestingly, the spectral 
property is congruent with the spectrum of the aforementioned lipoamide dehydrogenase from pig 
heart in which the interchange thiol had been alkylated (Thorpe and Williams 1976b). No indicative 
band in the range of 380 nm is present in the difference spectrum suggesting that the remaining 
cysteine residue is not bound to the cofactor per se. (5.2B, inset). A comparison with the EH2 mimic 
EcE3C45S leads to the assumption that Cys50 is mostly present in its thiol form since the typical 
charge transfer band in the 530 nm region indicating the thiolate-FAD interaction is missing. The fact 
that the main hydrogen bond donor - Cys45 during the EH2 state - stabilizing the anionic form of 
Cys50 was removed further underpins this assumption (3.1.4). Moreover, it was demonstrated that 
replacement of active sites cysteine residues with alanines in mercuric ion reductase increased the 
hydrophobicity and thus consequently raised the pKa leading to formation of the thiol form. (Miller et 
al. 1990). 
  






 led to small changes in the spectrum of EcE3C45A (Figure 3.5A). An increase in 
absorbance occurs from 300 to 400 nm with a concomitant smaller increase from 500 to 600 nm. 
However, the changes in absorption are not as pronounced as compared to the changes observed in the 
mercuric reductase ACAA mutant where a loss of the typical oxidized flavin absorption was observed 
(Miller et al. 1990). However, the generated difference spectra clearly indicated the presence of a band 
peaking at 380 nm with increasing NAD
+
 concentrations albeit with a small amplitude (Figure 3.5B). 
This increase is accompanied with a quenching of the flavin peak around 450 nm and a more 
pronounced increase in the red part of the spectrum. Strikingly, comparable spectral changes could be 
observed at pH 8.3 (Figure 5.2) indicating that the spectral changes also occur in a more basic 
environment. NAD
+
 titrations under the same conditions for the wild type enzyme did not lead to any 
increase throughout the entire spectrum, solely the quenching in the 450 nm region was visible (Figure 
5.3). 
The obtained spectra suggest that a covalent adduct populated in minor fractions since the rise in 
absorption at 380 nm is completely consistent with the formation of FAD-C4a-adducts (Ghisla et al. 
1974, 1977). Further, the necessity for NAD
+
 binding to induce adduct formation is consistent with 
previous studies (Matthews et al. 1979; Miller et al. 1990; Thorpe and Williams 1976b, 1981). It was 
Figure 3.5 NAD
+
 titration of EcE3C45A. 
(A) Lower temperature NAD
+
 titration at 10 °C and in 100 mM MES pH 6.0. Binding of NAD
+
 leads 
to increase in absorbance between 300 – 400 nm and between 500 – 600 nm, respectively. (B) 
Difference spectra of the same titration. NAD
+
 induces a band formation peaking at 380 nm with a 
concomitant broad increase in absorbance from 500 to 600 nm. Difference spectra were smoothed 
according to a bisquare weighting technique and a polynomial regression. The experiments were 
performed in duplicates.  
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suggested that binding of the positively charged nucleotide at the re face of the flavin increases the 
electrophilicity of the oxidized flavin, thereby promoting C4a-cysteinyl formation (Miller et al. 1990). 
However, recent results generally demonstrated that structural perturbations at the active site seem to 
be essential to close internuclear distances (Klinman 2009, 2010). The role of NAD
+
 during catalysis 
might therefore be expanded. Given the inevitable presence of NAD
+
 to drive adduct formation 
combined with the structural geometry of the FAD-C4a-cysteinyl bond (3.1.6), it is not unlikely that 
the pyridine nucleotide permits an active site compression which is pivotal for the enzyme’s transient 
catalysis. 
Formation of the C4a-adduct in the EcE3 monothiol variant was possible at both low and high pH. It is 
therefore likely that the remaining thiol delivers the proton required for N5 protonation during FAD-
C4a-cysteinyl adduct formation. For mercuric reductase ACAA mutant it was suggested that this 
process might be assisted by polarization of the thiol by general-base catalysis (Miller et al. 1990), 
however the residue qualified for this polarization (Tyr441) turned out to be not correctly positioned 
(Ledwidge et al. 2005). Further, the distance of the EcE3 active site His445 is too long for a direct 
interaction with the adduct forming thiol based on the information provided by the ground state 
structure (Figure 3.15). It is therefore likely that a general base catalysis is not required to drive a 
thiol-based adduct formation so that the increased electrophilicity of the oxidized flavin upon NAD
+
 
binding is sufficient to promote the collapse. 
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3.1.6 Crystallographic detection of the Cysteinyl-C4a Adduct 
During the course of this study it was possible to gather structural information of two distinct catalytic 
states of the EcE3 reaction cycle. Thereby, the ground state structure represents the oxidized state of 
the enzyme (3.1.3) and the structure of EcE3C45S mimics the two-electron reduced state (3.1.4). 
Moreover, the ground state structure also demonstrated the local flexibility of the active site due to 
opening of the redox active  disulfide bridge by radiation damage during data collection. Given the 
information that the synchrotron X-ray radiation can partially alter the enzyme’s redox state this 
radiation was used to trigger the formation of the covalent FAD-C4a-cysteinyl adduct in crystallo. 
Two prerequisites were therefore necessary, at first, a further accumulation of the open state of the 
reactive cysteines and, secondly, the presence of NAD
+
 in the crystal at the time-point of the data 
collection since the nucleotide is thought to facilitate adduct formation. The necessity of the presence 
of NAD
+
 to induce adduct formation was further discussed in 3.1.5. 
A single wild type crystal was therefore soaked with 5 mM NAD
+
 during the cryo protection step and 
the structure was determined using the wild type structure as the starting model (3.1.3). The six 
monomers present in the asymmetric unit were accordingly labeled A – F. The structure was refined to 
Rwork/Rfree of 17.6 /22.1 % against data to 2.6 Å resolution using NCS restraints (Table 5.3). Difference 
map peaks (mFo-DFc at 3 sigma level) which was not related to the protein or water molecules after 
structure refinement were modelled as described above. At least 469 out of the 474 residues were 
visible in each of the six molecules occupying the asymmetric unit whereas the missing residues are 
housed in the C-terminal part, a fact which was also observed in the structure resolved at higher 
resolution. Despite the reasonable quality of the structure no clear evidence for presence of an NAD
+
 
molecule at the re face of the flavin cofactor was found. It was demonstrated that NAD
+
 bound to 
human lipoamide dehydrogenase can adopt different conformations at the binding site (Brautigam et 
al. 2005) explaining a certain flexibility of this ligand-enzyme interaction. Moreover, the usage of a 
highly concentrated sulfate solution as precipitant (2.4 M compared to 5 mM NAD
+
) intrinsically leads 
to a higher occupancy of the precipitant at the diphosphate anchor binding site prohibiting a higher 
population for NAD
+
 (Figure 5.22). However, the usage of higher concentrations of the pyridine 
nucleotide during the phase of cryo protection led to deterioration of the diffraction properties of the 
crystals and was therefore not taken into consideration for further experiments. 
Occupancy refinements as conducted for the ground state structure revealed that the catalytic disulfide 
resided to ~90 % in the open conformation. The first requirement, a further radiation-induced 
reduction of the catalytic cystine, was therefore fulfilled. Moreover, during the phase of model 
improvement cohesive electron density between Cys50 and the C4a atom of the flavin cofactor could 
be observed in subunits A and F in the 2mFo-DFc density map. To further elucidate the nature of this 
density 2mFo-DFc and mFo-DFc difference maps were calculated using CNS program (Brunger 
2007). This analysis revealed the presence of positive difference peaks near Cys50 pointing towards 
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FAD-C4a (Figure 3.6A) in all EcE3 molecules present in the asymmetric unit. Since the default 
settings of the refinement program did not allow a further converging of Cys50 towards the flavin due 
to repulsive interactions the flavins were flagged as alternate conformations corresponding to Cys50 in 
open and closed state, which resulted in overcoming the restriction. Subsequent refinement led to a 






A comparison with the structure of the two-electron reduced enzyme (EcE3C45S) revealed that the 
converged Cys50 residue is in lower distance to the C4a atom of the cofactor (Figure 3.6B). Multiple 
rounds of PHENIX refinements with the same parameters, which led to convergence of Cys50 in the 
E3-NAD
+
 structure, confirmed that the anionic Cys50 of the EH2 structure resided at its position. This 


















Figure 3.6 The flexibility of cysteine50 is determined by its hydrogen bond donor. 
(A) Convergence of Cys50 towards FAD-C4a. CNS calculated 2mFo-DFc map countered at 2  
(blue mesh) and mFo-DFc difference map countered at 3  (green mesh) in molecule A. Applying 
an alternate conformation of FAD allowed a further convergence of Cys50 towards FAD since 
repulsive interactions restraints were overcome. The converging conformer of Cys50 is displayed by 
an enlarged ball and stick representation. Residual five molecules in the asu showed comparable 
difference peaks. 
(B) Superposition of the catalytic cystine of the EcE3-NAD structure (light grey) with the EH2 state 
of EcE3C45S (red). In EcE3C45S a further migration towards FAD-C4a is prevented. The hydrogen 
bond between Ser45 and Cys50 is indicated by a dashed line. For convenience the closed 
conformation of the EcE3-NAD structure is not shown. 
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EcE3C45S is impeded (Figure 3.4). In addition, this impairment is further confirmed by a significantly 
reduced enzyme activity compared to the wild type enzyme (5.4). The structural and electronic 
properties leading to this inertance of the thiolate in the variant have been discussed in 3.1.4. Though 
the convergence of Cys50 could be proven an appropriate model building was not possible since the 
difference map peak were at a position within the B-factor spread of the open conformation. 
To rule out that the additional density was only based on elevated atomic displacement parameters and 
was thus model biased the possible presence of a covalent conjugate between Cys50 and FAD-C4a 
was investigated by the generation of simulated-annealing OMIT maps in which both the flavin 
cofactor and the cystine were omitted. The calculated model-bias free mFo-DFc electron density map 
revealed the presence of prominent cohesive density between cysteine50 and the C4a atom of the 
flavin in molecule A and molecule F of the asymmetric unit and thus the likely presence of a 
populated covalent FAD-C4a-cysteinyl adduct (Figure 3.7). 
 
 
Two aspects have to be considered underpinning the likely presence of a covalent linkage between 
Cys50 and FAD-C4a. At first, the density approaches from both interacting partners towards each 
other, from the cysteine as well as the FAD. Thus, the congruent density is not only based on a highly 
mobile cysteine further migrating towards the cofactor but also on structural rearrangements at the 
flavin site presumably the formation of a tetrahedral C4a atom pointing towards Cys50. Secondly, the 
Figure 3.7 Evidence for cohesive electron density between Cys50 and FAD-C4a. 
The presence of cohesive density implicating a covalent linkage between Cys50 and FAD-C4a is 
supported by an mFo-DFc simulated-annealing OMIT map displayed at different sigma levels 
(magenta mesh) for one of the active sites (monomer F). Note that with decreasing sigma level the 
electron density converges from both omitted parts, the cystine and the FAD. An overview of SA 
OMIT maps for all molecules in the asymmetric unit countered at equal sigma level is shown in the 
appendix (Figure 5.25). 
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atomic displacement parameters of the cofactor and the redox active cystine are not significantly 
elevated compared to the residues around the active site (Figure 5.24). Taking these considerations 
into account an appropriate model building of the covalent adduct was possible. 
The electron density allowed the modelling of additional conformations of both the flavin and Cys50. 
An additional side chain rotamer for Cys50 (50 % probability) taken from the Coot side chain library 
(Emsley et al. 2010) suitable fitted into the SA OMIT maps without the need of further adjustments 
(Figure 3.8). A covalent adduct at the C4a position of the flavin requires a tetrahedral geometry of this 
part of the isoalloxazine moiety. Therefore, a tetrahedral FAD with the C4a atom pointing towards 
Cys50 was modeled in the OMIT density using a rigid body fit. This fit implicated a restrain 
concerning the bond length between the C4a and sulfur atom of Cys50 which was set to 1.81 Å, a 
typical length for a C-S bond (Figure 3.8). The resulting overall model adequately fitted into 
calculated OMIT maps and thus likely reflects the crystallographic detection of the FAD-C4a-
cysteinyl adduct which has been predicted to exist but an experimental proof was thus far missing. 
This study supports the existence of this long-sought-after intermediate not only by UV-Vis 





3.1.7 Is the geometry of the FAD-C4a-cysteinyl adduct the fundament for its 
transience? 
Given the spectroscopic and structural information about the transient nature of the FAD-C4a-










Figure 3.8 Structural model of the covalent C4a-
cysteinyl adduct. 
The model represents an additional redox state of 
EcE3. Besides the previously described open and 
closed conformation of the redox active  cystine 
the modelling of the conformer which is bound to 
the FAD is possible. The tetrahedral FAD was 
modelled into the mFo-DFc SA-OMIT map 
(countered at 4 ; magenta mesh) using a rigid 
body fit implying a bond length of 1.81 Å between 
C4a and Sγ of Cys50. 
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solution data suggested that the C4a-cysteinyl adduct only accumulates to a minor extent (3.1.5). In 
addition, a direct spectroscopic observation during the reaction cycle was also not possible, neither 
with the oxidative half-reaction (NADH as reductant) nor with the reductive half-reaction (Lip3H2 as 
reductant) as starting point (3.1.2 and 3.2.3). The half-life was estimated to be <2 ms and the decay is 
thus at least 250-fold faster compared to C4a-cysteinyl adducts in LOV domains. Here, the thermally 
driven dark state recovery is generally larger than 500 ms but can also last hours (Conrad et al. 2014). 
The decay in LOV domains is modulated by numerous of effects like the accessibility of solvent 
towards the active site, the electronic environment of the flavin and the hydrogen bonding network to 
the cofactor (Losi and Gärtner 2011, 2012; Zoltowski et al. 2009). Moreover, the presence of a base 
also has the ability to modulate adduct decay (Alexandre et al. 2007). The differences in the hydrogen 
bonding network of EcE3 compared to LOV domains around the flavin cofactor will be discussed later 
(3.4.4).  
Besides this plethora of key modulators, a geometrical aspect was also taken into account acting as 
driving force responsible for adduct decay. The energy content of the adduct state in LOV domains 
was estimated to be 110 – 140 kJ mol
-1
 indicating a strained protein conformation (Losi, Kottke, and 
Hegemann 2004; Losi, Quest, and Gärtner 2003). These results are in slight disagreement with X-ray 
crystallographic data (Crosson and Moffat 2001, 2002). Dark and lit state structures revealed that only 
minor rearrangements in the protein are required to induce both adduct formation and decay. Indeed, 
the structural changes seem to be limited to the FMN on the one, and the bond forming cysteine on the 
other hand yielding a tetrahedral C4a-cysteinyl adduct (Crosson and Moffat 2002) (Figure 3.9A). The 
small ɑ-helix of which the bond-forming cysteine is part of is positioned in a way that a simple 
rotamer movement of the latter cysteine is sufficient to fulfill adduct formation. On the contrary, the 
redox active cystine of EcE3 is part of a long ɑ-helix protruding through the entire EcE3 monomer 
which does not allow the formation of relaxed tetrahedral flavin-cysteinyl adducts. A more detailed 
comparison of these structural data revealed that the adduct in EcE3 deviates from tetrahedral 
geometry harboring a Cβ-Sγ-C4a angle of >117 ° (Figure 3.9B). Since geometrical aspects have been 
shown to be crucial to enhance enzyme catalysis (Lüdtke et al. 2013; Tittmann 2014) it is possible that 
this aspect also have to be taken into account for lipoamide dehydrogenases. It is therefore most likely 
that the high transience of the adduct is, at first, based on its distorted geometry of the C4a-cyteinyl 
adduct and secondly based on the necessity of the presence of NAD
+
 which is required per se to 
facilitate adduct formation (3.1.5). 
  




3.2 Investigation of the reductive half-reaction of EcE3 using EcLip3 as 
native Substrate 
The assignment of different reaction intermediates starting from the oxidative half-reaction with 
NADH as reductant was successfully established (3.1.2). To further investigate the reaction 
mechanism of EcE3 the isolated reductive half-reaction was also subjected to stopped-flow absorbance 
spectroscopy. The native substrate of lipoamide dehydrogenases are the reduced lipoamide arms of the 
E2 component of several multienzyme complexes. Thus, the most elementary in vitro substrates would 
be D,L-dihydrolipoamide or D,L-dihydrolipoate. However, these substrates show high KM values, and 
in addition, D,L-lipoamide has limited solubility in aqueous solutions (2.2.4.1) (Argyrou and 
Blanchard 2001). There has been effort to mimic the physiological substrate more closely thereby 
improving substrate affinity and water solubility by the synthesis of D,L-lipoylbutanoate and D,L-
lipoylpentanoate (Argyrou et al. 2003). Both artificial substrates, containing an extended lipoic acid 
arm, with three and four additional methylene groups, respectively, were used successfully as 
substrates after reduction with borohydride yielding the respective dihydro-form. Significant higher 
kcat/KM values for both synthesized substrates relative to that of D,L-lipoamide reflected the increased 


















Figure 3.9 Comparison of the geometries of C4a-cysteinyl adducts in LOV domains and in EcE3. 
(A) Superposition of the dark (dark grey) and lit state (light grey) of Adiantum LOV2 (PDB: 1G28 and  
1JNU). The angle of 113 ° between Cβ-Sγ-C4a allowed a tetrahedral modelling. (B) Structural model 
of the covalent adduct in EcE3. The Cβ-Sγ-C4a angle of >117 ° reveals an extended deviation from 
tetrahedral geometry. 
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Figure 3.10 In vitro and native 
substrates of lipoamide dehydrogenases. 
D,L-lipoate and D,L-lipoamide reflect 
the most elementary artificial substrates 
and suffer from high KM values and 
limited water solubility. D,L-
lipoylbutanoate and D,L-
lipoylpentanoate were synthesized and 
successfully used as substrates to 
overcome the mentioned problems 
showing increased catalytic proficiencies 
(Argyrou et al. 2003). EcLip3 is 
composed of the innermost lipoyl 
domain of EcE2 including lipoic acid 
covalently bonded to the ε-amino group 
of a lysine. residue (5.1). 
physiological substrate as reductant are missing. Therefore, the entire third lipoyl domain of the E. coli 
dihydrolipoyl transacetylase (EcE2) was isolated, transferred in its dihydro-form under physiological 
conditions and used as substrate during both stopped-flow and sequential stopped-flow absorbance 





3.2.1 Characterization of EcLip3 and its Reduction to the dihydro-form (EcLip3H2) 
Isolation and characterization of a single lipoyl domain has already been achieved, however, this 
isolated domain represented a hybrid between the first and third lipoyl domains of the E. coli E2 
component (Ali and Guest 1990). In contrast, EcLip3 harbors the native EcE2 amino acid sequence 
(5.1). His6-SUMO-EcLip3 could be purified in high amounts and removal of the fusion protein lead to 
the desired isolated domain. Since EcLip3 should serve as substrate for EcE3 the lipoylation status of 
the isolated domain after purification was essential since unlipoylated domains would compete with 
the active sites of the oxidoreductase and thus influence kinetic and spectroscopic parameters. The 
lipoylation status was checked by MALDI-TOF MS of tryptic fragments of EcLip3 (2.2.6.2). An MS 
approach without prior tryptic digestion to check the presence of the post-translational modification 
was described earlier (Seifert 2010; Wei et al. 2003). However, the application of the latter method is 
limited to the use of single isolated domains since a discrimination of two individual lipoylation sites 
is not possible. On the contrary, the generation and further analysis of tryptic fragments offers the 
potential for an future application on multidomain constructs, e.g. EcLip2-Lip3, or even the full-length 
EcE2 component. MALDI-TOF MS revealed that EcLip3 was fully lipoylated after purification 
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ensuring homogeneity of the future substrate (Figure 3.11A). Therefore, an in vitro post-translational 
modification using lipoate-protein ligase A was not necessary. 
Interaction of EcLip3 with EcE3 was investigated by ITC using the same buffer conditions as used for 
the kinetic experiments (3.2.2). Binding between the two individual components was evident, however 
detected changes in enthalpy were rather small (Figure 5.20). Thus, a reliable determination of binding 
parameters was not possible. A comparable binding behavior was described for the interaction of the 
human lipoyl domain 2 (hLip2) and the human pyruvate dehydrogenase (hE1) (Seifert 2010). It might 
be concluded that binding of lipoyl domains to other PDH components is always of a weak nature, 
however, this contrasts with earlier published results which showed binding constants in the lower 
micromolar range (Kato et al. 2008). The interaction of the motile parts of the PDH complexes are 
thus still a matter of controversial and were not further studied during this project. The affinity of 
reduced EcLip3 (EcLip3H2) to EcE3 was not investigated since EcLip3H2 is able to serve as substrate 
(see below) und thus detected heat changes would reflect reduction of the flavin cofactor rather than 
binding events. 
Reduction of a dithiolane moiety usually requires borohydride and low pH values (Argyrou et al. 
2003), conditions which are not suitable for isolated proteins. Therefore, the transfer into 
dihydrolipoamide under physiological conditions is required and can be realized by the usage of TCEP 
(Wang et al. 2014). Reduction of EcLip3 to EcLip3H2 by TCEP leads to opening of the dithiolane 
moiety and an concomitant loss in absorbance at 333 nm (Figure 3.11B). According to far-UV CD 
spectra the secondary structure of EcLip3 is not affected by the reduction retaining its signature typical 
for β-turns (Perczel and Fasman 1992). The spectroscopic results are moreover in line with previously 
published NMR data of the aforementioned hybrid lipoyl domain (Green et al. 1995). 
  













































































Figure 3.11 Evidence of the structural integrity of EcLip3 and EcLip3H2. 
(A) MALDI-TOF MS analysis of tryptic EcLip3. Presence of the fragment with an m/z 3032.0 shows 
that EcLip3 is fully lipoylated after purification (2.2.6.2). (B) Reduction of EcLip3 by TCEP to 
EcLip3H2 leads to decrease in absorbance at 333 nm. (C) Far-UV-Vis CD spectra of EcLip3 and its 
dihydro-form (0.1 mg/mL each). Reduction of the dithiolane moiety has no influence on the 
secondary structure. 
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3.2.2 EcLip3H2 as native Substrate to track the reductive Half-reaction of EcE3 
Since reduction of EcLip3 to EcLip3H2 was successful, the reduced form should serve as native 
reducing agent for EcE3 to track the reductive half-reaction using stopped-flow absorbance 
spectroscopy. Major emphasis was thereby devoted to the detection of the covalent FAD-C4a-
cysteinyl adduct. Rapid reduction of Eox by EcLip3H2 under single turnover conditions transferred the 
oxidized form of the enzyme into its two-electron reduced state (EH2). The absorbance increased at 
390-440 and 500-620 nm, and decreased at 340-380 and 440-500 nm. The presence of the broad 
absorption band between 500-620 nm and the concomitant blue shift of the flavin peak reflects the 
charge-transfer situation between the anionic form of Cys50 and the flavin cofactor (Figure 3.12A). 
Titration of EcE3 with >10-fold molar excess of Lip3H2 did not lead to EH4 formation indicating that 
the enzyme resided in the catalytically active EH2 state. This result is in disagreement with a previous 
study which demonstrated that dihydrolipoic acid is indeed able to overreduce the E. coli enzyme to 
the EH4 state under anaerobic conditions (Reed et al. 1960). The comparable reversible midpoint 
potential for dihydrolipoic acid was determined to be - 325 mV at pH 7 and 25 °C and is thus on par 
with that of NADH (Ke 1957; Unden and Bongaerts 1997). A comparable reduction behavior should 
be the consequence; however, reduction of EcE3 by the native domain seems to be more complex than 
with the low molecular weight substrates. 
Formation of the charge-transfer band at 530 nm occurs monoexponentially with ~180 s
-1
 (Figure 
3.12C), which is approximately 3.5-fold faster compared to single turnover conditions during the 
oxidative half-reaction using NADH as reductant (3.1.2). The following decay proceeds with at least 
two exponentials and probably results in the multiple equilibria of the EH2 state as described in detail 
in 3.1.2 and 3.1.4. According to the absorbance trace at 380 nm there is no evidence for a significant 
accumulation of the covalent FAD-C4a-cysteinyl adduct, neither during Cys50-thiolate-formation nor 
during development of the different equilibrium species (Figure 3.12D). The decrease in this 
absorbance range absorbance is in fact based on the blue shift of the entire EH2 flavin signature. 
Though a direct evidence for the cysteinyl-C4a adduct was not found, EcLip3H2 was successfully used 
as a native reductant for EcE3 allowing the spectroscopic and kinetic investigation of the reductive 
half-reaction. Besides the usage during rapid reaction measurements, an application of EcLip3H2 
during classic steady-state kinetics is also imaginable. Purification yields and the fact that EcLip3 
could be highly concentrated (>3 mM) would thus allow the determination of its catalytic proficiency. 
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Figure 3.12 Reduction of EcE3 by EcLip3H2 under single turnover conditions. 
(A) Stopped-flow absorbance traces after mixing 20 µM EcE3 with 20 µM EcLip3H2 at 4 °C and 
pH 7.6. The broad absorption band at 530 nm shows the presence of charge transfer between the 
Cys50  thiolate and the FAD. (B) Titration of EcE3 with EcLip3H2. The dotted line reflects a typical 
wt-EH4 spectrum after reduction with excess of NADH. >10-fold molar excess of EcLipH2 did not 
lead to formation of EH4. (C and D) Absorbance traces at 523 and 523 nm and corresponding fits. 
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3.2.3 Evidence for the Transience of the Cysteinyl-C4a Adduct 
As described above, the covalent C4a-flavin adduct did not accumulate significantly neither in the 
whole reverse direction (3.1.2) nor during the isolated oxidative half-reaction (3.2.2). However, a 
spectroscopic evidence for an NAD
+
-induced adduct formation was achieved using a monothiol 
variant of EcE3 using conventional absorbance spectroscopy (3.1.5). According to the latter, the 
accumulation of the adduct in solution under equilibrium conditions is rather minute. The successful 
establishment of EcLip3H2 as native reductant of EcE3 allows the spectroscopic characterization of 
the entire reaction cycle with the oxidative half-reaction as starting point. Therefore, EcE3 was 
transferred into the EH2 state by rapid reduction with EcLip3H2 followed by a second rapid mixing 
event with NAD
+
 to complete the cycle using low-temperature sequential stopped-flow absorbance 
spectroscopy (Figure 3.13A). A comparable method was described earlier for the Mycobacterium 
tuberculosis lipoamide dehydrogenase, however, the EH2 pre-equilibrium was generated by titration 
with dithionite and not with a native substrate as described here (Argyrou et al. 2003). 
The first mixing event generated the EH2 state of EcE3 indicated by its characteristic charge-transfer 
band at 530 nm (Figure 3.13B and C). After generation of the pre-equilibrium (50 ms) NAD
+
 
(equimolar  and 5-fold molar excess) was added in a second step leading to a loss in absorbance in the 
530 nm range and concomitant increase at 340 nm within the dead-time of mixing. Though the first 
spectrum was recorded after 5 ms the generation of NADH (340 nm) and loss of the charge-transfer 
band indicate that a spectroscopic detection of the C4a-flavin adduct was not possible since the 
reaction already came to an end (Figure 3.4B and C). Hence, a spectroscopic detection of the 
EH2·NAD
+
-complex was also not possible. The latter complex is characterized by a red-shifted (to ~ 
600 nm) charge-transfer band which could be detected for the Mycobacterium tuberculosis and the pig 
heart enzymes (Argyrou et al. 2003; Wilkinson and Williams 1979). The increased overall reaction 
velocity of the E. coli enzyme compared to mentioned isoforms further complicates not only the 
detection of the C4a-flavin adduct. Moreover, the determination of absolute kcat values in dependence 
of NAD
+
 is not possible with the setup described above. 
In conclusion, there is evidence that the covalent C4a-flavin adduct does not accumulate to a 
significant extent during catalysis. Its high instability and its transience were confirmed by monitoring 
the EcE3 reaction cycle from the forward (EH2 + NAD
+
) and the reverse direction (Eox + NADH). It 
was proposed that the instability of the intermediate is based on a faster decay compared to its 
relatively slow formation in both directions for the Mycobacterium tuberculosis enzyme (Argyrou et 
al. 2003). Thus, the transient nature of the covalent C4a-flavin adduct in lipoamide dehydrogenases 
seems to be a hallmark in this enzyme class. 
 























































1st shot pre-equilibrium 2nd shot
Figure 3.13 Sequential stopped-flow absorbance analysis of the EcE3 reduction by EcLip3H2 and 
subsequent oxidation by NAD
+
 at 4 °C. 
(A) Schematic of the sequential mixing experiment. First, EcE3 (40 µM) is mixed with Lip3H2 
(40 µM), forming the pre-equilibrium EH2 status of EcE3. Oxidation of EH2 is accomplished by the 
second mixing step (50 ms after the first step) with NAD
+
. (B) Oxidation of the pre-equilibrium 
with an equimolar amount (20 µM) and (C) with an 5-fold molar excess (100 µM) NAD
+
. Eox 
reflects the oxidized spectrum – obtained by mixing solely with buffer, EH2 is the two-electron 
reduced state – obtained as described above – with subsequent mixing with buffer. 5 ms reflects the 
first possible spectrum recorded after mixing with NAD
+
. 
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3.3 Mechanistic Investigation of EcE3 
The study thus far provided new insights in the catalytic function of lipoamide dehydrogenases. The 
findings were thereby mainly based on mutations targeting the redox active cystine moiety of the 
oxidoreductase. However, it was demonstrated that several other residues located around the active 
site harbor crucial functions during the catalytic cycle (Benen et al. 1991; Benen, Van Berkel, 
Dieteren, et al. 1992; Benen, Van Berkel, Veeger, et al. 1992; Maeda-Yorita et al. 1994). These and 
further residues were therefore investigated with the aforementioned methods to broaden the 
understanding of the reaction mechanism of EcE3. 
It is described that the level to which lipoamide dehydrogenases are reduced beyond the EH2 state 
allows qualitative statements about the flavin redox potential (Maeda-Yorita et al. 1994). The latter 
fact will be used to expand the knowledge about the sensitivity of the flavin surrounding against 
structural alterations. Since the reaction cycle can be subdivided into a reductive and an oxidative half-
reaction the results will be presented following the order of this subdivision starting with the reductive 
half-reaction (3.3.1). The oxidative half-reaction will be investigated in 3.3.2. An overview of all 
studied residues and their occurrence in lipoamide dehydrogenases from several organisms is given in 
the appendix (Figure 5.4). 
3.3.1 Characterization of the Reductive Half-Reaction using selected Active Site 
Variants 
In the reductive half-reaction, the substrate dihydrolipoamide binds to the Eox form of EcE3, and 
Cys45 forms a mixed disulfide with the substrate. Transfer of electrons leads to formation of the 
Cys50- thiolate and thus the two-electron reduced state (EH2) (1.5). This reaction is general-acid-base 
catalyzed by the essential and conserved catalytic diad located at the C-terminus of the adjacent 
monomer, namely His455 and Glu450 (Figure 3.14). Release of lipoamide completes the oxidative 
half-reaction. A further investigation of the Glu-His pair with respect to their individual roles during 
catalysis is therefore interesting. In addition, a highly conserved tyrosine residue is also located at the 
putative lipoamide entry site (Figure 3.14). In order to elucidate whether Tyr19 also harbors an 
essential catalytic function as it has been described for the diad (Benen et al. 1991; Benen, Van Berkel, 
Dieteren, et al. 1992; Kim and Patel 1992a) it was also targeted for the mechanistic investigation. 
  




The visible absorption spectra of EcE3Y19F, H445A and E450Q are very similar to that of the wild 
type enzyme (5.2). This indicates that the mutations did not influence the surrounding of the flavin to a 
significant amount. Mutations at the site of the catalytic diad, however, had severe impact on the 
catalytic activity (Table 3.1). EcE3H445A showed below 0.1 % residual activity under standardized 
assay conditions (5.4), but it should be noted that the actual activity might even be lower. When 
NADH served as reductant it cannot be excluded that reducing equivalents are transferred to other 
electron acceptors than lipoamide during diaphorase reactions. Hence, it is most likely that molecular 
oxygen oxidizes the reduced flavin intermediate leading to NADH consumption (5.4). The impact of 
mutation of Glu450 was not that drastic compared to its bonding partner showing ~4 % residual 
activity. According to far-UV CD spectroscopy mutation of Tyr19 to phenylalanine did not affect the 
secondary structure of the enzyme though it is located directly at the dimer interface (5.6). In addition 









Figure 3.14 Putative 
position of the lipoamide 
binding site. 
The residues studied 
involved in the reductive 
half-reaction are located at 
the si face of the FAD and 
comprise the highly 
conserved catalytic diad; 
His445 and Glu450; and 
Tyr19. The putative entry 
site for the lipoamide 
cofactor is located at the 
dimer interface. The 
displayed water molecule 
might harbor a placeholder 
function. 
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Table 3.1 Steady-state parameters of EcE3variants involved in the reductive half-reaction. 
Parameters were calculated from data of the reverse steady-state assay (2.2.4.1). Plots of lipoamide 
dependence for individual variants are shown in the appendix (5.4). 







72.9 ± 4.6 
70.7 ± 3.3 
0.06 ± 0.01 





*(Wilkinson and Williams 1981) 
 
3.3.1.1 Histidine445 and Glutamate450 – The Role of the Catalytic Diad during Catalysis 
As the steady-state assays demonstrated mutation of the catalytic diad severely slowed down the 
reaction rates of the respective enzyme. Therefore, they were likely candidates that are potentially able 
to stabilize the covalent C4a-cysteinyl adduct. An investigation using rapid reactions measurements 
was hence obligate. Reduction of EcE3H445A with NADH leads to spectroscopic properties which 
differ from that of the wild type enzyme (Figure 3.15A and B). Though a decrease in absorbance of 
the flavin is observable under single turnover conditions the typical blue-shift of the latter is way less 
pronounced. Moreover, there is no significant rise in absorbance in the 523 nm range indicating the 
Cys50-thiolate charge transfer complex with the FAD. However, the highly transient NAD
+
-FADH2 
complex is significantly stabilized in this variant indicated by the broad charge transfer band in the 
longer wavelength region. Reduction with 5-fold excess of NADH lead to a complete flavin reduction 
(Figure 3.15B), but also in this case there is no spectroscopic evidence for reduction of the disulfide. 
On the contrary, the NAD
+
-FADH2 complex accumulates to a way higher extent according to the 
broad absorption band between 600 and 700 nm. Reduction of EcE3E450Q with NADH leads to 
comparable results with respect to accumulation of the nucleotide-flavin complex. However, the 
presence of the charge transfer bands at 523 nm suggests that the intramolecular electron transfer to 
the disulfide is still possible albeit retarded when compared with the wild type enzyme (Figure 3.15C). 
During all experiments using NADH as reductant no increase in the 380-nm absorbance range was 
detected that would indicate a stabilization of the flavin adduct. 
  








The reduction of the mutated enzymes with NADH allowed the distinction of separate reactions steps 
and a subsequent comparison to the wild type. In both cases, the hydride transfer from NADH to FAD 
is fast and leads to a pronounced accumulation of the NAD
+
-FADH2 complex in comparison to the 
wild type. This indicates, that the transfer of reducing equivalents from the reduced flavin to the redox 
active disulfide is significantly slowed down (E450Q) or even impaired (H445A). The H445A mutant 
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Figure 3.15 General characterization of the EcE3 catalytic diad – His445 and Glu450. 
Stopped-flow absorbance traces of EcE3 variants upon reduction with NADH (A - C). 20 µM 
EcE3H445A were mixed with 20 µM (panel A) or with 100 µM NADH (B) at 4 °C and pH 7.6. (C) 
Reduction of EcE3E450Q with 100 µM NADH. The dashed line represents the oxidized form of the 
respective enzyme (Eox) derived from a single mixing event with buffer. The solid spectra were 
recorded using a diode-array detector after mixing at the concentrations indicated. (D) Hydrogen 
bond network between the catalytic diad and the redox active cystine. N3 of His445 is too far away 
for a direct stabilization of the Cys50-thiolate (see 3.1.4). A putative interaction with a Cys45-
thiolate is likely mediated via a water molecule (red sphere). Glu450 ensures the correct orientation 
of the imidazole moiety of His445 (distances in Å). 
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was not capable to stabilize the Cys50-thiolate charge transfer neither under single turnover 
conditions, nor in the presence of a five-fold molar excess of NADH. The small increase in the 523 nm 
region which can be observed in Figure 3.15A is most likely due to the offset correction of the spectra 
rather than the formation of a true thiolate species. The absence of a hypsochromic shift of the flavin 
peak underpins the assumption that no reduction of the disulfide occurs. Further, the almost complete 
loss of catalytic activity of EcE3H445A enhances the latter assumption. These results are in agreement 
with previous studies on the E3 from A. vinelandii which showed that the conserved histidine acts as 
catalyst being in involved in (de)protonation of the interchange thiol (Cys45) and the substrate 
dihydrolipoamide, a step which is essential for an opening of the disulfide (Benen et al. 1991; Benen, 
Van Berkel, Dieteren, et al. 1992). Structural data suggest that a direct interaction of His445 with the 
Cys50-thiolate is not very likely (Figure 3.15D). Stabilization of the latter thiolate was discussed in a 
previous chapter (3.1.4). However, it was suggested that the interchange thiol can also be present in its 
anionic form since the EH2 state of EcE3 is actually a mixture of distinct spectroscopic species 
(Benen, Van Berkel, Dieteren, et al. 1992; Wilkinson and Williams 1979). It was suggested that the 
interchange thiolate can be stabilized by an interaction with an hydronium ion (Benen et al. 1991) due 
to the easy accessibility of the latter residue to the solvent. In fact, the EcE3 ground state structure 
revealed the presence of such water molecule which is coordinated by both His445 and the open 
conformer of Cys45 (Figure 3.15D). 
When combining the spectroscopic and structural data the catalytic role of Glu450 during catalysis can 
be proposed. Glu450 ensures the correct orientation of the imidazole moiety of His445 towards Cys45 
and the putative entry site for dihydrolipoamide (Figure 3.15D). A substitution of this residue with 
glutamine consequently leads to a weakening or a loss of the hydrogen bond with the imidazole of 
His445 which most likely alters the orientation of the histidine relative to the interchange thiol. 
Further, this might also influence the pKa of the histidine, an aspect which has been discussed 
elsewhere (Benen et al. 1991). In contrast to His445, Glu450 is not essential for catalysis, but it is 
indicative that the carboxylic group of Glu450 functions as both as mediator for the pKa (Benen et al. 
1991) and as structural element positioning the imidazole N3 towards the redox active disulfide. 
Though the transfer of the reducing equivalents is slowed down (~5-fold with respect to thiolate 
formation) in EcE3E450Q there has not been evidence for the accumulation of the covalent flavin-
cysteinyl intermediate. It was suggested that the decay of the C4a adduct might be faster than its 
formation in either direction making an spectroscopic detection tedious work (Argyrou et al. 2002; 
Benen, Van Berkel, Dieteren, et al. 1992). Apparently, this also holds true for the E. coli enzyme. In 
the case of the His445 mutant the absence might be even more coherent assuming that an opening of 
the disulfide is entirely impaired in this variant. 
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3.3.1.2 Tyrosine19 acts as structural Element rather than as a catalytic Residue 
Mutation of Tyr19 to a phenylalanine did not influence the specific activity of the enzyme to high 
extent in the standard assay (5.4). In addition, rapid reaction experiments confirmed that the latter 
mutation also did not have an effect on the spectral properties during both reduction with NADH and 
EcLip3H2 (Figure 3.16). Formation of the Cys50-thiolate flavin complex can be observed during both 
reduction processes with similar rates, respectively, when comparing to the wild type enzyme. In 
addition, the highly transient NAD
+
-FADH2 complex does not accumulate during reduction with 




According to the results obtained it is most likely that Tyr19 does not contribute to catalysis in EcE3 
since removal of the hydroxyl function did not alter the catalytic abilities of the enzyme to a 
significant extent. However, these results are contradicting with studies on the corresponding residue 
in the A. vinelandii E3 (Tyr16 according to A. vinelandii numbering). For this enzyme variant no 
activity was observed during steady-state assays using NADH as reductant (Benen, Van Berkel, 
Veeger, et al. 1992). Moreover, the mutated enzyme was easily overreduced by NADH while lacking 
the thiolate-flavin complex upon reduction demonstrating that the reducing equivalents mainly resided 
on the flavin rather than being transferred to the disulfide (Benen, Van Berkel, Veeger, et al. 1992). 
Figure 3.16 Stopped-flow absorbance traces of EcE3Y19F. 
20 µM EcE3Y19F were mixed with 100 µM NADH (A) or with 20 µM EcLip3H2 (B) at 4 °C and 
pH 7.6. The dashed lines represent the oxidized form of EcE3Y19F (Eox) derived from a single 
mixing event with buffer. The solid spectra were recorded using a diode-array detector after mixing 
at the concentrations indicated. 
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These spectral properties are similar to that of the EcE3 variants which were used to study the 
oxidative half-reaction (3.3.2). Hence, the tyrosine raised the redox potential of the flavin in the 
A. vinelandii enzyme. This elevation was not observed in the E. coli mutant where a 5-fold molar 
excess of NADH was required to overreduce the enzyme to the dead-end EH4 state – the same amount 
which was also required for EcE3wt. 
In the A. vinelandii enzyme Tyr16 hydrogen bonds with His470 of the C-terminal part of the other 
subunit (Mattevi et al. 1991). It was speculated that this interaction stabilizes the homodimer thus 
contributing to optimal catalysis and protection against inhibition/overreduction by NADH (Benen, 
Van Berkel, Veeger, et al. 1992). However, it remained unclear how this interaction could influence 
the flavin redox potential since this interaction is far away from the active site. It was therefore 
speculated that the dimer interaction itself modulates the redox properties, but a clear proof was not 
given (Benen, Van Berkel, Veeger, et al. 1992). In EcE3, Tyr19 does not contribute to the subunit 
interaction via hydrogen bonding to a residue of the other subunit. Thus, a cross-talk between the two 
monomers assisted by Tyr19 is not likely. Moreover, the aforementioned histidine of the A. vinelandii 
enzyme is not present in the EcE3 (Figure 5.4). Hence, the results obtained for EcE3Y19F, which 
reflects a wild type behavior, are not unexpected in the light of catalysis potentially regulated by 
monomer-monomer interaction. That the flavin redox potential indeed can be regulated by mutation of 
a another residue present at the dimer interface (Glu354) will be shown and discussed in a following 
chapter (3.5). 
3.3.2 Characterization of the Oxidative Half-reaction using selected Active Site 
Variants 
In the oxidative half-reaction, NAD
+
 binds to the two-electron reduced state of the enzyme (EH2). This 
induces an internal electron transfer from the redox active disulfide towards the flavin cofactor 
yielding a transiently formed FADH2 intermediate. The flavin is immediately reoxidized by NAD
+
 
generating NADH and the oxidized form of the enzyme (Eox). Release of NADH completes the 
reductive half-reaction. 
Replacements of residues at the site of the catalytic diad significantly decreased or even depleted the 
rate of substrate turnover, but an accumulation of the flavin-C4a-cysteinyl adduct did not occur 
(3.3.1.1). Therefore, the investigation was expanded to residues at the re face of the flavin which are 
thought to assist (de)protonation of the N5 atom of the flavin cofactor during the oxidative half-
reaction (Maeda-Yorita et al. 1994) and therefore site directed mutagenesis of the residues involved 
might lead to EcE3 variants that accumulate the covalent intermediate. 
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The ammonium function of Lys54 is located close to the isoalloxazine ring and makes a weak polar 
interaction with N5 (Figure 3.17). The previously solved structure of EcE3 (PDB: 4JDR) 
demonstrated that the interaction of Lys54 with N5 is further mediated by a water molecule (Figure 
1.4) (Chandrasekhar et al. 2013). Difference map peaks (mFo-DFc at 3 sigma level) were visible in the 
same region for the structure presented here, but the peaks were too weak to allow an appropriate 
model building. However, the presence of a water molecule at the mentioned position is not unlikely. 
Besides the interaction with the cofactor, the lysine residue forms an ion pair with Glu189 positioning 
the positive end of this salt bridge towards the flavin (Figure 3.17). These two residues are not only 
conserved in E3s from different organisms (Figure 5.4), but also in all homologous enzymes of the 
pyridine nucleotide-disulfide oxidoreductase family. It has been suggested and later on demonstrated 
that the positive charge of the lysine plays a crucial role in mediating the redox potential of the flavin 
in both glutathione reductase as well in EcE3 thus contributing to optimal catalysis (Maeda-Yorita et 
al. 1994; Schulz and Pai 1983). Both residues were therefore mutated to glutamines, respectively, 
which lead to a disruption of the ion pair interaction but still allowed hydrogen bonding interactions. 
Arg386 of the adjacent monomer is located at the dimer interface and the distance of its guanidinium 
group is ~7 Å to the ε-amino group of Lys54 (Figure 3.17). The corresponding residue (Arg382) in 
E. coli mercuric ion reductase is thought to participate in a proton transfer reaction during catalysis by 
a direct interaction with the catalytic lysine (Susan Miller, University of California, personal 
communication). Hence, this residue was also targeted for the mechanistic investigation aiming to 








Figure 3.17 Overview of the 
re face of the FAD. 
Lys54 makes a polar 
interaction with N5 
(distances in Å). The residue 
is thereby positioned by 
Glu189. In the previously 
solved structure of EcE3 
(PDB: 4JDR) the interaction 
of Lys54 with N5 is further 
mediated by a water 
molecule (Chandrasekhar et 
al. 2013). Arg386 of the 
adjacent monomer (grey) is 
located at the dimer 
interface. For the putative 
role of this residue see text. 
RESULTS AND DISCUSSION 
93 
 
The visible absorption spectra of EcE3K54Q and E189Q harbor minor changes when compared to the 
wild type (5.2). In both cases the main flavin band is slightly blue-shifted and the shoulder at 487 nm 
is less pronounced. This might be indicative for a more hydrophilic environment around the flavin 
(Harbury et al. 1959). In contrast, the UV-Vis spectrum of EcE3R386A was almost identical to that of 
the wild type enzyme. Mutations near the flavin N5 site had severe impact on the catalytic activity 
(Table 3.2). EcE3K54Q only showed ~0.5 % residual activity under standardized assay conditions. 
Moreover, replacement of the negatively charged Glu189 lead to a further reduction of the enzymatic 
activity (<0.2 %). However, the latter activity also tends to be defective according to aforementioned 
limitations of the reverse assay (3.3.1). Mutation of Arg386 to alanine did not abolish the catalytic 
function of the enzyme. The variant showed ~22 % residual activity indicating that an involvement of 
the latter residue into a proton transfer reaction is questionable, at least with respect to its steady state 
activity. 
 
Table 3.2 Steady-state parameters of EcE3variants involved in the oxidative half-reaction. 
Parameters were calculated from data of the reverse steady-state assay (2.2.4.1). Plots of lipoamide 
dependence for individual variants are shown in the appendix (5.4). 







72.9 ± 4.6 
0.33 ± 0.01 
0.14 ± 0.01 
16.3 ± 0.4 
400* 
42.0 ± 1.8 
n.d. 
155 ± 16 
* (Wilkinson and Williams 1981) 
 
Reduction of EcE3K54Q with NADH under single turnover conditions in a stopped-flow apparatus 
demonstrated a strong accumulation of the NAD
+
-FADH2 charge transfer band between 600 – 700 nm. 
Moreover, almost a complete reduction of the flavin could be observed thereby lacking the 
characteristic blue shift and the Cys50-thiolate FAD charge transfer (Figure 3.18A). NAD
+
-FADH2 
complex formation occurs monoexponentially with ~103 s
-1
 and results in stabilization of the latter 
complex for ~300 ms (Figure 3.18B) prior to its decay. NADH titration revealed that in fact one 
equivalent NADH is sufficient to reduce one equivalent of EcE3K54Q (Figure 3.18C). Hence, internal 
transfer of reducing equivalents from the flavin site towards the redox active disulfide seems to be 
impaired. The pronounced nucleotide–flavin charge transfer indicates a strong binding of NAD
+
 to the 
enzyme. This tightened binding was confirmed by NAD
+
-titrations giving an apparent KD of 42 µM. 
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The binding constant for NAD
+
 is thus almost 10-fold lower to that observed for the wild type enzyme 
(Wilkinson and Williams 1981). 
Interestingly, the same qualitative results were observed for EcE3R386A; for this variant the apparent 
KD was ~3-fold higher than for EcE3K54Q (Figure 5.5). In addition, EcE3R386A was able to form the 
Cys50-thiolate FAD charge transfer when EcLip3H2 served as reductant (Figure 5.5D). 
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Figure 3.18 Spectral properties of EcE3K54Q. 
(A) Stopped-flow absorbance traces after mixing of 20 µM EcE3K54Q with 20 µM NADH at 4 °C 
and pH 7.6. The dashed line represents the oxidized form of the respective enzyme (Eox) derived 
from a single mixing event with buffer. The solid spectra were recorded using a diode-array detector 
after mixing. (B) Stopped-flow absorbance trace at 650 nm under same conditions. The points are 
the experimental data, and the solid line is the fit to a single exponential equation (A = A1·e
-k1·t
). 
Note the logarithmic time-scale. NAD
+
-FADH2 complex formation occurs with ~103 s
-1
 and runs 
into an transient equilibrium prior to its decay. (C) Absorbance traces derived from a stopped-flow 
NADH titration at 4 °C and pH 7.6. Complete reduction of the flavin can be achieved using an 
equimolar amount of NADH. The inset shows the relative absorbances at 455 nm plotted against the 
respective NADH concentration. Internal transfer of reducing equivalents to the disulfide is therefore 
most unlikely. (D) Lower temperature NAD
+
 titration (difference spectra) at 10 °C and pH 7.6. The 
inset shows a hyperbolic fit for the decrease in absorbance at 455 nm giving an apparent binding 
constant of ~42 µM for the nucleotide. 
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A 5-fold molar excess of NADH was not sufficient to induce EH4 formation thus, EcE3E189Q did not 
suffer from severe overreduction by NADH (Figure 3.19A and Figure 5.6A). However, the more 
pronounced accumulation of the NAD
+
-FADH2 complex and the absence of the Cys50-thiolate FAD 
charge transfer were also present in this variant. NAD
+
 titrations did not indicate a lowered binding 
constant for the nucleotide since no significant quenching of the flavin was observed (Figure 5.6B). 
Further, E189Q is also not capable to stabilize the Cys50-thiolate FAD charge transfer to a significant 
amount when using EcLip3H2 as reductant (Figure 3.19B) and reoxidation of the cofactor occurs 
remarkably faster than in the wild type enzyme. 
In summary, the alterations at residues near the flavin N5 influenced the spectroscopic and catalytic 
behavior of all three mutated enzymes studied. However, during all experiments using NADH or 
EcLip3H2 as reductant no increase in the 380-nm absorbance range was detected that would indicate a 
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Figure 3.19 Stopped-flow absorbance traces of EcE3E189Q. 
20 µM EcE3E189Q were mixed with 100 µM NADH (A) or with 20 µM EcLip3H2 (B) at 4 °C and 
pH 7.6. The dashed line represents the oxidized form of the enzyme (Eox) derived from a single 
mixing event with buffer. The solid spectra were recorded using a diode-array detector after mixing 
at the concentrations indicated. 
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3.3.2.1 Lys54 and Glu189 are crucial Mediators of the Flavin Redox Potential 
EcE3K54Q showed severe overreduction by NADH and a remarkably increased affinity for NAD
+
. 
The absence of thiolate-FAD charge transfer complex and the fact that one equivalent of NADH were 
sufficient for complete flavin reduction indicate that its flavin redox potential is way less negative than 
that of the wild type enzyme. Mutation of the same residue to arginine raised the FAD potential by 
approximately 60 mV (Maeda-Yorita et al. 1994), whereas the redox active disulfide potential was 
unaffected. The results presented here suggest that the redox potential of the FAD has been raised 
even further and underlie the already proposed sensitivity of the isoalloxazine ring to its electrostatic 
environment, especially the surrounding of the N5 atom. The positive charge donated by the 
ammonium group of the lysine residue to the latter atom is thus pivotal for the enzyme. An absolute 
determination of the flavin redox potential could be achieved using the method which was described in 
2.2.2.9 (McDonald et al. 2013). 
The role of Lys54 is presumably not limited to its redox-mediating function. It has been suggested that 
the ammonium group of the lysine repels the positively charged NAD
+
 from the active site in the 
related human glutathione reductase (Schulz and Pai 1983). The relatively high binding constant for 
the pyridine nucleotide in EcE3 might support this function. Further, ITC data suggest that binding of 
NAD
+
 to K54Q is characterized by an increased change in enthalpy (Figure 5.21). The increased 
affinity towards NAD
+
 in the variant is therefore most likely based on two aspects: At first, the 
repulsion of the nucleotide became abolished due to removal of the positive charge at the enzyme and 
secondly, hydrogen bonding between Gln54 and the nicotine amide part of NAD
+
 might have 
tightened the interaction. 
The mutation of Glu189 to glutamine had the opposite effect with respect to the flavin redox potential. 
NADH titrations revealed that the potential has been lowered compared to the wild type enzyme. The 
absence of thiolate-FAD charge transfer complex during both reduction with NADH and EcLip3H2 
suggest that the internal transfer of reducing equivalents from the flavin site towards the disulfide and 
vice versa is almost completely impaired. As observed for Glu450 in the studies on the reductive half-
reaction (3.3.1.1), Glu189 presumably acts as structural element that is responsible for positioning the 
ε-amino group of Lys54 towards the flavin N5 atom. Removal of the carboxylic group of Glu189 
might lead to a relaxation of Lys54 from its strained conformation (Figure 3.17) and hence a 
perturbation of the interaction with N5. 
3.3.2.2 A direct Involvement of Arg386 in a Proton Transfer Reaction is questionable 
In E. coli mercuric ion reductase the Arg386 homolog (Arg382) is thought to participate in a proton 
transfer reaction during catalysis by a direct interaction with the catalytic lysine. Most likely this 
transfer reaction is required to protonate FAD-N5 during the reductive half-reaction to induce covalent 
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adduct formation (Susan Miller, University of California, personal communication). Indeed, the fact 
that Arg386 could be modeled using two alternate conformations implies that this residue harbors 
certain motility (Figure 3.17) which may indicate that an interaction with Lys54 cannot be totally 
excluded. However, this would require Lys54 to undergo huge structural rearrangements as well, a 
scenario which is due to its interactions with Glu189 and FAD-N5 unlikely. In addition, kinetic and 
spectroscopic data further underpin that replacement of Arg386 reduces the enzyme activity but not to 
that amount which one would expect if a proton transfer reaction was completely disturbed. Assuming 
~1 % residual activity in a case of a fully abolished proton transfer reaction the detected 22 % residual 
activity are significantly higher. Though it cannot be excluded that a water molecule now occupies the 
space which became available due to the mutation it remains doubtful that a latter molecule can 
compensate the complex proposed role of Arg386. 
The data presented demonstrate that the mutation raised the redox potential of the flavin already 
leading to overreduction to the catalytically inactive EH4 state at equimolar  concentrations of NADH. 
However, the steady-state activity shows that NAD
+
 can oxidize the enzyme to the active EH2 state 
that results in substrate turnover. Further, though the detection of the Cys50-thiolate FAD charge 
transfer was not possible when NADH served as reducing titrant, EcE3R386A was able to form this 
complex when EcLip3H2 served, albeit with a smaller amplitude than the wild type. It can be 
speculated, the less pronounced thiolate FAD charge transfer was masked by the enhanced NAD
+
-
FADH2 complex during reduction with NADH. These data suggest that EcE3R386A is still capable to 
form all the intermediates required for catalysis and hence the role of Arg386 has to be seen from a 
more structural point of view: Mutations at the dimer interface of E3s have the ability to drastically 
alter the catalytic properties of the enzyme (3.3.1.2 and 3.5). Though the exact reasons for this 
alteration have not been identified yet, it was speculated that residues at the interface stabilizing the 
homodimer contribute to optimal catalysis and provide protection against inhibition/overreduction by 
NADH (Benen, Van Berkel, Veeger, et al. 1992). Since Arg386 is also located at the interface it is 
likely that the altered observed behavior is due to destabilization of the homodimer rather than a direct 
involvement in a proton transfer reaction. That the enzyme behavior can indeed be regulated by 
mutation of a residue present at the dimer interface (Glu354) will be shown and discussed in a 
following chapter (3.5). 
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3.4 Converting EcE3 into a light-sensitive blue Light Receptor 
A common feature of lipoamide dehydrogenases and LOV proteins is the formation of a covalent 
FAD-C4a-cysteinyl adduct during the respective reaction cycle. However, according to spectroscopic 
and structural data (3.1 and 3.2) and previous reports (Argyrou et al. 2002) the covalent adduct only 
accumulates to a minor fraction in lipoamide dehydrogenases. On the contrary, the lifetime of the 
same class of adducts can also last up to hours in LOV blue light photoreceptors (Conrad et al. 2014). 
To therefore extend the lifetime of the adduct in EcE3 a conversion of this oxidoreductase into a light-
sensitive LOV protein using a minimal system was attempted. The aim was to stabilize the adduct 
upon light activation and by this to overcome its transient nature which prohibited a more detailed 
spectroscopic and structural study. On the one hand, an accumulation of the C4a-cysteinyl adduct 
would allow the usage of different spectroscopic analyses and on the other hand further 
crystallographic studies, which may expand the gained knowledge about this reaction central 
intermediate during the course of this study. Further, this structure-guided protein engineering 
approach should combine the catalytic properties of a LOV protein and the EcE3 enzyme leading to a 
blue-light absorbing oxidoreductase capable of reducing NADH with light as the main driving force. 
The envisaged reaction cycle would include a photochemical induced C4a-cysteinyl adduct followed 
by binding of NAD
+
 to generate NADH. The required reduction of the thiol would be achieved by an 
externally added sulfhydryl-free reducing agent (TCEP). 
3.4.1 EcE3C45A/K54Q and C45S/K54Q – PseudoLOV variants 
Based on the structural and functional similarities of both protein classes minimal systems were 
created in which the active site of EcE3 was modified to mimic that of a LOV protein. Whereas LOV 
domains harbor a conserved cysteine residue close to the FMN cofactor lipoamide dehydrogenases 
exhibit a redox active cystine (Figure 3.20). Thus, mono-thiol variants of EcE3 were generated for the 
required active site modification. As aforementioned, UV-Vis spectroscopic data suggested that Cys50 
in EcE3C45A is present in its thiol form (3.1.5) and, moreover, is capable of NAD
+
-induced adduct 
formation (Figure 3.5 and Figure 5.2). Hence, EcE3C45A seemed to be a suitable starting point for the 
establishment of a pseudoLOV minimal system. In another mono-thiol variant, EcE3C45S, the 
remaining cysteine (Cys50) is present in its anionic form leading to a permanent charge transfer 
complex between the Cys50-thiolate and the flavin cofactor (3.1.4). Since the charge transfer complex 
is on-pathway in the reaction cycle of the native enzyme this variant was chosen as second mono-thiol 
variant. Besides targeting the cystine moiety as a site for mutations, another residue crucial for H-
bonding with FAD-N5 during the respective reaction cycle is different in both enzymes and was 
therefore the second target for site-directed mutagenesis. A highly conserved glutamine residue 
hydrogen bonds to flavin N5 in LOV proteins and has a key role in transducing the light signal 
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(Conrad et al. 2014) whereas a conserved lysine residue is thought to facilitate N5 protonation during 
the reaction cycle and to mediate the FAD redox potential (Maeda-Yorita et al. 1994). Thus, Lys54 
was mutated to Gln54 leading to the pseudo LOV proteins EcE3C45A/K54Q (pseudoLOV) and 




Both double-variants could be purified to homogeneity and their structural integrity was verified by 
far-UV CD spectra (5.6). In addition, both pseudoLOV proteins retained their typical color (yellow 
and orange-red, respectively) which was also observed for the respective single variant. UV-Vis 
ground-state spectra proofed that substitution of Lys54 did not change the respective protonation state 
in each mono-thiol variant (5.2D and E). Thus, the pseudo- and the thiolateLOV variant fulfill the 




Figure 3.20 Converting EcE3 into a pseudoLOV protein. 
(top) Schematics of the active sites of YF1 and EcE3. YF1 numbering is taken from PDB 
4GCZ. Targeted residues during mutagenesis are marked with a red box. (bottom) 
Schematics of the “pseudoLOV” variants EcE3C45A/K54Q and EcE3C45S/K54Q. For 
detailed description of the chosen mutations see text. 
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3.4.2 Photobleaching of pseudoLOV Variants leads to irreversible Alterations at the 
Flavin Site 
In order to investigate the photochemical response of re-engineered E3 variants the proteins were 
subjected to blue-light exposure with concomitant read out on a photodiode array. Exposure of 
EcE3C45A/K54Q to blue light (455 nm, 50 mW/cm
-2
) changed the absorption properties, indicating 
that the protein is photochemically reactive. The typical flavin band at 450 nm decreased during the 
time course with concomitant increase in the lower wavelength region at 340 to 350 nm showing an 
isosbestic point at 380 nm (Figure 3.21A). The final spectrum is different to that of a fully reduced 
flavin (Ghisla et al. 1974). Recovery kinetics showed that the absorbance change is irreversible. 
Photoreduction EcE3C45S/K54Q under the same conditions lead to comparable absorbance changes 
but with less drastic effects. However, the tendency of a decrease in absorbance in the longer 
wavelength range and increase in lower range is evident. As for the thiol variant these processes were 
irreversible. Noteworthy, the thiolate charge transfer between Cys50 and chromophore was only 
slightly affected (Figure 3.21B). In both variants, a significant increase in absorbance between 380 – 
390 nm was missing leading to the assumption that formation of a cysteinyl-C4a adduct is unlikely. 
Control experiments were performed to determine, at first, the photoreactivity of EcE3wt towards blue 
light and secondly to verify whether the observed absorbance changes were due to adduct formation 
involving the flavin N5 atom. It was demonstrated that light induced N5-adducts harbor a comparable 
spectroscopic signature as described above (Ghisla and Massey 1975) and therefore the investigation 
of a putative interaction of Cys50 with N5 was of special interest. The results obtained for the controls 
can be found in the appendix (5.7). EcE3 wild type also showed a certain photochemical reactivity but 
with a much lower extent than the pseudoLOV variant. Further, the formation of covalent N5-adducts 
is unlikely since the mono- or non-thiol variants showed comparable spectroscopic changes upon light 
illumination: mutation of Cys50 facing the flavin cofactor to either alanine (EcE3C50A) or serine 
(EcE3C50S) made adduct formation unlikely due to steric or chemical reasons. To further exclude a 
covalent bond formation between protein and cofactor during photobleaching the proteins denatured 
with 6 M guanidinium chloride which lead to a release of the chromophore in all cases. The formation 
of a flavin radical species during photobleaching is also unlikely since the UV-Vis signatures did not 
show specific bands for neither the neutral nor the anionic semiquinone radical (Choong and Massey 
1980; Massey and Palmer 1966). Time-resolved EPR measurements confirmed that radical species do 
not accumulate to an significant amount (5.8). 
Low intensity (5 mW/cm
-2
) blue light illumination of LOV domain YF1 (Diensthuber et al. 2013) 
drastically leads to changes in the UV-VIS signature of the protein. In the dark state, the flavin is fully 
oxidized having an absorption maximum at 447 nm. Formation of the flavin-(C4a)-cysteinyl covalent 
bond blue-shifts the absorbance to a new maximum at 390 nm (Figure 3.21C). Ten-fold higher light 
intensities (50 mW/cm
-2
) lead to the same spectroscopic changes and, more importantly, the lit state 
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spectrum was stable for at least one hour during photobleaching under the harsher conditions (personal 
communication by Prof. Andreas Möglich). In contrast, YF1C62A, a variant in which the bond-
forming cysteine residue is replaced by an alanine, was not resistant against long-term photobleaching 
(Figure 3.21D). The spectroscopic changes for this enzyme were similar to those observed for the 
pseudoLOV protein: a decrease of the main flavin peak with a simultaneous increase in the lower 
wavelength region, with an isosbestic point at 380 nm. However, in contrast to the pseudoLOV protein 
a broad absorption band with maxima at 570 and 610 nm developed during photobleaching. This 
spectral property is similar to those of other flavoprotein neutral radicals (Massey and Palmer 1966; 
Talfournier et al. 2001a). Radical formation came along with loss in absorbance at 447 nm but then 
also diminished during the further bleaching process leading to a single peak formation at ~330 nm. 
The entire bleaching process was also irreversible. 
  



























































































































Figure 3.21 Comparison of abosorbance changes in variants of pseudoLOVs and LOV domains 
upon blue light illumination. 
UV-Vis spectra of pseudoLOV (A) and thiolateLOV (B) during photobleaching (50mW/cm
-2
) with 
blue light (455 nm). The inset shows the recovery kinetic in the dark. (C) UV-Vis absorbance 
profiles of YF1 wild-type protein. The black trace represents the dark state spectrum and red trace 
the lit state spectrum. Data were kindly provided by Prof. Andreas Möglich, HU Berlin. (D) UV-Vis 
spectra of YF1C62A during photobleaching (50mW/cm
-2
). The inset shows formation and decay of 
the neutral semiquinone radical at 570 nm. 
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3.4.3 Mass Spectrometric Analysis of the photobleached Flavin Cofactor 
To further elucidate the alterations occurring at the flavin site upon light illumination the 
photobleached cofactor of pseudoLOV (EcE3C45A/K54Q) was isolated from the enzyme and 
subjected to both UPLC-ESI-TOF-MS and UHPLC-ESI-QTOF-MS/MS. MS analysis of FAD 
(purchased from AppliChem) and of isolated cofactor from unbleached pseudoLOV served as 
reference measurements. The usage of three different isolation techniques and their subsequent 
analysis excluded that modifications at the flavin site were due to the respective isolation method 
(2.2.6.5). All MS spectra belonging to the reference measurements and all spectra for the different 
isolation techniques for photobleached and unbleached samples are shown in the Appendix (5.9). 
UPLC-ESI-TOF-MS analysis of the photobleached flavin cofactor showed the presence of two 
additional flavin derivatives besides the non-modified FAD (Figure 3.22). The derivative eluting 
slightly earlier than native FAD has an m/z 782.13 and the corresponding UV-Vis spectrum shows 
maxima at 367 and 450 nm (Figure 3.22C and D, blue line). The lower m/z ratio of two protons 
compared to FAD (m/z 784.18) can be explained by a double bond formation whereas a localization of 
the latter in the isoalloxazine part is unlikely since the UV-Vis spectrum reflects the shape of an non-
modified FAD. According to the results obtained this derivative is termed FAD-2H. A more detailed 
investigation to localize the putative double bond is shown later (Figure 3.24).  
The retention time of the second derivative is shifted to a later time point with an m/z 241.07 and the 
UV-Vis spectrum harbors a maximum at 350 nm (Figure 3.22C and D, red line). The latter derivative 
was identified as lumichrom by comparing the data with the data obtained from a lumichrom standard 
solution (Figure 5.12 and 5.13). This indicates the formation of lumichrom during photobleaching of 
pseudoLOV. 
  




Besides the formation of lumichrom and FAD-2H a third derivative could be identified during UPLC-
ESI-TOF-MS analysis (Figure 3.23). This derivative was not shown in Figure 3.22 since the TCA used 
for cofactor extraction eluted in the same time scale making a UV-Vis detection impossible. The 
derivative has an m/z 542.07 and the UV-Vis spectrum shows a single peak with its maximum at 
260 nm. This UV-Vis signature is typical for an adenine moiety indicating that this FAD derivative 
lost its isoalloxazine part. The latter is almost congruent with the obtained mass, however a formation 



































































































Figure 3.22 UPLC-ESI-TOF-MS analysis of cofactors of bleached and unbleached psLOV. 
(A) Total wavelength chromatogram of TCA extracted cofactors from unbleached (top) and 
photobleached (bottom) pseudoLOV. Corresponding UV-Vis spectra are shown in (C) with the 
respective color. (B) Extracted ion chromatogram for m/z 782.13 (top) and m/z 241.07 (bottom) and 
corresponding MS analysis (D) in negative ionization mode. Allocation of FAD is based on the 
analysis of an FAD standard solution shown in the appendix (Figure 5.8). 
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UPLC-ESI-TOF-MS analysis thus far revealed the presence of three additional FAD derivatives 
formed upon photobleaching of pseudoLOV: lumichrom, FAD-2H and ribityl-ADP-2H. On the one 
hand, lumichrom could clearly be identified on the other hand, the exact position of the double bond in 
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Figure 3.23 UPLC-ESI-TOF-MS analysis of ribityl-ADP-2H. 
(A) Total wavelength chromatogram of heat extracted cofactors from unbleached (top) and 
photobleached (bottom) pseudoLOV. (B) Extracted ion chromatograms for m/z 542.07, respectively. 
(C) MS analysis (negative ionization mode) of B and corresponding UV-Vis spectrum of (inset). 
Allocation of FAD and lumichrom is based on the analysis of standard solutions shown in the 
appendix (Figure 5.8 and Figure 5.12). 
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the two remaining derivatives is unclear. The double bond position was then investigated by 
subjecting FAD and the FAD-2H derivative to UHPLC-ESI-QTOF-MS/MS. The interpreted 
fragmentation pattern indicates that no double is formed in neither the isoalloxazine, nor in the AMP 
part of the FAD since the respective fragments show the same m/z values (Figure 3.24, black arrows). 
This indicates that the double bond is positioned in the ribityl part which is consistent with the UV-Vis 
spectroscopic data obtained by UPLC-ESI-TOF-MS. The UV-Vis signature of FAD-2H and of ribityl-
ADP-2H resemble the one of FAD and an adenine moiety, respectively. Double bond formation in the 
ribityl part led to an altered MS/MS fragmentation pattern. While two fragments deviate by two 
protons (m/z 517.05 / 515.04 and m/z 437.08 / 435.07) one further fragment deviates by an additional 






3.4.3.1 C4a-cysteinyl Adduct Formation in LOV Domains prevents Photodegradation of the 
Flavin Cofactor 
The results obtained so far showed that the generated pseudoLOV minimal systems were not sufficient 
to promote light-driven cysteinyl-C4a adduct formation. A further spectroscopic and crystallographic 
investigation of these adducts was therefore not possible. However, the experiments offer a new 
perception regarding the LOV protein photocycle and photodegradation of enzyme-bound flavin 


















































Figure 3.24 The double bond in FAD-2H and in ribityl-ADP-2H is located the ribityl part. 
MS/MS fragmentation pattern at 20 eV collision energy for FAD at m/z 784.15 (left) and for FAD-2H 
at m/z 782.13 (right). FAD derivatives were interpreted in comparison to FAD spectra (METLIN 
ID2302) deposited in the METLIN database. Fragments harboring the same m/z ratios are indicated in 
black, different ratios are shown in blue and red, respectively. The fragmentation patterns indicate that 
the modified position is housed in the ribityl part of the FAD derivative. The MS/MS fragmentation 
pattern is shown in (Figure 5.16). 
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covalent bond formation between the conserved cysteine residue and the FMN cofactor during the 
photocycle harbors an intrinsic protective function against photodegradation. As described above, 
high-intensity photobleaching of the wild type LOV domain did not influence the lit state spectrum 
while the same intensities altered the spectral properties of the EcE3 wild type and its pseudo LOV 
derivatives. This spectral change is based on irreversible alterations at the flavin site (3.4.2). Hence, 
there must be a mechanistic or structural property preventing LOV domains from photodegradation 
and thus keeping the protein active to perform further rounds of photocycle and concomitant signal 
transduction. Mutation of the bond forming cysteine residue to alanine (YF1C62A) abolished this 
resistance leading to spectroscopic changes similar to those obtained for the oxidoreductase (Figure 
3.21D). Therefore, bond formation between a cysteine and flavin cofactor seems to be the crucial part 
of the protective function against photodegradation. C4a-cysteinly adduct formation leads to loss of 
aromaticity of the flavin ring system and thereby changes its electronic configuration. This results in a 
blue shifted spectrum and reduces absorption of light with longer wavelengths (>400 nm). It was 
demonstrated that longer wavelengths, especially in the range of 415 - 455 nm, drastically damage 
riboflavin in solution (Sattar, deMan, and Alexander 1977). Since the flavin adduct does not absorb 
light with this particular wavelength a relation between the latter and resistance against 
photodegradation is evident. Thus, LOV domains have evolved a structural feature which 
simultaneously permits both signal transduction on the one hand and protection against 






Figure 3.25 Protective mechanism of LOV proteins. 
(A) C4a-cysteinyl adduct formation exhibits two functions: Signal transduction and 
protection against photodegradation. (B) Blue light exposure of the cysteine-lacking variant 
induces formation of the neutral semiquinone, the potential pre-stage prior to 
photodegradation. 
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The formation of the flavin neutral semiquinone radical in YF1C62A was the major difference during 
photobleaching of the cofactor compared to the pseudoLOV protein. Though, the single peaks are 
blue-shifted by ~10 nm, the position of the radical band maxima are similar to those observed for 
glucose oxidase, DNA (6-4) photolyase or an animal-like cryptochrome (aCRY) (Beel et al. 2012; 
Hitomi et al. 1997; Massey and Palmer 1966). Since there is evidence for a neutral semiquinone 
intermediate between the excited triplet and the adduct state (Bauer et al. 2011) the accumulation of a 
neutral radical in the cysteine-missing variant is not unexpected. However, it remains unclear whether 
formation of the neutral radical lies on pathway, and thus accumulates since adduct formation is 
impaired, or whether radical formation is a side effect of the photodegradation of the FMN cofactor. 
According to the rate of the semiquinone formation the latter is more likely since radical formation in 
aCRY is ~40-fold faster and, even more important, reversible (Beel et al. 2012). To compare the 
putative influence of the semiquinone radical on the photodegradation a mass spectrometric analysis 
according to the pseudoLOV protein should be performed (see discussion below). 
3.4.3.2 Photodegradation of enzyme-bound FAD leads to Double Bond formation in the ribityl 
part 
Mass spectrometric analysis revealed three major FAD derivatives as photodegradation products upon 
blue light exposure of the pseudoLOV protein: lumichrom, FAD-2H and ribityl-ADP-2H (Figure 3.26) 
whereas the formation of lumichrom was confirmed by reference measurements. Photostability and 
degradation of riboflavin in aqueous solvents have been extensively studied due to its relevance in 
food products and pharmaceutical preparations. It is degraded into several photoproducts including the 
aforementioned lumichrom, but also into formylmethylflavin, lumiflavin, carboxymethylflavin and 
further derivatives (Sheraz, Kazi, Ahmed, Anwar, et al. 2014). Formation of lumichrom is 
controversially discussed and both excited singlet and excited triplet states of riboflavin are stated to 
be precursors in the photodegradation reactions by different mechanisms. On the one hand, lumichrom 
is formed by the excited triplet state (Ahmad et al. 2004; Huang, Hyun, and Min 2006; Jung et al. 
2007) on the other hand, the excited singlet was also claimed as a precursor (Ahmad et al. 2004; 
Cairns and Metzler 1971; Sheraz, Kazi, Ahmed, Mirza, et al. 2014). However, the distinction between 
these reactions in the photodegradation process lacks detailed information (Sheraz, Kazi, Ahmed, 
Anwar, et al. 2014). To get information about the excitations states of the enzyme-bound cofactor 
nanosecond time-resolved UV-Vis spectroscopy by flash photolysis should be performed (Bauer et al. 
2011). This would potentially allow a comparison of the flavin excitations states generated in solution 
and when bound to an enzyme. 
Though information in the nano- and microsecond time regime of the photobleaching event of the 
pseudoLOV protein are missing alterations of the degradation profile compared to riboflavin in 
solution are obvious. First, it has been described that the presence of divalent anions, such as 




) and sulfate (SO4
2–
), exclusively lead to the formation of cyclodehydroriboflavin as 
phtotodegradation product (Ahmad et al. 2010; Schuman Jorns, Schöllnhammer, and Hemmerich 
1975; Sheraz, Kazi, Ahmed, Mirza, et al. 2014). This product was not identified during MS analysis 
and thus an influence of the used buffer system (50 mM KPP pH 7.6, 100 mM NaCl) on the 
degradation process of the enzyme-bound flavin is unlikely. Moreover, among the plethora of 
riboflavin degradation products thus far described, out of the three derivatives formed lumichrom was 
the only one which has yet been reported. Hence, an influence of the enzyme surrounding on the 
photodegradation process is evident. The ultimate structure of the two remaining derivatives (FAD-2H 
and ribityl-ADP-2H) could not be determined since information about the absolute position of the 
light-induced double bond is missing (Figure 3.24). Formation of the latter fragments lead to the 
assumption that the double bond is delocalized between the C1, C2 and C2=O atoms of the ribityl part 
(Figure 3.26). This assumption is on the one hand underpinned by the UV-Vis spectroscopic 
signatures of both fragments indicating no influences of the double bond on the isoalloxazine nor the 
adenine moiety of FAD (Figure 3.22C and Figure 3.23C) and on the other hand by the altered MS/MS 
fragmentation pattern. A delocalized double bond between the C1, C2 and C2=O atoms might explain 
the altered fragmentation pattern around C1 and thus the presence of the one-carbon-elongated 
fragment with an m/z 192.99. Further, localization of the double bond in the mentioned region could 
result in a stabilization of ribityl-ADP-2H. Assuming an additional bond formation between C2 and 
C2=O the formation of a pseudo-six-membered ring system could be the consequence. Here the 
hydrogen atom the C4-OH group could hydrogen bond to C2=O (Figure 3.26). It cannot be ruled out 
whether FAD-2H is a potential precursor of ribityl-ADP-2H. Therefore, MS analysis of photobleached 
samples taken at different time points could provide further insights into the photodegradation process 
of enzyme-bound flavin. 
  






Figure 3.26 Putative FAD derivatives formed upon pseudoLOV photobleaching. 
The presence of lumichrom was verified by reference measurements with a lumichrom 
standard solution. The shown structures for FAD-2H and ribityl-ADP-2H are 
hypothetical (see discussion). The inset shows the AMP part of the FAD derivatives 
which is not modified during bleaching. 
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3.4.4 The H-bonding Network around the Flavin – The next Step on the Way to a 
light-sensitive Oxidoreductase? 
The studies on the re-engineered E3 variants have not yet yielded a light-driven system for production 
of reduction equivalents yet, but they have provided key insights into the inner workings of both E3 
metabolic enzymes and LOV photoreceptors (3.4.3.1 and 3.4.3.2). The used minimal system, in which 
the redox active cystine was converted into a monothiol moiety and in which the residue crucial for 
(de)protonation of FAD-N5 was exchanged (Lys54  Gln54), was thus too rudimentary to convert the 
oxidoreductase into a light-sensing protein. Hence, there must be additional factors which are required 
for light-driven adduct formation. The redox potential of the flavin cofactor in the LOV kinase LOVk 
from C. crescentus was determined to be -258 mV (Purcell et al. 2010) which is way more positive 
than the reported -314 mV in EcE3wt (Maeda-Yorita et al. 1991). However, redox titrations with the 
pseudoLOV protein (EcE3C45A/K54Q) revealed a redox potential of -268 mV (Table 5.2) which is 
strikingly close to the reported potential of the cofactor in LOVk. The elevation is thereby mainly 
related to the replacement of the N5 interacting lysine by a glutamine rather than the presence of the 
thiol at the si face of the cofactor (3.3.2.1). Though the tendency of the flavin to gain electrons was 
eased und thus the interaction of the Cys50 thiol moiety with the C4a atom should have been 
facilitated it is obvious that further features are required to promote adduct formation. It was 
demonstrated that the extended hydrogen bond network stabilizing the FMN cofactor in LOV domains 
(Figure 3.27A) can modulate the quantum yield, kinetics, and thermodynamics of the photocycle 
(Raffelberg et al. 2011). Consequently, a further step to convert EcE3 into a light-sensing protein 
should target the surrounding of the chromophore in the oxidoreductase (Figure 3.27B). Putative 
candidates to alter the microenvironment around the pteridine part of the EcE3 FAD are His445 and 
Ala321 which could be exchanged with uncharged, polar amino acids. However, negative side effect 
altering the FAD’s redox potential too much have to be considered. Redox titrations for further 
variants are hence obligate. 
Photobleaching of YF1C62A demonstrated that the LOV protein is capable of stabilizing the neutral 
flavin semiquinone radical if adduct formation is impaired (Figure 3.25). Taking into account that such 
species was identified between the triplet and the adduct state in a wild type enzyme (Bauer et al. 
2011) it is most likely that these photoreceptors provide a surrounding which relieves neutral 
semiquinone formation. This is further underpinned by the finding that a replacement of the conserved 
asparagines interacting with the pteridine part of the FMN with negatively charged aspartates did not 
affect the dynamics and energetics of adduct formation (Raffelberg et al. 2011). According to the 
authors the latter would be unlikely if a transiently charged species at the flavin site would occur 
during photocycle. Furthermore, FTIR techniques have provided evidence that the triplet state of FMN 
is unprotonated making an ionic mechanism (Alexandre et al. 2009; Pfeifer et al. 2009) even more 
questionable. Though there are multiple evidences that adduct formation might proceed through an 
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ionic intermediate (Kennis and Groot 2007; Losi and Gärtner 2011; Zoltowski and Gardner 2011) the 





biradical yielding the covalent bond between cofactor and cysteine still has to be considered. To 
demonstrate that neutral semiquinone formation in YF1C62A is not a side effect of the degradation of 
the cofactor, the method established by BAUR et al. using nanosecond flash photolysis with CCD 
camera detection should be applied to the active site variant (Bauer et al. 2011). This could proof that 
formation of the blue flavin radical is also possible in a transient time regime. However, a crucial 
limitation of the active site mutant is evident: the conserved Cys, the likely candidate for the proton 
source required for N5 protonation during neutral semiquinone formation (Alexandre et al. 2009; 
Kennis and Groot 2007; Losi and Gärtner 2011; Pfeifer et al. 2009; Zoltowski and Gardner 2011) is 
absent. It is hence possible that flash photolysis experiments do not show a transient formation of the 
neutral semiquinone and that the observation of the latter during the steady-state photobleaching assay 
(Figure 3.21D) was only possible because radical formation was slowed down due to limited access of 



















Figure 3.27 Comparison of the H-bonding network around the flavin cofactors in YF1 and EcE3. 
(A)The HB network in LOV proteins consists of interactions between the N5, C4=O, N3H, and 
C2=O atoms of the isoalloxazine moiety of FMN and a variety of conserved polar, uncharged 
amino acids(YF1; PDB: 4GCZ). In contrast, the interactions the isoalloxazine moiety in EcE3 
makes are  limited to two main chain atoms and the conserved lysine residue (distances in Å). 
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3.5 Expanding the Active Site – Glu354 is also a Mediator of the Flavin 
Redox Potential 
Mutation of Glu354, a second shell residue in EcE3 located at the dimer interface, to Lys354 reduced 
the sensitivity towards NADH inhibition of EcE3 and thereby affected the fermentation profile of 
E. coli (Kim et al. 2008). However, a more detailed or even a molecular investigation of this alteration 
was not conducted. In the following, the results obtained by Kim et al. will be summarized briefly and 
further extended with the help of spectroscopic and structural data. This extension shall broaden the 
understanding in which way the mutation of one single amino acid leads to such global effects. 
Kim et al. purified EcE3E354K from strain SE2378 and determined kinetic steady-state parameters for 
both the native forward reaction using dihydrolipoic acid and the reverse reaction using NADH as 
reductant, respectively (Kim et al. 2008). Briefly, EcE3E354K only showed 50 % activity in the native 
forward reaction, however the mutated enzyme was significantly more resistant towards NADH 
inhibition at saturation NAD
+
 concentrations. In the reverse reaction, EcE3E354K already reached 
approximately 75 % of its maximum catalytic activity (~75 U) in the absence of added NAD
+
 whereas 
the wild type enzyme required at least a NAD
+
/NADH ratio of 2.0 to reach its maximum (~70 U). 
While the results obtained so far unambiguously demonstrate the physiological importance of the 
NADH sensitivity of EcE3 with the inherent potential of unexplored biotechnological applications, a 
molecular understanding of the altered enzyme properties is missing. To further elucidate the latter 
EcE3E354K was derived from the wild type E. coli E3 enzyme by site-directed mutagenesis and 
subjected to both steady-state kinetics analysis and stopped-flow absorbance spectroscopy. The 
structural integrity was checked by far-UV CD spectroscopy revealing no significant alterations in the 
secondary structure compared to the wild type enzyme (5.6C). Further, the UV-Vis absorbance 
signature is congruent with the wild type spectrum indicating no influences of the mutation to the 
direct surrounding of the flavin cofactor (5.2 K). EcE3 follows a non-hyperbolic dependence with 
respect to lipoamide during the steady-state assay. However, EcE3E354K showed clear hyperbolic 
dependence leading to an ~18.5-fold increase in catalytic proficiency though the maximal specific 
activity deviated only by ~10 % (Figure 3.28A). The comparable catalytic activity of the reverse 
reaction and the altered behavior with respect to NAD
+
 activation (Figure 3.28B) are consistent with 
the results obtained recently (Kim et al. 2008). 
As described in 3.1.2 a 4-fold molar excess of NADH is sufficient to overreduce EcE3 to the catalytic 
incompetent four-electron reduced state (EH4). Assayed under the identical conditions EcE3E354K 
resides in the catalytic active two-electron reduced state (EH2) (Figure 3.28C). The presence of the 
charge transfer band at 523 nm and incomplete decrease in absorbance at 455 nm compared to the 
wild type EH4-level are indicative for the charge transfer complex between the thiolate formed by 
Cys50 and FAD. Thus, overreduction to the dead-end EH4 status is impaired in EcE3E354K under the 
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conditions tested. It should be noted that the charge transfer complex is formed with comparable rates 
and amplitudes as in the wild type (E354K: kobs = 135 ± 2 versus wt: 143 ± 3 s
-1
) (Figure 3.28D). In 
addition, reduction to EH4 in the wild type enzyme is completed after ~1 s, whereas approximately 
90 % of the 523 nm charge transfer signal is still present in EcE3E354K in the same time scale. 
 
 
Figure 3.28 Kinetic and spectroscopic comparison between EcE3E354K and EcE3wt. 
A Comparison of the steady-state activity in dependence of lipoamide (2.2.4.1) and B of NAD
+
 
(2.2.4.2). C Stopped-flow absorbance traces after mixing 20 µM EcE3E354K with 100 µM NADH at 
4 °C. The dotted spectrum reflects the wild type EH4 spectrum as described in 3.1.2. D Comparison of 
stopped-flow absorbance traces at 523 nm under the conditions as described before. 
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Considering the results obtained for mutations of Lys54 and Arg386 obtained by stopped-flow 
absorbance spectroscopy (3.3.2), Glu354 is also a ruler influencing the redox potentials of the different 
enzyme intermediate species. The altered redox potential in EcE3E354K is evident since reduction 
with a 5-fold molar excess of NADH do not lead to EH4 formation. The spectroscopic signature 
obtained rather reflects a spectrum which is similar to the EH2 status described for pig heart lipoamide 
dehydrogenase under equal reduction conditions (Massey et al. 1960). The redox potentials of 
lipoamide dehydrogenases from different organisms have been investigated and the corresponding 
consequences for the catalytic properties have been drawn. WILKINSON AND WILLIAMS stated the 
bigger disproportionation of EH2 to Eox and EH4 in the E. coli lipoamide dehydrogenase to be the 
major difference compared to the pig heart enzyme (Wilkinson and Williams 1979, 1981). The reason 
is the larger separation of the Eox/EH2 and EH2/EH4 redox potentials determined for the pig heart 
enzyme (~66 mV) compared to the closer separation (~53 mV) in the E. coli enzyme explaining the 
easier reduction to the 4-electron-reduced inactive enzyme. EcE3E354K therefore reflects a pig heart 
lipoamide dehydrogenase with respect to resistance against overreduction by NADH. To further 
underpin this assumption the absolute potentials of the Eox/EH2 and EH2/EH4 redox pairs in the mutant 
enzyme should be determined as described earlier (Matthews and Williams 1976). 
Though a direct investigation of the absolute potentials is missing, a further elucidation of the 
molecular basis for the altered catalytic properties of the mutated enzyme based on the secondary 
structure information of EcE3 (3.1.3) was used. Glu354 is localized at the dimer interface directly 
above the interface domain within a loop connecting two anti-parallel β-strands (Figure 3.29). The 
distance between the carboxylic group of Glu354 and N5 of the flavin cofactor is approximately 15 Å 
in the wild type enzyme. Thus, a direct interaction in the mutated enzyme is impossible. Further, there 
is no direct interaction with Lys54, Glu189 and Arg386 residues which were shown to modulate the 
flavin redox potential and hence susceptibility to overreduction by NADH (3.3.2). In addition, 
mutations of the latter residues showed remarkable effects in EcE3 concerning affinity towards NAD
+
 
(3.3.2). This indicates that the redox potential of the flavin cofactor is not only mediated by residues 
located in the direct vicinity (Lys54 and Glu189), but also by nearby active site residues (Arg386). A 
further, aspect which is thought to modulate the cofactor’s redox potential is the subunit interaction of 
the two monomers forming the catalytic functional enzyme. Such ability was attributed to Tyr16 in the 
A. vinelandii E3 which forms a hydrogen bond with a histidine residue of the C-terminus of the 
adjacent monomer (Benen, Van Berkel, Veeger, et al. 1992). Mutation of the latter residue lead to a 
significantly raised redox potential, thus altering the catalytic function of the mutated enzyme. 
However, the corresponding residue in EcE3 (Tyr19) did not harbor a comparable mediator function 
(3.3.1.2). Taking into account that mutations at the dimer interface have the potential to act as 
determinate of the redox potential this role might also be attributed to Lys354 in the mutated E. coli 
enzyme. According to the position of Glu354 at the dimer interface, it is possible that a mutation to a 
lysine influences the subunit interaction yielding in a lowered redox potential of the FAD and hence a 
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protection against overreduction by NADH. It still remains puzzling how this modulation proceeds 
and probably further mutations at the dimer interface are required to further elucidate that striking 
ability of a putative cross-talk between the two subunits. 
In summary, the single mutation of Glu354 to Lys354 in E. coli lipoamide dehydrogenase not only led 
to a severe alteration of the regulation of the enzyme activity but thereby concomitantly changed the 
entire fermentation profile of the bacterium. Thus, the investigation of second shell residues with 




Figure 3.29 Position of Glu354 in EcE3. 
(left) Cartoon representation of the EcE3 homodimer. Glu354 and the FAD cofactor are shown in 
spheres. E354 is localized at the dimer interface, above the interface domain. (right) Distances (Å) of 
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4 Summary 
The flavoenzyme lipoamide dehydrogenase is an ubiquitously distributed enzyme which is part of 
several multienzyme complexes involved in cellular carbon metabolism thus contributing to cellular 
homeostasis. It catalyzes the regeneration of reduced lipoamide cofactors using a disulfide exchange 
reaction of reduced lipoamide with a redox active cystine, transfer of two reducing equivalents from 
this disulfide bridge to the flavin cofactor and hydride transfer from the flavin site to final acceptor 
NAD
+
 (Perham 2000; Reed 1974, 2001). Lipoamide dehydrogenases have been thoroughly studied 
mechanistically and structurally over the last decades. However, the studies so far lack detailed 
spectroscopic and structural information about the central FAD-C4a-cyteinyl adduct the enzyme forms 
during catalysis. Moreover, there are no structural information about the two-electron reduced state 
(EH2). This doctoral thesis provides new insights into the nature of those intermediates that are 
transiently formed along the reaction coordinate in lipoamide dehydrogenase from E. coli by means of 
a structure-function analysis. By combining x-ray crystallography with spectroscopic methods, a more 
detailed picture of the EcE3 reaction cycle is now available helping to fill in the aforementioned blank. 
Robust expression systems for both EcE3 and the innermost lipoyl domain (EcLip3) of the E2 
component of EcPDHc were established which allowed a convenient purification of both components 
to homogeneity. Several reaction intermediates could be identified and allocated in EcE3 with the help 
stopped-flow absorbance spectroscopy and a previously established model (Argyrou et al. 2002). 
However, reduction of the EcE3 with NADH (reverse direction) and, for the first time, with the 
reduced form of an isolated lipoyl domain (EcLip3H2; forward direction) did not allow the detection of 
an absorbance increase which is typical for the covalent flavin adduct, neither in single nor in 
sequential mixing experiments. These results underpin the transience of the intermediate and that it 
only accumulates to a very minor extend in solution making an observation difficult which is 
consistent with previous studies. 
Though the spectroscopic detection of a covalent flavin adduct was not possible in the wild type 
enzyme there is evidence for an NAD
+
-induced FAD-C4a-cyteinyl formation in a monothiol variant, 
in which the interchange thiol forming the mixed disulfide during catalysis was substituted with an 
alanine. The necessity for the presence of NAD
+
 to trigger adduct formation is presumably based on 
the following aspect: Binding of the positively charged nucleotide at the re face of the flavin increases 
the electrophilicity of the oxidized flavin and concomitantly permits an active site compression pivotal 
for adduct formation. However, the spectroscopic signatures clearly demonstrated that the covalent 
adduct only accumulated to a small amount in the monothiol variant as well. 
The structural data obtained during this project suggest that the geometry of the FAD-C4a-cyteinyl 
adduct is most likely responsible for its transience and thus the reason for its limited accumulation in 
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solution. Two X-ray structures of EcE3 were solved, one in which NAD
+
 was present during the phase 
of cryoprotection, and led to models with reasonable quality. Both structures highlight the local 
flexibility of the disulfide bridge contributing to the redox center and enabled the observation of 
structural rearrangements required for catalysis. The radiation-induced reduction of the disulfide 
bridge during data collection lead to partial opening of the latter and was thus used to trigger the 
formation of the covalent flavin adduct in crystallo. The EcE3 ground state structure allowed the 
observation of two different redox states of EcE3 simultaneously: the oxidized (Eox) and the two-
electron reduced state (EH2). In addition, in the E3-NAD
+
 structure electron density is observable that 
is consistent with an FAD-C4a-cyteinyl adduct, a central long-sought-after intermediate, whose 
existence has been predicted but has never been proven experimentally in a wild type enzyme. 
Geometrical analysis revealed that the adduct deviates from tetrahedral geometry harboring an Cβ-Sγ-
C4a angle of >117 °. It is therefore most likely, that the high transience of the adduct is based on the 
distorted geometry of the C4a-cysteinyl adduct. Presumably, this prevents an elongated stabilization of 
the intermediate as it can be observed for the same kind of adducts in LOV domain photo receptors. 
In order to stabilize the FAD-C4a-cyteinyl adduct with the perspective of a further improved structural 
analysis, the metabolic EcE3 should be converted into a light-sensing LOV domain. The generated 
EcE3-pseudoLOV minimal system was not capable of light-induced adduct formation, but provided 
new insights into the protection mechanism against photo degradation in LOV domains and the 
formation of new flavin derivatives upon enzyme-bound photo degradation. The data suggest that 
covalent flavin adduct formation in LOV domains not only serves as structural feature which permits 
signal transduction, but also provides protection against photodegradation of the cofactor. The isolated 
flavin derivatives derived from the EcE3-pseudoLOV protein unambiguously demonstrate that the 
enzyme surrounding influenced the photo degradation process. A light-induced double bond formation 
in an intact FAD molecule has thus far never been described. However, further analytical and 
photochemical investigations are required to elucidate the mechanism yielding this modification. 
The study also demonstrates the susceptibility of the enzyme to alterations of the flavin redox 
potential. Active site residues could be identified which act as rulers in mediating the potential thereby 
ensuring a suitable potential which allows optimal catalysis. Even more impressive is the fact, that the 
redox potential can be influenced by mutations which are not in the direct vicinity of the cofactor. It 
turned out that especially mutations at the dimer interface drastically alter the redox potential, either 
raising (R386A) or lowering it (E354K). This not only altered the enzymatic behavior of EcE3 alone, 
but moreover led to global effects which altered the entire fermentation profile of the bacterium (Kim 
et al. 2008). A further investigation of the dimer interface with respect to its ability to modulate the 
flavin redox potential is therefore mandatory regarding the physiological importance of the enzyme. 
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5 Appendix 
5.1 Amino Acid Sequences 
SUMO-EcLip3 
Number of amino acids: 184 Molecular weight: 20 kDa Theoretical pI: 4.67 
        10         20         30         40         50         60  
MSDSEVNQEA KPEVKPEVKP ETHINLKVSD GSSEIFFKIK KTTPLRRLME AFAKRQGKEM  
 
        70         80         90         100        110        120  
DSLRFLYDGI RIQADQTPED LDMEDNDIIE AHREQIGG|AP AAGVKEVNVP DIGGDEVEVT  
 
       130        140        150        160        170        180  
EVMVKVGDKV AAEQSLITVE GDKASMEVPA PFAGVVKELK VNVGDKVKTG SLIMIFEVEG  
 
        




Number of amino acids: 86 Molecular weight: 8777 Da Theoretical pI: 4.39    
        10         20         30         40         50         60  
APAAGVKEVN VPDIGGDEVE VTEVMVKVGD KVAAEQSLIT VEGDKASMEV PAPFAGVVKE  
 
        70         80  
LKVNVGDKVK TGSLIMIFEV EGAAPA  _ = lipoyl lysine  
 
EcE3 derived from pGS523 
        10         20         30         40         50         60  
MSTEIKTQVV VLGAGPAGYS AAFRCADLGL ETVIVERYNT LGGVCLNVGC IPSKALLHVA  
 
        70         80         90        100        110        120  
KVIEEAKALA EHGIVFGEPK TDIDKIRTWK EKVINQLTGG LAGMAKGRKV KVVNGLGKFT  
 
       130        140        150        160        170        180  
GANTLEVEGE NGKTVINFDN AIIAAGSRPI QLPFIPHEDP RIWDSTDALE LKEVPERLLV  
 
       190        200        210        220        230        240  
MGGGIIGLEM GTVYHALGSQ IDVVEMFDQV IPAADKDIVK VFTKRISKKF NLMLETKVTA  
 
       250        260        270        280        290        300  
VEAKEDGIYV TMEGKKAPAE PQRYDAVLVA IGRVPNGKNL DAGKAGVEVD DRGFIRVDKQ  
 
       310        320        330        340        350        360  




       370        380        390        400        410        420  
GLTEKEAKEK GISYETATFP WAASGRAIAS DCADGMTKLI FDKESHRVIG GAIVGTNGGE  
 
       430 440 450      460 470 
LLGEIGLAIE   MGCDAEDIAL    TIHAHPTLHE   SVGLAAEVFE    GSITDLPNPK   AKKK  
 
pET28a-EcE3 
        10          20         30         40         50         60  
MGSSHHHHHH SSGLVPR|GSH MSTEIKTQVV VLGAGPAGYS AAFRCADLGL ETVIVERYNT  
 
        70         80         90        100        110        120  
LGGVCLNVGC IPSKALLHVA KVIEEAKALA EHGIVFGEPK TDIDKIRTWK EKVINQLTGG  
 
       130        140        150        160        170        180  
LAGMAKGRKV KVVNGLGKFT GANTLEVEGE NGKTVINFDN AIIAAGSRPI QLPFIPHEDP  
 
       190        200        210        220        230        240  
RIWDSTDALE LKEVPERLLV MGGGIIGLEM GTVYHALGSQ IDVVEMFDQV IPAADKDIVK  
 
       250        260        270        280        290        300  
VFTKRISKKF NLMLETKVTA VEAKEDGIYV TMEGKKAPAE PQRYDAVLVA IGRVPNGKNL  
 
       310        320        330        340        350        360  
DAGKAGVEVD DRGFIRVDKQ LRTNVPHIFA IGDIVGQPML AHKGVHEGHV AAEVIAGKKH  
 
       370        380        390        400        410        420  
YFDPKVIPSI AYTEPEVAWV GLTEKEAKEK GISYETATFP WAASGRAIAS DCADGMTKLI  
 
       430        440        450        460        470        480  
FDKESHRVIG GAIVGTNGGE LLGEIGLAIE MGCDAEDIAL TIHAHPTLHE SVGLAAEVFE  
 
       490  
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Wavelength (nm)



















































5.2 UV-VIS Ground-state Spectra 
UV-Vis ground-state spectra of EcE3 and variants thereof were recorded as described in 2.2.5.1. The 
insets show the differential spectra, calculated by subtraction of the wild type spectrum from the 
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Wavelength (nm)




















































































































































































5.3 Molar Extinction Coefficients 
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5.4 Steady-state Activity of EcE3 and Variants thereof 
Steady-state activities in dependence of the lipoamide concentration of EcE3 and variants thereof were 
determined as described in 2.2.4.1. Data were fitted, if applicable, according to the Michaelis-Menten 
equation (red lines). Red arrows indicate NADH consumption at 0 mM lipoamide. Variants are 
ordered by the position of their mutation site starting from the N-terminus. The red arrows at a 
lipoamide concentration of 0 mM indicate putative diaphorase activity when molecular oxygen serves 
as electron acceptor. 
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Figure 5.1 Reduction of EcE3 with NADH under single turnover conditions. 
Stopped-flow absorbance traces after mixing 20 µM EcE3 with 20 µM NADH at 487 nm (A) 
and at 523 nm (B) at 4 °C and at pH 7.6. The points are the experimental data, and the solid 
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 titration of EcE3wt. 
(A) Lower temperature NAD
+
 titration at 10 °C and in 100 mM MES pH 6.0. Binding of NAD
+
 does 
not significantly alter the spectrum. (B) Difference spectra of the same titration. NAD
+
 induces a 
quenching of the flavin signature. Difference spectra were smoothed according to a bisquare 
weighting technique and a polynomial regression. 
Figure 5.2 NAD
+
 titration of EcE3EC45A. 
(A) Lower temperature NAD
+
 titration at 10 °C and in 100 mM Tris pH 8.3. Binding of NAD
+
 does 
not significantly alter the spectrum. (B) Difference spectra of the same titration. NAD
+
 induces a 
quenching of the flavin signature. Difference spectra were smoothed according to a bisquare weighting 
technique and a polynomial regression. 
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Figure 5.4 Primary amino acid sequences of E3 from different organisms. 
The residues studied in this thesis are highlighted. Alignment was done with 
ClustalOmega. The figure was compiled with ESPript 3.0. 
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Figure 5.5 Spectral properties of EcE3R386A. 
(A) Stopped-flow absorbance traces after mixing of 20 µM EcE3R386A with 100 µM NADH at 
4 °C and pH 7.6. The dashed line represents the oxidized form of the respective enzyme (Eox) 
derived from a single mixing event with buffer. The solid spectra were recorded using a diode-
array detector after mixing. (B) NADH titration of 20 µM EcE3R386A at 4 °C and pH 7.6. Flavin 
reduction is almost complete at an equimolar amount of NADH. The inset shows the relative 
absorbances at 455 nm plotted against the respective NADH concentration. (C) Lower temperature 
NAD
+
 titration at 10 °C and pH 7.6. The inset shows a hyperbolic fit for decrease in absorbance at 
455 nm giving an apparent binding constant of ~155 µM for the nucleotide. (D) Stopped-flow 
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Figure 5.6 Further spectral properties of EcE3E189Q. 
(A) Relative absorbance at 455 nm derived from a stopped-flow NADH titration of EcE3E189Q at 
4 °C and pH 7.6. No complete reduction of the flavin can be achieved with a 12.5-fold molar excess  
of NADH in this variant. (B) Lower temperature NAD
+
 titration (difference spectra) at 10 °C and pH 
pH 7.6. Binding of NAD
+
 leads to an increase in absorbance at 360 nm. 
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5.6 Far-UV CD Spectra 























































































































5.7 Photobleaching of EcE3 

















































































Figure 5.7 Photobleaching of wild type, monothiol or non-thiol variants of EcE3. 
Bleaching of EcE3wt (A), EcE3C50A (B) and of EcE3C45S/C50S (C). The insets show a highly 
simplified model of the respective active sites used for photobleaching control experiments. 
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5.8 EPR 
EcE3C45A/K54Q (pseudoLOV) was subjected to EPR measurements as described in 2.2.5.4 
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5.9 Mass Spectrometry - Supplementary 
Table 5.1 Expected fragmentation pattern of EcLip3 after tryptic digestion 
Position of 
cleavage site 





7 APAAGVK 7 612.727 
27 EVNVPDIGGDEVEVTEVMVK 20 2158.406 
31 VGDK 4 417.462 
45 VAAEQSLITVEGDK 14 1459.616 
59 ASMEVPAPFAGVVK 14 1402.672 
62 ELK 3 388.464 
68 VNVGDK 6 630.699 
70 VK 2 245.322 
86 TGSLIMIFEVEGAAPA 16 1605.866 
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Figure 5.8 UPLC-ESI-TOF-MS analysis of FAD. 
Flavin adenine dinucleotide disodium salt hydrate (10 µg/mL in ddH2O) was purchased from 
AppliChem (Darmstadt). (A) Total wavelength chromatogram. (B) Extracted ion chromatogram for 
m/z 784.150. (C) MS analysis (negative ionization mode) of B and corresponding UV-Vis spectrum 
of (inset). 
m/z


































































Figure 5.9 UPLC-ESI-TOF-MS analysis of FAD released of EcE3C45A/K54Q by heat precipitation. 
 (A) Total wavelength chromatogram. (B) Extracted ion chromatogram for m/z 784.150. (C) MS 
analysis (negative ionization mode) of B and corresponding UV-Vis spectrum of (inset). 
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Figure 5.10 UPLC-ESI-TOF-MS analysis of FAD released of EcE3C45A/K54Q by TCA 
precipitation. 
(A) Total wavelength chromatogram. (B) Extracted ion chromatogram for m/z 784.150. (C) MS 
analysis (negative ionization mode) of B and corresponding UV-Vis spectrum of (inset). 
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Figure 5.11 UPLC-ESI-TOF-MS analysis of FAD released of EcE3C45A/K54Q by acetone 
precipitation. 
(A) Total wavelength chromatogram. (B) Extracted ion chromatogram for m/z 784.150. (C) MS 
analysis (negative ionization mode) of B and corresponding UV-Vis spectrum of (inset). 
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Figure 5.12 UPLC-ESI-TOF-MS comparison of lumichrom. 
Released lumichrom from photobleached EcE3C45A/K54Q by heat precipitation (red) and 
lumichrom (100 µg/mL in MeOH) purchased from Sigma (Deisenhofen) (black). 
(A) Total wavelength chromatograms. (B) Extracted ion chromatograms for m/z  243.087. (C) UV-
Vis spectra extracted from (A). (D) MS analysis (positive ionization mode) of B. 
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Figure 5.13 Evidence for lumichrom formation in EcE3C45A/K54Q by UPLC-ESI-TOF-MS. 
Comparison of unbleached (black) and photobleached EcE3C45A/K54Q (red). (A) Extracted ion 
chromatograms (left) and corresponding MS analyses in negative ionization mode (right) of heat 
extracted samples (A) and of TCA extracted samples (B). 
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Figure 5.14 Evidence for FAD-2H formation in EcE3C45A/K54Q by UPLC-ESI-TOF-MS. 
Comparison of unbleached (black) and photobleached EcE3C45A/K54Q (red). Extracted ion 
chromatograms (left) and corresponding MS analyses in negative ionization mode (right) of heat 
extracted samples (A), of TCA extracted samples (B) and of acetone extracted samples (C). 
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Figure 5.15 Ribityl-ADP-2H formation in EcE3C45A/K54Q by UPLC-ESI-TOF-MS. 
Comparison of unbleached (black) and photobleached EcE3C45A/K54Q (red). Extracted ion 
chromatograms (left) and corresponding MS analyses in negative ionization mode (right) of heat 
extracted samples (A), of TCA extracted samples (B) and of acetone extracted samples (C). 
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Figure 5.16 UHPLC-ESI-QTOF-MS/MS analysis of FAD and FAD-2H. 
Extracted from photobleached EcE3C45A/K54Q. 
MS/MS fragmentation pattern at 20 eV collision energy at m/z 784.150 (black) 

















































5.10 Redox Potentials of selected EcE3 Variants 
Determination of the flavin redox potentials was performed as described in 2.2.2.9 
     Table 5.2 Redox potentials of relevant enzymes 





























































































































Figure 5.17 Determination of the redox potential of EcE3C45A/K54Q 
Reduction of the enzyme (A) and of phenosafranin (B) under anaerobic conditions with 
dithionite. (C) Reduction of enzyme and dye under the same conditions. (D) Nernst analysis of 
the absorbance changes of the enzyme and dye according to 2.2.2.9. 


















































































































Figure 5.18 Determination of the redox potential of EcE3C50A. 
Reduction of the enzyme (A) and of neutral red (B) under anaerobic conditions with dithionite. 
(C) Reduction of enzyme and dye under the same conditions. (D) Nernst analysis of the 












































































































Figure 5.19 Determination of the redox potential of EcE3C45S/C50S. 
Reduction of the enzyme (A) and of methyl viologen (B) under anaerobic conditions with 
dithionite. (C) Reduction of enzyme and dye under the same conditions. (D) Nernst analysis of 
the absorbance changes of the enzyme and dye according to 2.2.2.9. 
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5.11 Isothermal Titration Calorimetry 
ITC experiments were performed according to 2.2.5.3. 
 
  
Figure 5.20 Titration of EcLip3 to EcE3. 
Both enzymes were desalted into the same buffer 
(50 mM KPP pH 7.6, 100 mM NaCl). The ITC cell 
was filled with 100 µM (active sites) EcE3. The 
injection syringe was filled with 1 mM of EcLip3 
Measurements were performed at 20 °C with a 
stirring speed of 500 min
-1
. A titration of 1 mM 
EcLip3 into buffer served as control to check for heat 
effects due to dilution (red). 
 
 










 was dissolved in 50 mM KPP pH 7.6, 
100 mM NaCl. The ITC cell was filled with 144 µM 
(active sites) enzyme, respectively. The injection 
syringe was filled with 2 mM of NAD
+
 solution. 
Measurements were performed at 20 °C with a 
stirring speed of 500 min
-1
. 
The inset shows a putative interaction between Gln54 














































5.12 Crystallographic Tables 
Table 5.3 Crystallographic data and refinement statistics. 
The highest resolution shell is shown in parenthesis. 
 EcE3 ground state EcE3 + NAD
+
 EcE3C45S 
Data collection BESSYII PETRAIII PETRAIII 
Wavelength (Å) 0.91841 0.82480 0.92012 
Space Group P212121 P212121 I422 
Cell dimensions    
a (Å) 111.68 112.59 179.90 
b (Å) 129.32 129.58 179.90 
c (Å) 258.34 257.46 197.17 
ɑ (°) 90.0 90.0 90.0 
β (°) 90.0 90.0 90.0 
γ (°) 90.0 90.0 90.0 







No. of reflections 743377 403884 1338625 
No. of unique 
reflections 
198344 103624 51245 
Completeness (%) 99.8 (99.9) 98.5 (98.9) 99.7 (98.8) 
I/sigma (I) 19.3 (2.7) 16.6 (2.6) 34.2 (6.7) 
Rmerge (%) 5.5 (61.8) 6.4 (69.2) 8.9 (62.7) 
CC1/2 99.9 (73.3) 99.8 (70.3) 100.0 (96.8) 





44.36 62.28 46.02 
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 EcE3 ground state EcE3 + NAD
+
 EcE3C45S 
Refinement PHENIX PHENIX PHENIX 
Resolution Range 
(Å) 
42.51-2.17 47.92-2.69 45.96-2.57 
Monomers per AU 6 6 2 
Reflections 198214 103540 51228 
Rwork / Rfree (%) 17.7 / 20.8 17.6 / 22.1 23.3 / 27.4 
Number of atoms    
protein 21417 21303 7103 
ligands 569 466 192 
water 1752 24 78 
B-factor protein 38.89 66.29 97.81 
B-factor ligands 41.65 66.42 105.32 
B-factor water 40.42 54.13 74.32 
Deviations from 
ideals (r.m.s.d) 
   
Bond distances (Å) 0.006 0.010 0.012 
Bond angles (°) 1.083 1.271 1.331 
Dihedrals (°) 13.902 15.926 17.072 
Ramachandran plot    
favoured regions (%) 96.73 98.12 88.47 
allowed regions (%) 3.24 1.88 8.51 



















2.7  3.8  
FAD
Figure 5.22 The placeholder ability of sulfate ions serving as precipitant.  
Top views on the re face of the flavin showing the nucleotide binding site. (A) Cartoon 
representation of EcE3 in ground state showing the presence of a sulfate ion at the 
NAD-binding site. A superposition with the human E3 structure in complex with NAD
+
 
(PDB: 1ZMC) confirms the placeholder abilities of the precipitant. For convenience 
only the nucleotide is presented. (B) Repeating motive of the precipitant in the adduct 
structure. 2mFo-DFc maps are countered at 2  (blue mesh), respectively. 
Figure 5.23 Further bending of the flavin 
cofactor at the two-electron reduced state. 
Ball and stick representation of the FADs from 
EcE3 at ground state (yellow) and in EcE3C45S 
(orange). The dimethylbenzene part is ~1.3 ° 
further bent compared to the wild type FAD 
indicating its altered electronic state. 






Figure 5.24 B-factor representation of the EcE3 active site at 2.69 Å. 
Atoms of the redox active  cystine and the flavin cofactor are color-coded according to their 
individual B-factors. Both cysteine residues in molecule A (A) and in molecule F (B) of the 










































Figure 5.25 Active site of EcE3 at 2.69 Å.  
Simulated annealing OMIT maps for all molecules in the asymmetric unit (mFo-DFc at 
3 ). Figure numbering reflects the respective molecule label. Cohesive density is present 
in chain A and chain F, suggesting the formation of a covalent adduct. 
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